{"add": {"doc": {"field": [{"@name": "docid", "#text": "BR-TU.13441"}, {"@name": "filename", "#text": "19409_Jackeline%20da%20Costa%20Maciel_TESE.pdf"}, {"@name": "filetype", "#text": "PDF"}, {"@name": "text", "#text": "UNIVERSIDADE FEDERAL DE PERNAMBUCO \n\nCENTRO DE CI\u00caNCIAS BIOL\u00d3GICAS \n\nPROGRAMA DE P\u00d3S-GRADUA\u00c7\u00c3O EM CI\u00caNCIAS BIOL\u00d3GICAS \n\n \n\n \n\n \n\n \n\n \n\nJACKELINE DA COSTA MACIEL \n\n \n\n \n\n \n\nCOMP\u00d3SITOS DE PART\u00cdCULAS MAGN\u00c9TICAS E POL\u00cdMEROS PARA \nIMOBILIZA\u00c7\u00c3O DE TRIPSINA  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n \n \n \n \n \n\nRecife \n2012 \n\nTese apresentada ao Programa de P\u00f3s-Gradua\u00e7\u00e3o em \nCi\u00eancias Biol\u00f3gicas para obten\u00e7\u00e3o do t\u00edtulo de Doutora em \nCi\u00eancias Biol\u00f3gicas pela Universidade Federal de \nPernambuco. \n\nOrientador: Prof. Dr. Luiz Bezerra de Carvalho J\u00fanior \n\nCo-orientadora: Profa. Dra. Maria da Paz Carvalho da Silva \n\nCo-orientador: Prof. Dr. David Fernando Morais Neri \n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\nElaine Barroso \nCRB 1728 \n\n \n \n \n \n\nMaciel, Jackeline da Costa \n      Comp\u00f3sitos de part\u00edculas magn\u00e9ticas e pol\u00edmeros para imobiliza\u00e7\u00e3o \nde tripsina/ Jackeline da Costa Maciel. \u2013 Recife: O Autor, 2012. \n        \n      104 folhas : il., fig., tab. \n\n Orientador: Luiz Bezerra de Carvalho J\u00fanior \n         Coorientadores: Maria da Paz Carvalho da Silva e David \n\nFernando Morais Neri \n Tese (doutorado) \u2013 Universidade Federal de Pernambuco, \n\nCentro de Ci\u00eancias Biol\u00f3gicas. Ci\u00eancias Biol\u00f3gicas, 2012. \nInclui bibliografia e anexos \n\n \n1. Enzimas 2. Biotecnologia 3. Pol\u00edmeros I.  Carvalho J\u00fanior, \n\nLuiz Bezerra de (orientador) II. Silva, Maria da Paz Carvalho da \n(coorientadora) III. Neri, David Fernando Morais IV. T\u00edtulo \n\n \n                                             \n572.7             CDD (22.ed.)                UFPE/CCB-2012-211                                                           \n                               \n\n \n \n \n \n \n \n \n \n \n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\nJACKELINE DA COSTA MACIEL \n\n \n\nCOMP\u00d3SITOS DE PART\u00cdCULAS MAGN\u00c9TICAS E POL\u00cdMEROS PARA \nIMOBILIZA\u00c7\u00c3O DE TRIPSINA \n\n \n\n \n\nTese apresentada ao Programa de P\u00f3s-Gradua\u00e7\u00e3o em Ci\u00eancias Biol\u00f3gicas para obten\u00e7\u00e3o do t\u00edtulo de \nDoutora em Ci\u00eancias Biol\u00f3gicas (\u00c1rea de concentra\u00e7\u00e3o Biotecnologia) pela Universidade Federal \nde Pernambuco. \n\n \n\nAprovada em 26 de julho de 2012 pela banca examinadora: \n\n \n \n\n  \nProf. Dr. Luiz Bezerra de Carvalho J\u00fanior \n\nDepartamento de Bioqu\u00edmica/UFPE \nOrientador e Presidente da banca \n\n \n \n \n\nProfa. Dra. Adriana Fontes \nDepartamento de Biof\u00edsica e Radiobiologia/UFPE \n\nExaminadora \n \n \n\n \nProfa. Dra. Maria Danielly Lima de Oliveira \n\nDepartamento de Bioqu\u00edmica/UFPE \nExaminadora \n\n \n \n \n\nProf. Dr. Jos\u00e9 Luiz de Lima Filho \nDepartamento de Bioqu\u00edmica/UFPE \n\nExaminador \n \n \n \n\nDr. Ian Porto Gurgel do Amaral \nPesquisador do Departamento de Bioqu\u00edmica/UFPE \n\nExaminador \n \n  \n\n \n \n \n\n\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\nPara minha av\u00f3, Orminda (in memorian),  \n\npelo amor incondicional que sempre demonstrou por mim.  \n\n \n\nPara minha m\u00e3e, M\u00e1rcia, pelo grande exemplo de m\u00e3e e mulher. \n\n \n\nPara meu pai, Ronaldo, por tudo que me ensinou. \n\n \n\nPara o grande amor da minha vida, Humberto,  \n\npor ser essa pessoa maravilhosa e que eu amo tanto. \n\n \n\n\n\nAGRADECIMENTOS \n\nGostaria de agradecer a todos aqueles que colaboraram direta ou indiretamente para a realiza\u00e7\u00e3o \ndeste trabalho. \n \nAo meu orientador, Prof. Luiz Bezerra de Carvalho J\u00fanior, pela paci\u00eancia e confian\u00e7a depositados \nao longo desses quatro anos. \n \n\u00c0 minha co-orientadora, Profa. Maria da Paz Carvalho da Silva, pela amizade, respeito e \ncredibilidade desde a inicia\u00e7\u00e3o cient\u00edfica. \n \nAo meu co-orientador, Prof. David Fernando Morais Neri, pela disponibilidade e ajuda na \npublica\u00e7\u00e3o do meu primeiro artigo como \u201cprimeira-autora\u201d. \n \nAo Prof. Jos\u00e9 Albino Aguiar (Departamento de F\u00edsica, UFPE), pela colabora\u00e7\u00e3o valiosa e \ncredibilidade. \n \nAo Prof. Cl\u00e1udio Ant\u00f4nio Cardoso (Departamento de F\u00edsica, UFSCar), pelas an\u00e1lises de \nmagnetometria e pelas discuss\u00f5es esclarecedoras. \n \n\u00c0 Profa. Maristela Olzon-Dionysio (Departamento de F\u00edsica, UFSCar) e a Willian Takemitsu \nShigeyosi (Doutorando em F\u00edsica, UFSCar), pelas an\u00e1lises de M\u00f6ssbauer e por toda ajuda na \ninterpreta\u00e7\u00e3o dos resultados. \n \n\u00c0 Profa. M\u00e1rcia Attias, ao Prof. Kildare Miranda e ao MSc. Thiago Luiz Moreira (Laborat\u00f3rio de \nUltraestrutura Celular Herta Meyer, UFRJ), pelas an\u00e1lises de microscopia eletr\u00f4nica de transmiss\u00e3o \ne pelos relat\u00f3rios exemplares disponibilizados. \n \nAo CNPq e \u00e0 FACEPE, pelo apoio financeiro concedido. \n \nAo Laborat\u00f3rio de Imunopatologia Keizo Asami (LIKA), pela infraestrutura fornecida para \nrealiza\u00e7\u00e3o dos experimentos. \n \nAos amigos do Grupo IMOBIO, pelo clima de amizade e coleguismo sempre presentes. \n \n\u00c0 minha amiga, Mariana Paola Cabrera, pela amizade, carinho e disponibilidade em todos os \nmomentos e por ter-me \u201caguentado\u201d t\u00e3o pacientemente todas \u00e0s vezes que lhe pedi \u201csocorro\u201d para \ncompreender algo que, muitas vezes, parecia incompreens\u00edvel. \n \n\u00c0s minhas amigas, Priscyla Lima de Andrade e Valdeene Albuquerque Jansen da Silva, pela \namizade, momentos de descontra\u00e7\u00e3o e por nossas colabora\u00e7\u00f5es cient\u00edficas em todos esses anos. \n \nA TODOS os meus queridos amigos, pela amizade e bons momentos compartilhados. \n \nAos meus irm\u00e3os, cunhados e cunhadas, tios e tias, av\u00f4, primos e primas e \u00e0 minha exclusiv\u00edssima \nsobrinha Brenda Laryssa, pela for\u00e7a e pelo apoio dados desde que cada um come\u00e7ou a fazer parte \nda minha vida. \n \nAos meus pais, M\u00e1rcia e Ronaldo, pelo amor, confian\u00e7a e apoio sempre incondicionais. \n \nAo meu esposo, Humberto Silva, pela amizade, carinho, paci\u00eancia, companheirismo e acima de \ntudo amor. Amo voc\u00ea! \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\u201c... Um trabalho cient\u00edfico n\u00e3o deve ser avaliado do ponto de vista de sua utilidade direta.  \n\nEle precisa ser feito por si s\u00f3, pela beleza da ci\u00eancia.\u201d \n\n \n\nMarie Curie (1867\u20131934) \n\n  \n\n\n\nResumo \n \nAs enzimas s\u00e3o muito utilizadas em processos industriais; ent\u00e3o, a busca por novas tecnologias, que \npermitam o uso otimizado dessas biomol\u00e9culas, confere redu\u00e7\u00e3o dos custos e permite melhor \nrendimento da enzima. Uma das alternativas para isso consiste na imobiliza\u00e7\u00e3o dessas prote\u00ednas em \nsuportes insol\u00faveis. Dentre os diferentes tipos de suportes existentes, os comp\u00f3sitos de \nnanopart\u00edculas magn\u00e9ticas e pol\u00edmeros apresentam algumas vantagens, tais como: oferecem maior \n\u00e1rea superficial para liga\u00e7\u00e3o da enzima devido ao reduzido tamanho; permitem a r\u00e1pida separa\u00e7\u00e3o \nutilizando apenas um campo magn\u00e9tico externo e a presen\u00e7a do revestimento polim\u00e9rico contribui \ncom grande quantidade de grupos funcionaliz\u00e1veis. Embora se conhe\u00e7am todas as ferramentas, \u00e9 \npreciso escolher as mais adequadas para a aplica\u00e7\u00e3o desejada. Neste trabalho, foram produzidos \ncomp\u00f3sitos de part\u00edculas magn\u00e9ticas e pol\u00edmeros. Dois tipos de pol\u00edmeros foram utilizados, o \npolissacar\u00eddeo levana e o pol\u00edmero sint\u00e9tico polianilina (PANI). Nosso objetivo foi obter derivados \nenzim\u00e1ticos com boa reten\u00e7\u00e3o de atividade. O comp\u00f3sito de part\u00edculas magn\u00e9ticas e levana foi \nobtido pelo m\u00e9todo de co-precipita\u00e7\u00e3o na presen\u00e7a do polissacar\u00eddeo. Para produ\u00e7\u00e3o do comp\u00f3sito \ncom PANI, o pol\u00edmero s\u00f3 foi adicionado ap\u00f3s a s\u00edntese das part\u00edculas magn\u00e9ticas por co-\nprecipita\u00e7\u00e3o. O processo de revestimento das part\u00edculas magn\u00e9ticas com PANI foi otimizado por \nmeio do uso de dois planejamentos fatoriais completos (23). Propriedades f\u00edsicas, qu\u00edmicas e \nmagn\u00e9ticas de ambos os comp\u00f3sitos foram determinadas atrav\u00e9s de t\u00e9cnicas de microscopia \neletr\u00f4nica, FTIR, difra\u00e7\u00e3o de raios-X, espectroscopia M\u00f6ssbauer, \u00e1rea de superf\u00edcie BET e \nporosidade e medidas de magnetiza\u00e7\u00e3o. Os resultados mostraram que as part\u00edculas magn\u00e9ticas \nsintetizadas, na aus\u00eancia do pol\u00edmero, possuem menores tamanhos e estrutura cristalina bem \ndefinida. Ambos comp\u00f3sitos foram utilizados para imobiliza\u00e7\u00e3o de tripsina. No caso do comp\u00f3sito \nde part\u00edculas magn\u00e9ticas e levana, ap\u00f3s dez reutiliza\u00e7\u00f5es, o derivado enzim\u00e1tico exibiu 84% de sua \natividade inicial. Em rela\u00e7\u00e3o, a tripsina imobilizada em comp\u00f3sito de part\u00edculas magn\u00e9ticas e PANI, \no derivado enzim\u00e1tico apresentou maior estabilidade t\u00e9rmica em temperaturas acima de 25C\u00b0; \nmaior afinidade pelo substrato BAPNA (Kmap 1,4 vezes menor que aquele para enzima sol\u00favel); \npequena redu\u00e7\u00e3o na efici\u00eancia catal\u00edtica (1,1 vezes menor que aquele para enzima sol\u00favel); reten\u00e7\u00e3o \nde 89% de sua atividade inicial ap\u00f3s 48 dias de estocagem a 4\u00b0C e reten\u00e7\u00e3o de 81% de sua atividade \ninicial ap\u00f3s vinte reutiliza\u00e7\u00f5es. Tanto o comp\u00f3sito magn\u00e9tico com PANI quanto aquele com levana \napresentaram bom resultado quanto \u00e0 reten\u00e7\u00e3o da atividade da enzima imobilizada, sendo o \nderivado com PANI o de menor custo. \n \n \n \nPalavras-chave: part\u00edculas magn\u00e9ticas, levana, polianilina, imobiliza\u00e7\u00e3o, tripsina \n\n \n \n\n \n\n  \n\n\n\nAbstract \n \n\nEnzymes are widely used in industrial processes, so the search for new technologies that allow the \noptimal use of these biomolecules, provides reduced costs and allow better use of the enzyme. An \nalternative to this is the immobilization of these proteins on insoluble supports. Among the different \ntypes of existing supports, the composite magnetic nanoparticles and polymers have certain \nadvantages such as providing greater surface area for binding of the enzyme due to the reduced size; \nallow rapid separation using only an external magnetic field and the presence of the polymeric \ncoating contributes large amounts of functional groups. Although you can learn all the tools you \nneed to choose the most appropriate for the desired application. In this paper, were produced \ncomposite magnetic particles and polymers. Two types of polymers were used: the polyaniline \n(PANI) and the polysaccharide levan. Our goal was to obtain enzymatic derivatives with good \nretention of activity. The composite magnetic particles and levan was produced by co-precipitation \nin the presence of the polysaccharide. For production of the composite with PANI, the polymer was \nonly added after synthesis of the magnetic particles by co-precipitation. The process of coating \nmagnetic particles with PANI was optimized by using two full factorial design (23). Physical, \nchemical and magnetic properties of both composites were determined by electron microscopy, \nFTIR, X-ray diffraction, M\u00f6ssbauer spectroscopy, BET surface area and porosity, and \nmagnetization measurements. The results showed that the magnetic particles synthesized in the \nabsence of polymer exhibit lower sizes and have well defined crystal structure. Both composites \nwere used for immobilization of the trypsin. In the case of the composite of magnetic particles and \nlevan, after ten reuses, the enzymatic derivative exhibited 84% of its initial activity. Regarding the \nimmobilized trypsin on composite of magnetic particles and PANI, the enzymatic derivative had \ngreater thermal stability at temperatures up to 25\u00b0C, greater affinity for the substrate BAPNA (Kmap \n1.4 times lower than that for the soluble enzyme), a slight decrease in catalytic efficiency (1.1 times \nlower than that for soluble enzyme), retaining 89% of its initial activity after 48 days of storage at \n4\u00b0C and retaining 81% of its initial activity after twenty reuses. The two magnetic composites \nshowed good results with regard to retention of activity of the immobilized trypsin, and the PANI \nderivative with the lowest cost. \n \n\nKeywords: magnetic particles, levan, polyaniline, immobilization, trypsin \n \n\n \n\n  \n\n\n\nLISTA DE ILUSTRA\u00c7\u00d5ES \n \n\nCap\u00edtulo 1 \n \nFigura 1. Mol\u00e9cula de tripsina. Em vermelho, liga\u00e7\u00f5es dissulfeto.......................................... \n\n \n03 \n\n  \nFigura 2. M\u00e9todos de imobiliza\u00e7\u00e3o de enzimas. Representa\u00e7\u00e3o esquem\u00e1tica da enzima (em \nazul) e do suporte (em roxo).................................................................................................... \n\n05 \n\n  \nFigura 3. Intera\u00e7\u00e3o entre suporte e enzima.............................................................................. 06 \n  \nFigura 4. Procedimento de extra\u00e7\u00e3o em fase s\u00f3lida magn\u00e9tica............................................... \n \n\n09 \n\nFigura 5. Representa\u00e7\u00e3o do octaedro de ferro (a) e sua polimeriza\u00e7\u00e3o pelo \u00e1pice (b), aresta (c) \ne face (d).............................................................................................................................. \n \n\n \n10 \n\nFigura 6. Estrutura de espin\u00e9lio inversa da magnetita. (a) ilustra\u00e7\u00e3o de c\u00e9lula unit\u00e1ria c\u00fabica; \n(b) organiza\u00e7\u00e3o ferrimagn\u00e9tica na magnetita; lustra\u00e7\u00e3o do plano [1, 1, 1].................. \n\n \n12 \n\n  \nFigura 7. Representa\u00e7\u00e3o esquem\u00e1tica da superf\u00edcie de nanopart\u00edculas magn\u00e9ticas (Fe3O4) \ncom e sem revestimento org\u00e2nico na presen\u00e7a de um campo magn\u00e9tico aplicado. As setas \nrepresentam o momento ferrimagn\u00e9tico resultante...................................................................  \n\n \n \n\n14 \n  \nFigura 8. Estrutura qu\u00edmica da levana..................................................................................... 15 \n\n \nFigura 9. Desenho esquem\u00e1tico de um \u201cnanobead\u201d magn\u00e9tico que aprisiona mol\u00e9culas de \nenzima em sua camada de s\u00edlica............................................................................................... \n\n \n20 \n\n  \nFigura 10. Aplica\u00e7\u00f5es m\u00e9dicas de nanopart\u00edculas magn\u00e9ticas................................................  21 \n  \n \nCap\u00edtulo 2 \n\n \nFigure 1. Pareto chart for the effects of variables KMnO4 concentration (a), aniline \nconcentration (b) and polymerization time (c) on residual specific activity of mPANIG-\nTrypsin from 1st factorial design.................................................................................................   \n\n \n \n\n46 \n  \nFigure 2. Pareto chart for the effects of variables contact time of KmnO4 (d), polymerization \ntemperature \u20ac and offered protein (f) on residual specific activity of mPANIG-Trypsin from \n2nd factorial design.......................................................................................................................   \n\n \n \n\n47 \n  \nFigure 3. Thermal stability of the mPANIG-Trypsin (B). The obtained activities were \nreferred to the highest activity (100%)\u2026\u2026\u2026\u2026\u2026\u2026\u2026\u2026........................................................ \n\n \n49 \n\n  \nFigure 4. Shelf life of mPANIG-Trypsin at 4\u00b0C stored in Tris-HCl buffer................................ 50 \n  \n  \n\n\n\nCap\u00edtulo 3 \n \nFigure 1. Electron microscopic images. TEM image of (A) magnetic nanoparticles and SEM \nimages of (B) magnetic nanoparticles, (C) mPANI (lower resolution), (D) mPANI (higher \nresolution)......................................................................................................................................  \n\n \n \n \n \n62 \n \n\nFigure 2. FTIR spectra of magnetic nanoparticles and mPANI..................................................  64 \n  \nFigure 3. Nitrogen adsorption/desorption isotherms of magnetic nanoparticles and mPANI..... 65 \n\nFigure 4. XRD patterns of magnetic nanoparticles and mPANI................................................. 66 \n  \nFigure 5. M\u00f6ssbauer spectra of (A) magnetic nanoparticles and (B) mPANI............................. 67 \n  \nFigure 6. Magnetization curves of magnetic nanoparticles and mPANI at 298 K and 323 K..... 69 \n\n \nFigure 7. Specific activity of mPANIG-Trypsin. The immobilized trypsin on mPANIG was \nincubated with a 4 mM initial concentration of BAPNA and Tris-HCl buffer. After each cycle, \nthe derivative were washed before new step.................................................................................  \n\n \n \n\n70 \n \n \n\nCap\u00edtulo 4 \n \nFigura 1. Scanning electron microscopy images of magnetite (A) and magnetic levan (B) \nparticles........................................................................................................................................  \n\n \n80 \n\n  \nFigura 2. Magnetization curves of magnetite (A) and magnetic levan (B) particles at 293 K \nand 313 K....................................................................................................................................  \n\n \n81 \n\n  \nFigura 3. X-ray powder diffraction patterns of magnetite and magnetic levan particles..........  81 \n\nFigura 4. FTIR spectra of the levan polysaccharide (A), magnetic levan (B) and magnetite \n(C)............................................................................................................................................... \n\n \n82 \n\n  \nFigura 5. Re-utilization of immobilized trypsin (?) and magnetic levan (?) particles. The \nmaximum specific activity of enzyme (100%) was 20.65\u00b10.69 mU/mg for trypsin \nimmobilized on magnetic levan and 18.59\u00b10.08 mU/MG for trypsin immobilized on \nmagnetite.....................................................................................................................................  \n\n \n \n \n\n82 \n \n\n  \n\n\n\nLISTA DE TABELAS  \n \n\nCap\u00edtulo 1 \n \nTabela 1. Fatores que influenciam o desempenho de um sistema de enzima imobilizada............. 07 \n  \nTabela 2. Os tr\u00eas estados de oxida\u00e7\u00e3o mais importantes da polianilina: leucoesmeraldina, \nesmeraldina (isolante e condutora) e pernigranilina................................................................... \n \n\n \n18 \n\n \nCap\u00edtulo 2 \n\n \nTable 1. Matrix of experiments and results for 1st factorial design........................................... 45 \n\n \nTable 2. Main and interaction effects for the 1st complete factorial design\u2026\u2026\u2026..................... \n \n\n45 \n \n\nTable 3. Matrix of experiments and results for 2nd factorial design........................................... 47 \n  \nTable 4. Main and interaction effects for the 2nd complete factorial design \u2026........................... \n \n\n48 \n\nTable 5. Identified peptide residues obtained from 15 min digestion using mPANIG-Trypsin... 51 \n\n \n \nCap\u00edtulo 3 \n\n \nTable 1. Analyzed results of M\u00f6ssbauer spectra for magnetic nanoparticles and mPANI. Bhf: \nhyperfine field; ?: quadrupole splitting; ?: isomer shift relative to the isomer shift of ?-iron at \nroom temperature............................................................................................................................ \n\n \n \n\n68 \n\n \n\n  \n\n \n\n \n\n \n\n  \n\n\n\nLISTA DE ABREVIATURAS E SIGLAS  \n\n \n \n\nmPANI  comp\u00f3sito de nanopart\u00edculas magn\u00e9ticas e polianilina \nT  Temperatura \nM  Magnetiza\u00e7\u00e3o \nH  Campo magn\u00e9tico \nT  tesla \nnm   nan\u00f4metro \n\u00b5m   micr\u00f4metro \n\u00b0C   Grau celsius \npH   Potencial hidrogeni\u00f4nico \nTris   Tris (hidroximetil) aminometano \nDRX   Difra\u00e7\u00e3o de raios-X \nXDR   X-ray Diffractometry \nMEV   Microscopia Eletr\u00f4nica de Varredura \nSEM   Scanning Electron Microscopy \nIV   Infravermelho \nFTIR  Fourier Transform Infrared \nKm   Constante de Michaelis-Menten \nVmax   Velocidade m\u00e1xima \n2?  \u00c2ngulo de espalhamento (graus) \n?  Comprimento de onda \nK  kelvin \nOe  oersted \nKOe  kilooersted \ncm-1  n\u00famero de ondas \nmg  miligrama \natm  atmosfera \nemu  unidade eletromagn\u00e9tica \ng  grama \nmin  minuto \nh  hora \nM  molar \nmM  milimolar \nmL  mililitro \n\u00b5L  microlitro \n\u00b5mol  micromol \nU  unidade \nBhf  campo hiperfino \n?  desdobramento quadrupolar \n?  deslocamento isom\u00e9rico \n  \n\n\n\nxii \n\n \n\nSUM\u00c1RIO \n \n\n1. Introdu\u00e7\u00e3o................................................................................................................... 01 \n  \nCap\u00edtulo 1  \n2. Revis\u00e3o Bibliogr\u00e1fica...................................................................................................... 03 \n2.1. Enzimas proteol\u00edticas ou proteases............................................................................... 03 \n2.2. Imobiliza\u00e7\u00e3o de enzimas em suportes insol\u00faveis............................................................ 04 \n   2.2.1. Classifica\u00e7\u00e3o das enzimas imobilizadas.................................................................... 04 \n   2.2.2. M\u00e9todos de imobiliza\u00e7\u00e3o de enzimas........................................................................ 05 \n   2.2.3. Suportes para a imobiliza\u00e7\u00e3o de enzimas.................................................................. 06 \n   2.2.4. Vantagens e limita\u00e7\u00f5es da imobiliza\u00e7\u00e3o de enzimas................................................. 07 \n2.3. Sistemas de imobiliza\u00e7\u00e3o de biomol\u00e9culas: part\u00edculas magn\u00e9ticas................................. 08 \n   2.3.1. \u00d3xidos de ferro: os principais tipos de n\u00facleo magn\u00e9tico......................................... 09 \n   2.3.2. Magnetita e maghemita: os \u00f3xidos de ferro mais utilizados......................................  11 \n2.4.  Estabilidade de part\u00edculas magn\u00e9ticas............................................................................ 14 \n   2.4.1. Polissacar\u00eddeos como revestimento: levana.............................................................. 15 \n   2.4.2. Pol\u00edmeros org\u00e2nicos sint\u00e9ticos como revestimento: polianilina................................ 16 \n2.5. Aplica\u00e7\u00f5es de part\u00edculas magn\u00e9ticas na \u00e1rea biom\u00e9dica e biotecnol\u00f3gica...................... 18 \n   2.5.1. Imagem por resson\u00e2ncia magn\u00e9tica (IRM)............................................................... 19 \n   2.5.2. Separa\u00e7\u00e3o magn\u00e9tica................................................................................................. 19 \n   2.5.3. Imobiliza\u00e7\u00e3o de enzimas........................................................................................... 19 \n   2.5.4. Hipertermia magn\u00e9tica.............................................................................................. 20 \n   2.5.5. Carreador de f\u00e1rmacos............................................................................................... 21 \n   2.5.6. Chips de c\u00e9lulas............................................................................................... 21 \n  \n3. Refer\u00eancias bibliogr\u00e1ficas.................................................................................................. 23 \n  \nCap\u00edtulo 2  \n4. Artigo submetido ao peri\u00f3dico Analytica Chimica Acta.................................................... 38 \n  \nCap\u00edtulo 3  \n5. Artigo submetido ao peri\u00f3dico Composites Science and Technology............................... 55 \n  \nCap\u00edtulo 4  \n6. Artigo publicado no peri\u00f3dico Journal of Magnetism and Magnetic Materials................ 78 \n  \n7. Conclus\u00f5es.......................................................................................................................... 84 \n  \n8. Anexos................................................................................................................................ 85 \n8.1. Instru\u00e7\u00f5es para autores.................................................................................................... 85 \n8.2. Comprova\u00e7\u00e3o da submiss\u00e3o dos artigos.......................................................................... 100 \n   8.2.1. Artigo submetido ao peri\u00f3dico Analytica Chimica Acta........................................... 100 \n   8.2.2. Artigo submetido ao peri\u00f3dico Composites Science and Tecnology......................... 101 \n8.3. Artigos publicados em peri\u00f3dicos................................................................................... 102 \n8.4. Artigos a serem submetidos............................................................................................. 102 \n8.5. Trabalhos apresentados em congressos........................................................................... 102 \n8.6. Participa\u00e7\u00e3o em bancas examinadoras............................................................................ 103 \n8.7. Orienta\u00e7\u00f5es e colabora\u00e7\u00f5es............................................................................................. 104 \n \n\n  \n\n\n\n1 \n\n \n\n1. Introdu\u00e7\u00e3o \n\nA prote\u00f3lise \u00e9 uma das etapas mais importantes para o sequenciamento de prote\u00ednas em \n\npesquisa prote\u00f4mica (PARKER e TOMER, 2000; WANG, 2002), sendo a tripsina a enzima \n\nproteol\u00edtica mais utilizada nessa etapa. A imobiliza\u00e7\u00e3o dessas enzimas em suportes insol\u00faveis visa \n\ndiminuir o longo tempo de digest\u00e3o quando comparado \u00e0 enzima em sua forma sol\u00favel. As \n\nvantagens das enzimas imobilizadas, em rela\u00e7\u00e3o \u00e0s sol\u00faveis, surgem de sua maior estabilidade e \n\nfacilidade de separa\u00e7\u00e3o do meio de rea\u00e7\u00e3o, o que acarreta economia significativa no custo global do \n\nprocesso (BON et al., 2008). \n\nAs propriedades das prepara\u00e7\u00f5es de enzimas imobilizadas s\u00e3o influenciadas pelas \n\npropriedades da enzima e do material do suporte (TISCHER e KASCHE, 1999). A intera\u00e7\u00e3o entre \n\nesses dois componentes proporciona um derivado imobilizado com propriedades qu\u00edmicas, \n\nbioqu\u00edmicas, mec\u00e2nicas e cin\u00e9ticas espec\u00edficas. A imobiliza\u00e7\u00e3o da enzima tem um efeito ben\u00e9fico \n\nna sua estabilidade, em fun\u00e7\u00e3o das intera\u00e7\u00f5es f\u00edsicas e qu\u00edmicas entre o suporte e as mol\u00e9culas da \n\nenzima (DE CASTRO e ANDERSON, 1995; VILLENEUVE et al., 2000). Diferentes tipos de \n\nmateriais t\u00eam sido usados como suportes para imobiliza\u00e7\u00e3o de enzimas, entre eles os suportes que \n\npossuem propriedade magn\u00e9tica. Al\u00e9m de serem utilizadas como adsorventes em separa\u00e7\u00e3o \n\nmagn\u00e9tica, essas part\u00edculas, dentro da escala nanom\u00e9trica \u00e0 microm\u00e9trica, est\u00e3o sendo usadas em \n\num n\u00famero crescente de aplica\u00e7\u00f5es m\u00e9dicas devido a n\u00e3o toxicidade (ITO et al., 2005; TOKORO et \n\nal., 2009). \n\n\u00d3xidos de ferro com estrutura \u201ccore/shell\u201d s\u00e3o os mais usados como fontes de materiais \n\nmagn\u00e9ticos (DRBOHLAVOVA et al., 2009). Este tipo de estrutura consiste em part\u00edculas \n\nmagn\u00e9ticas formadas por um n\u00facleo magn\u00e9tico (\u201ccore\u201d) e um revestimento (\u201cshell\u201d). No entanto, \n\nsomente maghemita e magnetita encontraram maior interesse em bioaplica\u00e7\u00f5es (TUCEK et al., \n\n2006). V\u00e1rios procedimentos sint\u00e9ticos foram desenvolvidos para sintetizar nanopart\u00edculas de \u00f3xido \n\nde ferro (AH et al., 2007), sendo o m\u00e9todo de co-precipita\u00e7\u00e3o o procedimento mais simples, barato \n\ne ecologicamente correto, que envolve a precipita\u00e7\u00e3o simult\u00e2nea de \u00edons Fe2+ e Fe3+ em meio \n\naquoso b\u00e1sico (KANG et al., 1996; QU et al., 1999).  \n\nAs nanopart\u00edculas de \u00f3xido de ferro apresentam alta sensibilidade magn\u00e9tica e baixa \n\ntoxicidade, por\u00e9m pequena estabilidade coloidal na fase aquosa. Modifica\u00e7\u00f5es da superf\u00edcie dessas \n\npart\u00edculas representam um ponto-chave para impedir a agrega\u00e7\u00e3o e para torn\u00e1-las altamente \n\nmonodispersas (SAWANT et al., 2009). Para melhorar a estabilidade e biocompatibilidade, \n\nnanopart\u00edculas de \u00f3xido de ferro s\u00e3o frequentemente modificadas com alguns surfactantes ou \n\npol\u00edmeros (BERRY et al., 2003). O uso de um revestimento de superf\u00edcie adequado permite que \n\nessas nanopart\u00edculas sejam dispersas dentro de fluidos homog\u00eaneos e melhorem sua estabilidade. \n\nV\u00e1rios grupos de materiais de revestimento s\u00e3o usados para modificar a superf\u00edcie qu\u00edmica de \n\n\n\n2 \n\n \n\nnanopart\u00edculas magn\u00e9ticas (SHUBAYEV et al., 2009) tais como pol\u00edmeros org\u00e2nicos, surfactantes \n\norg\u00e2nicos, metais inorg\u00e2nicos, \u00f3xidos inorg\u00e2nicos, mol\u00e9culas e estruturas bioativas. \n\nO objetivo deste trabalho foi produzir derivados enzim\u00e1ticos magn\u00e9ticos para serem \n\nutilizados em digest\u00e3o de prote\u00ednas. Sabe-se que a presen\u00e7a do revestimento polim\u00e9rico confere \n\nestabilidade \u00e0s part\u00edculas magn\u00e9ticas, diminuindo sua agrega\u00e7\u00e3o e melhorando a \n\nbiocompatibilidade; al\u00e9m de estabilizar a enzima imobilizada. A escolha dos pol\u00edmeros foi baseada \n\nem alguns crit\u00e9rios. No caso da polianilina, o fato de ser um pol\u00edmero de f\u00e1cil s\u00edntese e de baixo \n\ncusto foram fatores importantes; al\u00e9m de ser promissor para uso em biossensores. J\u00e1 o \n\npolissacar\u00eddeo levana, foi escolhido por ser biocompat\u00edvel, n\u00e3o t\u00f3xico e possuir propriedades \n\nbiol\u00f3gicas interessantes para aplica\u00e7\u00f5es em sistemas de libera\u00e7\u00e3o de drogas e hipertermia \n\nmagn\u00e9tica. \n\nUma vez que a presen\u00e7a do revestimento forneceria uma superf\u00edcie quimicamente \n\ncontrolada, esses comp\u00f3sitos magn\u00e9ticos poderiam ser usados como suportes para imobilizar \n\ntripsina. Com o objetivo inicial de aplicar estes derivados enzim\u00e1ticos na etapa de prote\u00f3lise, que \n\nantecede a identifica\u00e7\u00e3o e o sequenciamento de uma prote\u00edna e, assim diminuindo custos, reduzindo \n\no tempo de digest\u00e3o e tornando o procedimento o mais simples poss\u00edvel. No entanto, outras \n\nposs\u00edveis aplica\u00e7\u00f5es para estes materiais tamb\u00e9m s\u00e3o visadas, como a montagem de reatores para \n\nprodu\u00e7\u00e3o de hidrolisados prot\u00e9icos.  \n\n \n\n\n\n \n\n2. Revis\u00e3o da literatura \n\n2.1. Enzimas proteol\u00edticas ou proteases\n\n As proteases s\u00e3o amplamente utilizadas em aplica\u00e7\u00f5es industriais e biom\u00e9dicas, entre as \n\nquais a tripsina (Figura 1) foi mais extensivamente empregada. \n\natrai consider\u00e1vel interesse devido a\n\nde detergentes, no amaciamento do couro, \n\nnutricional (ROCHA et al., 2011), \n\nBANUMATHI et al., 2009; YANG \n\nde sequenciamento (SCHUCHERT\n\nfibrose c\u00edstica (TZETIS et al., 2007) e pancreatite cr\u00f4nica (CHEN \n\naplica\u00e7\u00f5es s\u00e3o limitadas no que diz respeito \n\ndurante os per\u00edodos operacionais e de estocagem resultantes da aut\u00f3lise, desnatura\u00e7\u00e3o e agrega\u00e7\u00e3o \n\ndessas enzimas (VILLALONGA et al., 2000). A imobiliza\u00e7\u00e3o de enzimas pode superar essas \n\nlimita\u00e7\u00f5es; a imobiliza\u00e7\u00e3o estabiliza a estrutura e, por conseguinte, \n\npontos-chave s\u00e3o o suporte e o m\u00e9todo de imobiliza\u00e7\u00e3o adequados (NIKOLIC et al., 2010).\n\n \n\nFigura 1. Mol\u00e9cula de tripsina. Em vermelho, liga\u00e7\u00f5es dissulfeto. \n\n Dependendo das propriedades do suporte, a simples sedimenta\u00e7\u00e3o, filtra\u00e7\u00e3o ou centrifu\u00e7\u00e3o \n\npodem ser suficientes. Se propriedades magn\u00e9ticas podem ser adicionadas\n\nremovido com maior facilidade e rapidez \n\n2011). Por essa vantagem, a imobiliza\u00e7\u00e3o de tripsina em suporte magn\u00e9tico tem sido considerada \n\ncomo um procedimento potencialmente poderoso nos \u00faltimos anos (AMARAL et al., \n\nal., 2007; BAYRAMO?LU et al., 2008\n\ncrescente na \u00e1rea de prote\u00f4mica induz esfor\u00e7os intensivos para desenvolver metodologias anal\u00edticas \n\nautomatizadas, sens\u00edveis e com alto rendimento. \n\n2.1. Enzimas proteol\u00edticas ou proteases \n\nAs proteases s\u00e3o amplamente utilizadas em aplica\u00e7\u00f5es industriais e biom\u00e9dicas, entre as \n\nfoi mais extensivamente empregada. A tripsina, uma serino protease,\n\natrai consider\u00e1vel interesse devido a sua ampla variedade de aplica\u00e7\u00f5es, tais como\n\nde detergentes, no amaciamento do couro, na produ\u00e7\u00e3o de hidrolisados prot\u00e9icos com valor \n\nnutricional (ROCHA et al., 2011), em cultura de c\u00e9lulas e tecidos (SOLEIMANI \n\n2009; YANG et al., 2009), na identifica\u00e7\u00e3o de prote\u00ednas por meio de t\u00e9cnicas \n\n(SCHUCHERT-SHI e HAUSER, 2009), em doen\u00e7as pancre\u00e1ticas, incluindo \n\n2007) e pancreatite cr\u00f4nica (CHEN et al., \n\naplica\u00e7\u00f5es s\u00e3o limitadas no que diz respeito a sua instabilidade e r\u00e1pida perda de atividade catal\u00edtica \n\ndurante os per\u00edodos operacionais e de estocagem resultantes da aut\u00f3lise, desnatura\u00e7\u00e3o e agrega\u00e7\u00e3o \n\ndessas enzimas (VILLALONGA et al., 2000). A imobiliza\u00e7\u00e3o de enzimas pode superar essas \n\nimobiliza\u00e7\u00e3o estabiliza a estrutura e, por conseguinte, a atividad\n\nm\u00e9todo de imobiliza\u00e7\u00e3o adequados (NIKOLIC et al., 2010).\n\n \n. Em vermelho, liga\u00e7\u00f5es dissulfeto. Fonte: http://prince.openwetware.org/FASP.html\n\n \n\nDependendo das propriedades do suporte, a simples sedimenta\u00e7\u00e3o, filtra\u00e7\u00e3o ou centrifu\u00e7\u00e3o \n\npodem ser suficientes. Se propriedades magn\u00e9ticas podem ser adicionadas ao suporte, ele pode ser \n\ncom maior facilidade e rapidez pela aplica\u00e7\u00e3o de um campo magn\u00e9tico\n\nimobiliza\u00e7\u00e3o de tripsina em suporte magn\u00e9tico tem sido considerada \n\ncomo um procedimento potencialmente poderoso nos \u00faltimos anos (AMARAL et al., \n\nLU et al., 2008; SUN et al., 2011; MACIEL et al., 2012)\n\ncrescente na \u00e1rea de prote\u00f4mica induz esfor\u00e7os intensivos para desenvolver metodologias anal\u00edticas \n\nautomatizadas, sens\u00edveis e com alto rendimento. Por exemplo, Krogh et al. (1999) demonstraram a \n\n3 \n\nCap\u00edtulo 1 \n\nAs proteases s\u00e3o amplamente utilizadas em aplica\u00e7\u00f5es industriais e biom\u00e9dicas, entre as \n\n, uma serino protease, \n\ntais como na composi\u00e7\u00e3o \n\nna produ\u00e7\u00e3o de hidrolisados prot\u00e9icos com valor \n\nSOLEIMANI et al., 2009; \n\nna identifica\u00e7\u00e3o de prote\u00ednas por meio de t\u00e9cnicas \n\nem doen\u00e7as pancre\u00e1ticas, incluindo \n\n 2009). Contudo, suas \n\nsua instabilidade e r\u00e1pida perda de atividade catal\u00edtica \n\ndurante os per\u00edodos operacionais e de estocagem resultantes da aut\u00f3lise, desnatura\u00e7\u00e3o e agrega\u00e7\u00e3o \n\ndessas enzimas (VILLALONGA et al., 2000). A imobiliza\u00e7\u00e3o de enzimas pode superar essas \n\na atividade da enzima. Os \n\nm\u00e9todo de imobiliza\u00e7\u00e3o adequados (NIKOLIC et al., 2010). \n\nnce.openwetware.org/FASP.html \n\nDependendo das propriedades do suporte, a simples sedimenta\u00e7\u00e3o, filtra\u00e7\u00e3o ou centrifu\u00e7\u00e3o \n\nao suporte, ele pode ser \n\npela aplica\u00e7\u00e3o de um campo magn\u00e9tico (ROCHA et al., \n\nimobiliza\u00e7\u00e3o de tripsina em suporte magn\u00e9tico tem sido considerada \n\ncomo um procedimento potencialmente poderoso nos \u00faltimos anos (AMARAL et al., 2006; LIU et \n\n; MACIEL et al., 2012). O interesse \n\ncrescente na \u00e1rea de prote\u00f4mica induz esfor\u00e7os intensivos para desenvolver metodologias anal\u00edticas \n\nplo, Krogh et al. (1999) demonstraram a \n\n\n\n4 \n\n \n\nr\u00e1pida digest\u00e3o de prote\u00ednas usando enzimas imobilizadas em \u201cbeads\u201d de vidro paramagn\u00e9tico. \n\nWang et al. (2008) tamb\u00e9m ligaram tripsina a nanoc\u00f3mposito magn\u00e9tico para digest\u00e3o de prote\u00ednas, \n\nresultando em boa sequ\u00eancia de convers\u00e3o.  \n\n \n\n2.2. Imobiliza\u00e7\u00e3o de enzimas em suportes insol\u00faveis  \n\n As vantagens das enzimas imobilizadas, em rela\u00e7\u00e3o \u00e0s sol\u00faveis, surgem de sua maior \n\nestabilidade e facilidade de separa\u00e7\u00e3o do meio de rea\u00e7\u00e3o, o que acarreta economia significativa no \n\ncusto global do processo, desde que o procedimento de imobiliza\u00e7\u00e3o n\u00e3o seja muito dispendioso, \n\nhaja boa recupera\u00e7\u00e3o da atividade enzim\u00e1tica e que a meia-vida operacional da enzima imobilizada \n\nseja suficientemente longa (BON et al., 2008). \n\n De particular interesse \u00e9 o aumento do uso de enzimas imobilizadas, fisicamente confinadas \n\nou localizadas numa certa regi\u00e3o do espa\u00e7o com reten\u00e7\u00e3o de sua atividade catal\u00edtica, podendo ser \n\nusada repetida e continuadamente (WINGARD JR., 1972). Nesta t\u00e9cnica, a enzima fica retida no \n\ninterior (poros) ou na superf\u00edcie de um material que \u00e9 utilizado como suporte. O complexo enzima-\n\nsuporte mant\u00e9m as caracter\u00edsticas f\u00edsicas do suporte e, ao mesmo tempo, ret\u00e9m a atividade biol\u00f3gica \n\nda enzima na forma sol\u00favel (BON et al., 2008).  \n\n \n\n2.2.1. Classifica\u00e7\u00e3o das enzimas imobilizadas \n\n Zaborsky (1973, 1976) prop\u00f4s uma classifica\u00e7\u00e3o que leva em considera\u00e7\u00e3o \u2013 o tipo de \n\nintera\u00e7\u00e3o respons\u00e1vel pela imobiliza\u00e7\u00e3o \u2013, que pode ser conseguida por meios qu\u00edmicos (forma\u00e7\u00e3o \n\nde liga\u00e7\u00e3o covalente) ou por meios f\u00edsicos (envolvem somente for\u00e7as f\u00edsicas: adsor\u00e7\u00e3o, intera\u00e7\u00f5es \n\neletrost\u00e1ticas e outras); \u2013 a natureza dos suportes \u2013, que podem ser porosos ou n\u00e3o-porosos, \n\norg\u00e2nicos ou inorg\u00e2nicos (VIETH, 1994; ZANIN e MORAES, 2004).   \n\nDo ponto de vista pr\u00e1tico, o m\u00e9todo de classifica\u00e7\u00e3o n\u00e3o altera o sistema obtido, uma vez \n\nque as t\u00e9cnicas mais utilizadas para a prepara\u00e7\u00e3o dos biocatalisadores de aplica\u00e7\u00e3o comercial \n\nenvolvem uma combina\u00e7\u00e3o de m\u00e9todos b\u00e1sicos (BON et al., 2008). \n\n A classifica\u00e7\u00e3o dos m\u00e9todos de imobiliza\u00e7\u00e3o de enzimas, mais aceita na literatura, foi \n\nproposta por Kennedy e Roig (1995), que considera a combina\u00e7\u00e3o da natureza da intera\u00e7\u00e3o \n\nrespons\u00e1vel pela imobiliza\u00e7\u00e3o e o tipo de suporte utilizado. Assim: \n\n \n\n1) Liga\u00e7\u00e3o em suportes \u2013 modifica\u00e7\u00e3o da enzima, por meio de t\u00e9cnicas apropriadas, para \n\ntorn\u00e1-las im\u00f3veis no meio de rea\u00e7\u00e3o e \u201ccross-linking\u201d \u2013 liga\u00e7\u00e3o cruzada intermolecular. \n\n2) Enzimas sol\u00faveis sem derivatiza\u00e7\u00e3o \u2013 enzimas sol\u00faveis, utilizadas em reatores \n\nequipados com membranas semiperme\u00e1veis de ultrafiltra\u00e7\u00e3o e fibras ocas que ret\u00eam a \n\nenzima no interior do reator. \n\n\n\n \n\n3) Enzimas sol\u00faveis com derivatiza\u00e7\u00e3o \n\nliga\u00e7\u00e3o com outra macromol\u00e9cula, por\u00e9m permanecendo o complexo sol\u00favel em \u00e1gua.\n\n \n\n2.2.2. M\u00e9todos de imobiliza\u00e7\u00e3o de enzimas\n\n\u00c9 muito importante escolher um m\u00e9todo de imobiliza\u00e7\u00e3o que conserve \n\natividade catal\u00edtica da enzima. Dentre as t\u00e9cnicas de \n\ncitar-se: adsor\u00e7\u00e3o, onde h\u00e1 uma intera\u00e7\u00e3o f\u00edsica n\u00e3o\n\nmatriz; oclus\u00e3o ou enclausuramento em uma matriz semi\n\nrea\u00e7\u00f5es cruzadas ou cross-linking, consiste na liga\u00e7\u00e3o da enzima a uma outra prote\u00edna ou a grupos \n\nfuncionais existentes na matriz; e \n\nentre a enzima e a matriz (POWELL, 1990). \n\nO m\u00e9todo de liga\u00e7\u00e3o covalente \u00e9 o mais estudado entre os m\u00e9todos j\u00e1 citados. Este m\u00e9todo \n\npode ser classificado de acordo com o tipo de liga\u00e7\u00e3o (diaz\n\ncondi\u00e7\u00f5es para imobiliza\u00e7\u00e3o por este m\u00e9todo s\u00e3o mais \n\nliga\u00e7\u00e3o covalente, pode ainda, alterar a estrutura conformacional e o s\u00edtio ativo da enzima, \n\nresultando em maior perda da atividade e/ou mudan\u00e7as do substrato. Contudo, a for\u00e7a de liga\u00e7\u00e3o \n\nentre a enzima e a matriz \u00e9 t\u00e3o forte que mesmo na presen\u00e7a do substrato ou de solu\u00e7\u00f5es de alta \n\nfor\u00e7a i\u00f4nica a liga\u00e7\u00e3o n\u00e3o \u00e9 desfeita e a enzima continua imobilizada (HERMANSON \n\nHERMANSON, 1996).  \n\nA imobiliza\u00e7\u00e3o covalente de biomol\u00e9culas em superf\u00edcies \u00e9 de substancial interesse em \n\naplica\u00e7\u00f5es biom\u00e9dicas, tais como biosensores, cromatografia de afinidade, bioprocessamento, \n\ndiagn\u00f3sticos de fase s\u00f3lida, terapia extracorp\u00f3rea e libe\n\nal., 1999). \n\n \n\nFigura 2. M\u00e9todos de imobiliza\u00e7\u00e3o de enzimas.\nroxo). Reproduzido de http://www.turqase.com/research/5/ \n\ncom derivatiza\u00e7\u00e3o \u2013 enzimas cuja mobilidade foi restringida pela \n\nliga\u00e7\u00e3o com outra macromol\u00e9cula, por\u00e9m permanecendo o complexo sol\u00favel em \u00e1gua.\n\n.2. M\u00e9todos de imobiliza\u00e7\u00e3o de enzimas \n\n\u00c9 muito importante escolher um m\u00e9todo de imobiliza\u00e7\u00e3o que conserve \n\natividade catal\u00edtica da enzima. Dentre as t\u00e9cnicas de imobiliza\u00e7\u00e3o (Figura \n\nnde h\u00e1 uma intera\u00e7\u00e3o f\u00edsica n\u00e3o-espec\u00edfica entre a enzima e a superf\u00edcie da \n\nmatriz; oclus\u00e3o ou enclausuramento em uma matriz semi-perme\u00e1vel ou no interior de pol\u00edmeros; \n\nlinking, consiste na liga\u00e7\u00e3o da enzima a uma outra prote\u00edna ou a grupos \n\n; e liga\u00e7\u00e3o covalente, onde h\u00e1 a forma\u00e7\u00e3o de liga\u00e7\u00f5es covalentes \n\nentre a enzima e a matriz (POWELL, 1990).  \n\nO m\u00e9todo de liga\u00e7\u00e3o covalente \u00e9 o mais estudado entre os m\u00e9todos j\u00e1 citados. Este m\u00e9todo \n\npode ser classificado de acordo com o tipo de liga\u00e7\u00e3o (diazotiza\u00e7\u00e3o, amida, base de Schiff, etc). As \n\ncondi\u00e7\u00f5es para imobiliza\u00e7\u00e3o por este m\u00e9todo s\u00e3o mais elaboradas que a t\u00e9cnica de\n\npode ainda, alterar a estrutura conformacional e o s\u00edtio ativo da enzima, \n\natividade e/ou mudan\u00e7as do substrato. Contudo, a for\u00e7a de liga\u00e7\u00e3o \n\nentre a enzima e a matriz \u00e9 t\u00e3o forte que mesmo na presen\u00e7a do substrato ou de solu\u00e7\u00f5es de alta \n\nfor\u00e7a i\u00f4nica a liga\u00e7\u00e3o n\u00e3o \u00e9 desfeita e a enzima continua imobilizada (HERMANSON \n\nA imobiliza\u00e7\u00e3o covalente de biomol\u00e9culas em superf\u00edcies \u00e9 de substancial interesse em \n\naplica\u00e7\u00f5es biom\u00e9dicas, tais como biosensores, cromatografia de afinidade, bioprocessamento, \n\ndiagn\u00f3sticos de fase s\u00f3lida, terapia extracorp\u00f3rea e libera\u00e7\u00e3o controlada de drogas \n\nM\u00e9todos de imobiliza\u00e7\u00e3o de enzimas. Representa\u00e7\u00e3o esquem\u00e1tica da enzima (em azul) e do suporte (em \nhttp://www.turqase.com/research/5/  \n\n5 \n\nenzimas cuja mobilidade foi restringida pela \n\nliga\u00e7\u00e3o com outra macromol\u00e9cula, por\u00e9m permanecendo o complexo sol\u00favel em \u00e1gua. \n\n\u00c9 muito importante escolher um m\u00e9todo de imobiliza\u00e7\u00e3o que conserve grande parte da \n\nFigura 2) conhecidas podem \n\nentre a enzima e a superf\u00edcie da \n\nperme\u00e1vel ou no interior de pol\u00edmeros; \n\nlinking, consiste na liga\u00e7\u00e3o da enzima a uma outra prote\u00edna ou a grupos \n\nliga\u00e7\u00e3o covalente, onde h\u00e1 a forma\u00e7\u00e3o de liga\u00e7\u00f5es covalentes \n\nO m\u00e9todo de liga\u00e7\u00e3o covalente \u00e9 o mais estudado entre os m\u00e9todos j\u00e1 citados. Este m\u00e9todo \n\notiza\u00e7\u00e3o, amida, base de Schiff, etc). As \n\nque a t\u00e9cnica de adsor\u00e7\u00e3o. A \n\npode ainda, alterar a estrutura conformacional e o s\u00edtio ativo da enzima, \n\natividade e/ou mudan\u00e7as do substrato. Contudo, a for\u00e7a de liga\u00e7\u00e3o \n\nentre a enzima e a matriz \u00e9 t\u00e3o forte que mesmo na presen\u00e7a do substrato ou de solu\u00e7\u00f5es de alta \n\nfor\u00e7a i\u00f4nica a liga\u00e7\u00e3o n\u00e3o \u00e9 desfeita e a enzima continua imobilizada (HERMANSON et al., 1992; \n\nA imobiliza\u00e7\u00e3o covalente de biomol\u00e9culas em superf\u00edcies \u00e9 de substancial interesse em \n\naplica\u00e7\u00f5es biom\u00e9dicas, tais como biosensores, cromatografia de afinidade, bioprocessamento, \n\nra\u00e7\u00e3o controlada de drogas (MALMSTEN et \n\n \n\nRepresenta\u00e7\u00e3o esquem\u00e1tica da enzima (em azul) e do suporte (em \n\n\n\n \n\n2.2.3. Suportes para a imobiliza\u00e7\u00e3o de enzimas\n\n As propriedades das prepara\u00e7\u00f5es de enzimas imobilizadas s\u00e3o influenciadas pelas \n\npropriedades da enzima e do material do suporte (TISCHER e KASCHE, 1999). A intera\u00e7\u00e3o entre \n\nesses dois componentes proporciona um derivado imobilizado \n\nbioqu\u00edmicas, mec\u00e2nicas e cin\u00e9ticas \n\n \n\nFigura 3. Intera\u00e7\u00e3o entre suporte e enzima. \n\n \n\nDentre os v\u00e1rios par\u00e2metros que devem ser considerados\n\nenzimas, os mais importantes s\u00e3o apresentados na \n\nfor\u00e7a i\u00f4nica, press\u00e3o, agita\u00e7\u00e3o, libera\u00e7\u00e3o de co\n\nEstes fatores influem no desempenho do suporte, na conforma\u00e7\u00e3o \n\ntransfer\u00eancia de massa e de rea\u00e7\u00e3o intr\u00ednseca, e, portanto, afetam o comportamento da enzima \n\nimobilizada. De todos os fatores anteriormente citados, com exce\u00e7\u00e3o da enzima, a maior \n\ncontribui\u00e7\u00e3o para o bom desempenho da enzima imo\n\nsuporte para uma determinada aplica\u00e7\u00e3o, devem ser analisadas suas propriedades f\u00edsicas e qu\u00edmicas, \n\nbem como as relativas \u00e0 possibilidade de regenera\u00e7\u00e3o do material.\n\nresistente nas condi\u00e7\u00f5es de ativa\u00e7\u00e3o, durante o processo de imobiliza\u00e7\u00e3o e nas condi\u00e7\u00f5es em que se \n\nprocessa a rea\u00e7\u00e3o. Em geral, os supores inorg\u00e2nicos s\u00e3o mais apropriados para uso industrial por \n\napresentarem elevada resist\u00eancia mec\u00e2nica, boa estabilidade t\u00e9rmica, res\n\norg\u00e2nicos e ao ataque por microrganismos \n\nimobiliza\u00e7\u00e3o de enzimas \n\nAs propriedades das prepara\u00e7\u00f5es de enzimas imobilizadas s\u00e3o influenciadas pelas \n\npropriedades da enzima e do material do suporte (TISCHER e KASCHE, 1999). A intera\u00e7\u00e3o entre \n\nesses dois componentes proporciona um derivado imobilizado com propriedades qu\u00edmicas, \n\nbioqu\u00edmicas, mec\u00e2nicas e cin\u00e9ticas espec\u00edficas (Figura 3). \n\nIntera\u00e7\u00e3o entre suporte e enzima. Reproduzido de BON et al., 2008. \n\nDentre os v\u00e1rios par\u00e2metros que devem ser considerados, no processo de imobiliza\u00e7\u00e3o de \n\nos mais importantes s\u00e3o apresentados na Tabela 1, os quais incluem pH, temperatura, \n\nfor\u00e7a i\u00f4nica, press\u00e3o, agita\u00e7\u00e3o, libera\u00e7\u00e3o de co-fatores e do substrato com a remo\u00e7\u00e3o dos produtos. \n\nEstes fatores influem no desempenho do suporte, na conforma\u00e7\u00e3o da enzima, na velocidade de \n\ntransfer\u00eancia de massa e de rea\u00e7\u00e3o intr\u00ednseca, e, portanto, afetam o comportamento da enzima \n\nDe todos os fatores anteriormente citados, com exce\u00e7\u00e3o da enzima, a maior \n\ncontribui\u00e7\u00e3o para o bom desempenho da enzima imobilizada \u00e9 dada pelo suporte. Na escolha de um \n\nsuporte para uma determinada aplica\u00e7\u00e3o, devem ser analisadas suas propriedades f\u00edsicas e qu\u00edmicas, \n\nbem como as relativas \u00e0 possibilidade de regenera\u00e7\u00e3o do material. O suporte deve ser quimicamente \n\nas condi\u00e7\u00f5es de ativa\u00e7\u00e3o, durante o processo de imobiliza\u00e7\u00e3o e nas condi\u00e7\u00f5es em que se \n\nprocessa a rea\u00e7\u00e3o. Em geral, os supores inorg\u00e2nicos s\u00e3o mais apropriados para uso industrial por \n\napresentarem elevada resist\u00eancia mec\u00e2nica, boa estabilidade t\u00e9rmica, res\n\norg\u00e2nicos e ao ataque por microrganismos (BON et al., 2008). \n\n6 \n\nAs propriedades das prepara\u00e7\u00f5es de enzimas imobilizadas s\u00e3o influenciadas pelas \n\npropriedades da enzima e do material do suporte (TISCHER e KASCHE, 1999). A intera\u00e7\u00e3o entre \n\ncom propriedades qu\u00edmicas, \n\n \n\n, no processo de imobiliza\u00e7\u00e3o de \n\n, os quais incluem pH, temperatura, \n\nfatores e do substrato com a remo\u00e7\u00e3o dos produtos. \n\nda enzima, na velocidade de \n\ntransfer\u00eancia de massa e de rea\u00e7\u00e3o intr\u00ednseca, e, portanto, afetam o comportamento da enzima \n\nDe todos os fatores anteriormente citados, com exce\u00e7\u00e3o da enzima, a maior \n\nbilizada \u00e9 dada pelo suporte. Na escolha de um \n\nsuporte para uma determinada aplica\u00e7\u00e3o, devem ser analisadas suas propriedades f\u00edsicas e qu\u00edmicas, \n\nO suporte deve ser quimicamente \n\nas condi\u00e7\u00f5es de ativa\u00e7\u00e3o, durante o processo de imobiliza\u00e7\u00e3o e nas condi\u00e7\u00f5es em que se \n\nprocessa a rea\u00e7\u00e3o. Em geral, os supores inorg\u00e2nicos s\u00e3o mais apropriados para uso industrial por \n\napresentarem elevada resist\u00eancia mec\u00e2nica, boa estabilidade t\u00e9rmica, resist\u00eancia a solventes \n\n\n\n7 \n\n \n\nTabela 1. Fatores que influenciam o desempenho de um sistema de enzima imobilizada. Reproduzido de TISCHER e \nKASCHE, 1999. \n\n \n\nEnzima Propriedades Bioqu\u00edmicas: massa molar, grupos funcionais da \nsuperf\u00edcie proteica, pureza (fun\u00e7\u00f5es de inativa\u00e7\u00e3o ou prote\u00e7\u00e3o das \nimpurezas).  \n \nPar\u00e2metros Cin\u00e9ticos: atividade espec\u00edfica, perfil de pH e \ntemperatura, par\u00e2metros cin\u00e9ticos para ativa\u00e7\u00e3o e inibi\u00e7\u00e3o, estabilidade \nt\u00e9rmica, pH, solventes, contaminantes e impurezas.  \n \n\nSuporte Caracter\u00edsticas Qu\u00edmicas: composi\u00e7\u00e3o e base qu\u00edmica, grupos \nfuncionais, estabilidade qu\u00edmica, contribui\u00e7\u00f5es da superf\u00edcie do \nsuporte, tais como os microefeitos (pH, carga da superf\u00edcie, natureza \nhidrof\u00f3bica e hidrof\u00edlica, efeito redutor e a presen\u00e7a de \u00edons met\u00e1licos). \n \nCaracter\u00edsticas Mec\u00e2nicas: di\u00e2metro do poro, comportamento de \ncompress\u00e3o, tamanho da part\u00edcula; \u00e1rea superficial; volume acess\u00edvel \nda matriz, resist\u00eancia \u00e0 compacta\u00e7\u00e3o em opera\u00e7\u00f5es em altas vaz\u00f5es \npara reatores de leito fixo; abras\u00e3o para reatores agitados e velocidade \nde sedimenta\u00e7\u00e3o para leitos fluidizados.  \n \nCaracter\u00edsticas Morfol\u00f3gicas: suportes n\u00e3o-porosos (baixa \u00e1rea \nsuperficial), porosos (grande \u00e1rea superficial), estrutura de gel. \n \n\nEnzima imobilizada M\u00e9todo de Imobiliza\u00e7\u00e3o: fixa\u00e7\u00e3o de prote\u00edna, efici\u00eancia da enzima \nativa, par\u00e2metros cin\u00e9ticos intr\u00ednsecos.  \n \nEfeitos de Transfer\u00eancia de Massa: parti\u00e7\u00e3o (diferente concentra\u00e7\u00e3o \ndo soluto dentro e fora das part\u00edculas do catalisador), difus\u00e3o interna \n(poros) e externa.  \n \nEstabilidade: operacional (expressa em tempo de meia-vida sob \ncondi\u00e7\u00f5es operacionais), estabilidade em estocagem.  \n \nDesempenho: produtividade (produto formado por unidade de \natividade ou massa de enzima), consumo de enzima (por exemplo, \nunidades por kg de produto).  \n\n \n\n2.2.4. Vantagens e limita\u00e7\u00f5es da imobiliza\u00e7\u00e3o de enzimas \n\n A enzima imobilizada tem muitas vantagens sobre a enzima sol\u00favel, tais como capacidade \n\nde reutiliza\u00e7\u00e3o, estabilidade melhorada, t\u00e9rmino da rea\u00e7\u00e3o r\u00e1pido, f\u00e1cil separa\u00e7\u00e3o entre \n\nbiocatalisador e produto, redu\u00e7\u00e3o dos custos operacionais, etc. (ELIF BOYUKBAYRAM et al., \n\n2006). A imobiliza\u00e7\u00e3o tamb\u00e9m auxilia a dispers\u00e3o homog\u00eanea da enzima no meio, essencial, para a \n\ncondu\u00e7\u00e3o de rea\u00e7\u00f5es enzim\u00e1ticas (DE CASTRO e ANDERSON, 1995; VILLENEUVE et al., \n\n2000). Do ponto de vista comercial, as principais vantagens da utiliza\u00e7\u00e3o de enzimas imobilizadas, \n\nem rela\u00e7\u00e3o \u00e0s enzimas sol\u00faveis s\u00e3o, praticamente, as relativas \u00e0 cat\u00e1lise.  \n\n O sucesso da tecnologia de imobiliza\u00e7\u00e3o mostra que, de modo geral, as vantagens superam \n\nas limita\u00e7\u00f5es. Por\u00e9m, alguns fatores devem ser apontados, n\u00e3o como desvantagens do processo, mas \n\n\n\n8 \n\n \n\nsim como pontos a serem evitados. Dentre estes fatores podem ser citados (ROSEVEAR et al., \n\n1987): perda da atividade durante o processo de imobiliza\u00e7\u00e3o, os efeitos difusionais (transfer\u00eancia \n\nde massa), as caracter\u00edsticas f\u00edsicas do biocatalisador e do fluido e a estabilidade do biocatalisador. \n\nComo os m\u00e9todos de imobiliza\u00e7\u00e3o, de modo geral, envolvem intera\u00e7\u00f5es fracas, ou fortes, \n\nentre a fr\u00e1gil estrutura da enzima e o suporte, ocorre invariavelmente altera\u00e7\u00e3o da estrutura \n\ntridimensional da prote\u00edna, resultando em menor atividade. Para se superar esse problema, busca-se \n\na prote\u00e7\u00e3o do s\u00edtio ativo da enzima durante o processo de imobiliza\u00e7\u00e3o, o que pode ser conseguido \n\nempregando-se altas concentra\u00e7\u00f5es de substrato ou um inibidor de s\u00edtio ativo (BON et al., 2008). \n\n A mobilidade restringida da enzima imobilizada consiste em outra desvantagem e provoca \n\numa diminui\u00e7\u00e3o na acessibilidade ao substrato, o que leva \u00e0 aparente redu\u00e7\u00e3o da atividade, neste \n\ncaso provocada por restri\u00e7\u00f5es difusionais (limita\u00e7\u00f5es do acesso do substrato ao s\u00edtio ativo devido \u00e0 \n\npresen\u00e7a da matriz s\u00f3lida). Este efeito deve ser evitado ou diminu\u00eddo pela escolha criteriosa do \n\nsuporte, ou pelas condi\u00e7\u00f5es de opera\u00e7\u00e3o. Normalmente, as enzimas imobilizadas devem ser \n\nutilizadas quando o substrato \u00e9 sol\u00favel. Quando as enzimas est\u00e3o retidas no interior de matrizes \n\nporosas, os poros devem facilitar o livre acesso do substrato e reter ao mesmo tempo a mol\u00e9cula de \n\nenzima no seu interior. O custo da imobiliza\u00e7\u00e3o deve ser compensado pela longa vida do \n\nbiocatalisador. O suporte deve manter suas propriedades f\u00edsicas (resist\u00eancia mec\u00e2nica e ao ataque \n\npor reagentes qu\u00edmicos) durante o tempo de meia-vida estimado (BON et al., 2008). \n\n \n\n2.3. Sistemas de imobiliza\u00e7\u00e3o de biomol\u00e9culas: part\u00edculas magn\u00e9ticas \n\nO emprego de part\u00edculas magn\u00e9ticas ocorreu pela primeira vez na d\u00e9cada de 1940 como uma \n\nnova tecnologia no tratamento de \u00e1gua polu\u00edda (ARIAS et al., 2001). Hoje em dia, a s\u00edntese e a \n\naplica\u00e7\u00e3o de part\u00edculas magn\u00e9ticas funcionalizadas tem despertado grande interesse em diferentes \n\n\u00e1reas (WU et al., 2008; HAO et al., 2010), sendo as t\u00e9cnicas de separa\u00e7\u00e3o magn\u00e9tica as mais \n\nestudadas, uma vez que elas apresentam benef\u00edcios sobre a centrifuga\u00e7\u00e3o, filtra\u00e7\u00e3o e extra\u00e7\u00e3o em \n\nfase s\u00f3lida. No caso da extra\u00e7\u00e3o em fase s\u00f3lida usando materiais magn\u00e9ticos, o adsorvente \n\nmagn\u00e9tico \u00e9 adicionado \u00e0 solu\u00e7\u00e3o ou \u00e0 suspens\u00e3o contendo o analito alvo. Esse analito \u00e9, ent\u00e3o, \n\nadsorvido sobre o adsorvente magn\u00e9tico; capturado e recuperado da suspens\u00e3o usando um \n\nseparador magn\u00e9tico apropriado, sendo, em seguida, eluido do adsorvente e analisado (CHEN et al., \n\n2011) como pode ser visto no esquema da Figura 4.  \n\nEsses s\u00f3lidos magn\u00e9ticos s\u00e3o amplamente usados em sistemas de detec\u00e7\u00e3o e anal\u00edtico, pois \n\noferecem algumas vantagens quando comparados aos s\u00f3lidos similares que n\u00e3o possuem \n\npropriedades magn\u00e9ticas. Tais s\u00f3lidos podem ser usados na pr\u00e9-concentra\u00e7\u00e3o de analitos, na \n\nsepara\u00e7\u00e3o magn\u00e9tica, na identifica\u00e7\u00e3o molecular de biomol\u00e9culas, de compostos org\u00e2nicos e \n\ninorg\u00e2nicos (AGUILAR-ARTEAGA et al., 2010).  \n\n\n\n \n\nFigura 4. Procedimento de extra\u00e7\u00e3o em fase s\u00f3lida magn\u00e9tica. \n\nAl\u00e9m de serem utilizadas como adsorventes em separa\u00e7\u00e3o magn\u00e9tica, essas part\u00edculas, \n\ndentro da escala nanom\u00e9trica \u00e0 microm\u00e9trica, est\u00e3o sendo usadas em um n\u00famero crescente de \n\naplica\u00e7\u00f5es m\u00e9dicas (hipertermia magn\u00e9tica, agentes de contraste para imagem por re\n\nmagn\u00e9tica e libera\u00e7\u00e3o de drogas, por exemplo), em especial, devido a suas importantes propriedades \n\ntais como n\u00e3o toxicidade, biocompatibilidade, injetabilidade e alto n\u00edvel de acumula\u00e7\u00e3o no tecido \n\nou \u00f3rg\u00e3o (ITO et al., 2005; TOKORO et al., 2009).\n\npropriedades mencionadas acima, a mais importante \u00e9 a n\u00e3o toxicidade.  De acordo com Kreuter \n\n(1983), em nanopart\u00edculas com um di\u00e2metro geralmente menor que cerca de 100 nm, o \n\nrevestimento \u00e9 provavelmente o fator\n\ncaso de grandes microesferas magn\u00e9ticas de di\u00e2metros acima de 10 \u00b5 m, o revestimento da \n\nmicroesfera tem maior influencia na rea\u00e7\u00e3o tecidual (\n\nEm geral, um \u00fanico tipo de part\u00ed\n\ntamanho e o processo de produ\u00e7\u00e3o das micropart\u00edculas ou nanopart\u00edculas magn\u00e9ticas s\u00e3o \n\ndeterminados pelo tipo de aplica\u00e7\u00e3o. Part\u00edculas superparamagn\u00e9ticas, ferromagn\u00e9ticas e \n\nferrimagn\u00e9ticas podem ser usadas como carreadores magn\u00e9ticos de drogas; enquanto que part\u00edculas \n\nsuperparamegn\u00e9ticas s\u00e3o utilizadas para uso biom\u00e9dico por que elas n\u00e3o exibem magnetismo \n\nquando n\u00e3o est\u00e3o sob influencia de um campo magn\u00e9tico externo, prevenindo a aglomera\u00e7\u00e3o \n\nmagn\u00e9tica indesejada (BRANDL et al., 2010).\n\n2.3.1. \u00d3xidos de ferro: os principais tipos de n\u00facleo magn\u00e9tico\n Os \u00f3xidos de ferro com estrutura \u201ccore/shell\u201d s\u00e3o os mais usados como fontes de materiais \n\nmagn\u00e9ticos (DRBOHLAVOVA et al., 2009).\n\nmagn\u00e9ticas formadas por um n\u00facleo magn\u00e9tico (\u201ccore\u201d) e um revestimento (\u201cshell\u201d).\n\nformas cristalinas conhecidas como \n\nProcedimento de extra\u00e7\u00e3o em fase s\u00f3lida magn\u00e9tica. Reproduzido de CHEN et al., 2011\n\n \n\nAl\u00e9m de serem utilizadas como adsorventes em separa\u00e7\u00e3o magn\u00e9tica, essas part\u00edculas, \n\ndentro da escala nanom\u00e9trica \u00e0 microm\u00e9trica, est\u00e3o sendo usadas em um n\u00famero crescente de \n\naplica\u00e7\u00f5es m\u00e9dicas (hipertermia magn\u00e9tica, agentes de contraste para imagem por re\n\nmagn\u00e9tica e libera\u00e7\u00e3o de drogas, por exemplo), em especial, devido a suas importantes propriedades \n\ntais como n\u00e3o toxicidade, biocompatibilidade, injetabilidade e alto n\u00edvel de acumula\u00e7\u00e3o no tecido \n\nou \u00f3rg\u00e3o (ITO et al., 2005; TOKORO et al., 2009). Segundo Ito et al. (2005),  dentre todas as \n\npropriedades mencionadas acima, a mais importante \u00e9 a n\u00e3o toxicidade.  De acordo com Kreuter \n\n(1983), em nanopart\u00edculas com um di\u00e2metro geralmente menor que cerca de 100 nm, o \n\nrevestimento \u00e9 provavelmente o fator mais importante e determina muitas de suas propriedades. No \n\ncaso de grandes microesferas magn\u00e9ticas de di\u00e2metros acima de 10 \u00b5 m, o revestimento da \n\nmicroesfera tem maior influencia na rea\u00e7\u00e3o tecidual (H\u00c4FELI e PAUER, 1999).\n\nEm geral, um \u00fanico tipo de part\u00edculas n\u00e3o pode ser usado para todas as aplica\u00e7\u00f5es. O \n\ntamanho e o processo de produ\u00e7\u00e3o das micropart\u00edculas ou nanopart\u00edculas magn\u00e9ticas s\u00e3o \n\ndeterminados pelo tipo de aplica\u00e7\u00e3o. Part\u00edculas superparamagn\u00e9ticas, ferromagn\u00e9ticas e \n\nas como carreadores magn\u00e9ticos de drogas; enquanto que part\u00edculas \n\nsuperparamegn\u00e9ticas s\u00e3o utilizadas para uso biom\u00e9dico por que elas n\u00e3o exibem magnetismo \n\nquando n\u00e3o est\u00e3o sob influencia de um campo magn\u00e9tico externo, prevenindo a aglomera\u00e7\u00e3o \n\nesejada (BRANDL et al., 2010). \n\nprincipais tipos de n\u00facleo magn\u00e9tico \nxidos de ferro com estrutura \u201ccore/shell\u201d s\u00e3o os mais usados como fontes de materiais \n\nmagn\u00e9ticos (DRBOHLAVOVA et al., 2009). Este tipo de estrutura consiste em part\u00edculas \n\nmagn\u00e9ticas formadas por um n\u00facleo magn\u00e9tico (\u201ccore\u201d) e um revestimento (\u201cshell\u201d).\n\nformas cristalinas conhecidas como ?-Fe2O3 (hematita), ?-Fe2O3, ?-Fe2O3 (maghemita), \n\n9 \n\n \n\nReproduzido de CHEN et al., 2011. \n\nAl\u00e9m de serem utilizadas como adsorventes em separa\u00e7\u00e3o magn\u00e9tica, essas part\u00edculas, \n\ndentro da escala nanom\u00e9trica \u00e0 microm\u00e9trica, est\u00e3o sendo usadas em um n\u00famero crescente de \n\naplica\u00e7\u00f5es m\u00e9dicas (hipertermia magn\u00e9tica, agentes de contraste para imagem por resson\u00e2ncia \n\nmagn\u00e9tica e libera\u00e7\u00e3o de drogas, por exemplo), em especial, devido a suas importantes propriedades \n\ntais como n\u00e3o toxicidade, biocompatibilidade, injetabilidade e alto n\u00edvel de acumula\u00e7\u00e3o no tecido \n\nSegundo Ito et al. (2005),  dentre todas as \n\npropriedades mencionadas acima, a mais importante \u00e9 a n\u00e3o toxicidade.  De acordo com Kreuter \n\n(1983), em nanopart\u00edculas com um di\u00e2metro geralmente menor que cerca de 100 nm, o \n\nmais importante e determina muitas de suas propriedades. No \n\ncaso de grandes microesferas magn\u00e9ticas de di\u00e2metros acima de 10 \u00b5 m, o revestimento da \n\n, 1999). \n\nculas n\u00e3o pode ser usado para todas as aplica\u00e7\u00f5es. O \n\ntamanho e o processo de produ\u00e7\u00e3o das micropart\u00edculas ou nanopart\u00edculas magn\u00e9ticas s\u00e3o \n\ndeterminados pelo tipo de aplica\u00e7\u00e3o. Part\u00edculas superparamagn\u00e9ticas, ferromagn\u00e9ticas e \n\nas como carreadores magn\u00e9ticos de drogas; enquanto que part\u00edculas \n\nsuperparamegn\u00e9ticas s\u00e3o utilizadas para uso biom\u00e9dico por que elas n\u00e3o exibem magnetismo \n\nquando n\u00e3o est\u00e3o sob influencia de um campo magn\u00e9tico externo, prevenindo a aglomera\u00e7\u00e3o \n\nxidos de ferro com estrutura \u201ccore/shell\u201d s\u00e3o os mais usados como fontes de materiais \n\nEste tipo de estrutura consiste em part\u00edculas \n\nmagn\u00e9ticas formadas por um n\u00facleo magn\u00e9tico (\u201ccore\u201d) e um revestimento (\u201cshell\u201d). H\u00e1 v\u00e1rias \n\n(maghemita), ?-Fe2O3, \n\n\n\n \n\nFe3O4 (magnetita) (ZBORIL et al., 2002)\n\nmagn\u00e9tico. No entanto, somente maghemita e magnetita encontraram maior interesse em \n\nbioaplica\u00e7\u00f5es (TUCEK et al., 2006).\n\n Em alguns trabalhos, metais puros, tais como Fe e Co foram utilizad\n\nmagn\u00e9tico por que eles t\u00eam v\u00e1rias vantagens sobre os \u00f3xidos de ferro, por ex., melhores \n\npropriedades magn\u00e9ticas e alta magnetiza\u00e7\u00e3o de satura\u00e7\u00e3o (ARIAS et al., 2009). Contudo, Fe e Co \n\napresentam menor estabilidade oxidativa, baixa compatibil\n\ntoxicidade que os \u00f3xidos de ferro (CHOMOUKA et al., 2010).\n\n A estrutura b\u00e1sica de um \u00f3xido de ferro \u00e9 de um octaedro, no qual cada \u00e1tomo ferro (Fe\n\nFe3+) \u00e9 rodeado por seis O2- ou por seis OH\n\ncompactos, em que essas unidades podem interagir por meio de seus \u00e1pices, arestas ou faces, forma \n\na estrutura cristalina de todos os minerais deste grupo. A caracter\u00edstica comum entre todos os \u00f3xidos \n\nde ferro \u00e9 a presen\u00e7a de um\n\ncompartilhados, que varia de 0,288 a 0,289 nm para liga\u00e7\u00f5es com \u00e1pices comuns (\n\n(PEREIRA, 2010).  \n\nFigura 5. Representa\u00e7\u00e3o do octaedro de ferro (a) e sua polimeriza\u00e7\u00e3o pelo \u00e1pice (b), a\nPEREIRA, 2010. \n\nV\u00e1rios procedimentos sint\u00e9ticos foram desenvolvidos para sintetizar nanopart\u00edculas de \u00f3\n\nde ferro (AH et al., 2007), sendo a\n\ndecomposi\u00e7\u00e3o t\u00e9rmica e/ou redu\u00e7\u00e3o (PARK et al., 2004) e s\u00edntese hidrotermal (WANG et al., 2005) \n\nos m\u00e9todos mais usados e com altos r\n\nO procedimento mais simples, barato e ecologicamente correto \u00e9 o m\u00e9todo de co\n\nprecipita\u00e7\u00e3o, que envolve a precipita\u00e7\u00e3o simult\u00e2nea de \u00edons\n\nIL et al., 2002) que podem ser utilizadas para composi\u00e7\u00e3o do n\u00facleo \n\n. No entanto, somente maghemita e magnetita encontraram maior interesse em \n\nbioaplica\u00e7\u00f5es (TUCEK et al., 2006). \n\nEm alguns trabalhos, metais puros, tais como Fe e Co foram utilizad\n\nmagn\u00e9tico por que eles t\u00eam v\u00e1rias vantagens sobre os \u00f3xidos de ferro, por ex., melhores \n\npropriedades magn\u00e9ticas e alta magnetiza\u00e7\u00e3o de satura\u00e7\u00e3o (ARIAS et al., 2009). Contudo, Fe e Co \n\napresentam menor estabilidade oxidativa, baixa compatibilidade em sistemas n\u00e3o aquosos e maior \n\ntoxicidade que os \u00f3xidos de ferro (CHOMOUKA et al., 2010). \n\nA estrutura b\u00e1sica de um \u00f3xido de ferro \u00e9 de um octaedro, no qual cada \u00e1tomo ferro (Fe\n\nou por seis OH-. A polimeriza\u00e7\u00e3o destes octaedros em arranjos \n\ncompactos, em que essas unidades podem interagir por meio de seus \u00e1pices, arestas ou faces, forma \n\na estrutura cristalina de todos os minerais deste grupo. A caracter\u00edstica comum entre todos os \u00f3xidos \n\nde ferro \u00e9 a presen\u00e7a de uma dist\u00e2ncia interat\u00f4mica Fe-Fe, comuns entre dois octaedros \n\ncompartilhados, que varia de 0,288 a 0,289 nm para liga\u00e7\u00f5es com \u00e1pices comuns (\n\n \n\n \n\nRepresenta\u00e7\u00e3o do octaedro de ferro (a) e sua polimeriza\u00e7\u00e3o pelo \u00e1pice (b), aresta (c) e face (d). \n\n \n\nV\u00e1rios procedimentos sint\u00e9ticos foram desenvolvidos para sintetizar nanopart\u00edculas de \u00f3\n\nde ferro (AH et al., 2007), sendo as t\u00e9cnicas de co-precipita\u00e7\u00e3o (WILLIS et al., 2005), \n\nredu\u00e7\u00e3o (PARK et al., 2004) e s\u00edntese hidrotermal (WANG et al., 2005) \n\nos m\u00e9todos mais usados e com altos rendimentos.  \n\nO procedimento mais simples, barato e ecologicamente correto \u00e9 o m\u00e9todo de co\n\nprecipita\u00e7\u00e3o, que envolve a precipita\u00e7\u00e3o simult\u00e2nea de \u00edons Fe2+ e Fe3+ em meio aquoso b\u00e1sico \n\n10 \n\nque podem ser utilizadas para composi\u00e7\u00e3o do n\u00facleo \n\n. No entanto, somente maghemita e magnetita encontraram maior interesse em \n\nEm alguns trabalhos, metais puros, tais como Fe e Co foram utilizados como n\u00facleo \n\nmagn\u00e9tico por que eles t\u00eam v\u00e1rias vantagens sobre os \u00f3xidos de ferro, por ex., melhores \n\npropriedades magn\u00e9ticas e alta magnetiza\u00e7\u00e3o de satura\u00e7\u00e3o (ARIAS et al., 2009). Contudo, Fe e Co \n\nidade em sistemas n\u00e3o aquosos e maior \n\nA estrutura b\u00e1sica de um \u00f3xido de ferro \u00e9 de um octaedro, no qual cada \u00e1tomo ferro (Fe2+ ou \n\ndestes octaedros em arranjos \n\ncompactos, em que essas unidades podem interagir por meio de seus \u00e1pices, arestas ou faces, forma \n\na estrutura cristalina de todos os minerais deste grupo. A caracter\u00edstica comum entre todos os \u00f3xidos \n\nFe, comuns entre dois octaedros \n\ncompartilhados, que varia de 0,288 a 0,289 nm para liga\u00e7\u00f5es com \u00e1pices comuns (Figura 5) \n\nresta (c) e face (d). Fonte: \n\nV\u00e1rios procedimentos sint\u00e9ticos foram desenvolvidos para sintetizar nanopart\u00edculas de \u00f3xido \n\nprecipita\u00e7\u00e3o (WILLIS et al., 2005), \n\nredu\u00e7\u00e3o (PARK et al., 2004) e s\u00edntese hidrotermal (WANG et al., 2005) \n\nO procedimento mais simples, barato e ecologicamente correto \u00e9 o m\u00e9todo de co-\n\nem meio aquoso b\u00e1sico \n\n\n\n11 \n\n \n\n(KANG et al., 1996; QU et al., 1999). Durante ou ap\u00f3s a sua prepara\u00e7\u00e3o, as nanopart\u00edculas s\u00e3o \n\nusualmente revestidas com pol\u00edmeros tais como dextrana, por exemplo, para garantir sua \n\nestabilidade sob condi\u00e7\u00f5es fisiol\u00f3gicas (FIGUEROLA et al., 2010).  \n\nNo m\u00e9todo de co-precipita\u00e7\u00e3o, a temperatura de rea\u00e7\u00e3o \u00e9 limitada pelo ponto de ebuli\u00e7\u00e3o da \n\n\u00e1gua, e nanopart\u00edculas de \u00f3xido de ferro sintetizadas, sob essas condi\u00e7\u00f5es, exibem usualmente um \n\nbaixo grau de cristalinidade e grande polidispers\u00e3o. Uma melhoria neste sentido foi representada \n\npelas rotas de s\u00edntese empregando microemuls\u00f5es \u00e1gua em \u00f3leo (MUNSHI et al., 1997). Nesses \n\ntipos de s\u00ednteses, uma melhoria na dispers\u00e3o das part\u00edculas foi relatada devido ao confinamento de \n\ntamanho oferecido pela \u00e1gua dentro de cada micela. Mesmo nesses casos, a limitada temperatura de \n\nrea\u00e7\u00e3o leva a baixa cristalinidade do material e adicionalmente os produtos s\u00e3o obtidos com baixo \n\nrendimento (FIGUEROLA et al., 2010). \n\n As t\u00e9cnicas de s\u00edntese hidrot\u00e9rmicas s\u00e3o um m\u00e9todo alternativo para a prepara\u00e7\u00e3o de \n\nnanopart\u00edculas de \u00f3xido de ferro altamente cristalinas (WANG et al., 2005). Neste caso, uma \n\nmistura de sais de ferro dissolvidos em meio aquoso \u00e9 introduzida em um recipiente de teflon selado \n\ne aquecida acima da temperatura de ebuli\u00e7\u00e3o da \u00e1gua, e consequentemente, a press\u00e3o da rea\u00e7\u00e3o \u00e9 \n\naumentada muito acima da press\u00e3o atmosf\u00e9rica. O efeito sin\u00e9rgico de altas temperaturas e press\u00f5es \n\nmelhora a qualidade dos nanocristais e por isso suas caracter\u00edsticas magn\u00e9ticas. Infelizmente, e em \n\ncontraste \u00e0 t\u00e9cnica de microemuls\u00e3o, n\u00e3o h\u00e1 um caminho simples para controlar o tamanho e a \n\nforma das part\u00edculas resultantes e usualmente amostras polidispersas s\u00e3o obtidas (FIGUEROLA et \n\nal., 2010). \n\nO tamanho e a forma das nanopart\u00edculas de \u00f3xido de ferro depende do tipo de sal usado (tais \n\ncomo cloretos, sulfatos, nitratos, percloratos, etc), da propor\u00e7\u00e3o entre os \u00edons f\u00e9rrico e ferroso, da \n\ntemperatura de rea\u00e7\u00e3o, do valor do pH, da for\u00e7a i\u00f4nica do meio e de outros par\u00e2metros da rea\u00e7\u00e3o \n\n(por ex., velocidade de agita\u00e7\u00e3o, velocidade de gotejamento da solu\u00e7\u00e3o b\u00e1sica) (WU et al., 2008). \n\n2.3.2. Magnetita e maghemita: os \u00f3xidos de ferro mais utilizados  \nA magnetita (Fe3O4) pertence \u00e0 fam\u00edlia dos \u00f3xidos de ferro, sendo um mineral magn\u00e9tico de \n\ncor preta encontrado em rochas. J\u00e1 a maghemita (?-Fe2O3) \u00e9 um mineral magn\u00e9tico castanho \n\navermelhado, estruturalmente similar \u00e0 magnetita, mas com vac\u00e2ncias (CORNELL e \n\nSCHWERTMANN, 2003). Suas propriedades globais s\u00e3o muito semelhantes, o que torna muito \n\ndif\u00edcil distinguir entre elas.  \n\nA magnetita tem a particularidade de conter tanto o \u00edon Fe2+ quanto Fe3+, dentro de uma \n\nestrutura de espin\u00e9lio inversa. Trinta e dois \u00e2nions oxig\u00eanio formam uma face centrada c\u00fabica com \n\num comprimento da aresta de 0.839 nm. Nesta c\u00e9lula unit\u00e1ria, os \u00edons de ferro est\u00e3o localizados em \n\n8 s\u00edtios tetra\u00e9dricos (cercado por 4 \u00edons oxig\u00eanio) e 16 s\u00edtios octa\u00e9dricos (cercado por 8 \u00edons \n\noxig\u00eanio). Os s\u00edtios tetra\u00e9dricos s\u00e3o ocupados exclusivamente por \u00edons Fe3+, enquanto que os \u00edons \n\n\n\n \n\nFe2+ e Fe3+ ocupam alternadamente s\u00edtios octa\u00e9dricos (\n\nde \u00edons Fe3+ tetra\u00e9dricos e octa\u00e9dricos, o momento resultante em um cristal de magnetita surge \n\napenas dos \u00edons Fe2+ octa\u00e9dricos n\u00e3o compensados (\n\nmaghemita s\u00e3o devidas aos \u00edons Fe\n\nSCHWERTMANN, 2003). \n\n \n\nFigura 6. Estrutura de espin\u00e9lio inversa da magnetita.\nferrimagn\u00e9tica na magnetita. Reproduzido de \n\n \n\nSuspens\u00f5es aquosas est\u00e1veis de nanopart\u00edculas de magnetita (ou maghemita) s\u00e3o ditas ser \n\nsuperparamagn\u00e9ticas por que elas n\u00e3o mostram\n\nao campo magn\u00e9tico, seu momento magn\u00e9tico global alinha na dire\u00e7\u00e3o do campo, mas quando o \n\ncampo \u00e9 zero, o momento magn\u00e9tico da amostra tamb\u00e9m retorna a zero. Este comportamento \u00e9 o \n\nmesmo do paramagn\u00e9tico, mas com um mome\n\naquele de um \u00edon paramagn\u00e9tico, por exemplo): este fen\u00f4meno \u00e9 chamado de superparamagnetismo \n\n(CORNELL e SCHWERTMANN, 2003).\n\nPor sua biocompatibilidade, a magnetita, incluindo outras formas de nanopart\u00edculas de \u00f3\n\nde ferro, tem sido ressaltada p\n\npart\u00edculas usualmente se refere ao di\u00e2metro total destas incluindo o n\u00facle\n\nrevestimento. Part\u00edculas com tamanhos maiores e/ou agregados de part\u00edcula\n\naprisionadas, causando embolia dent\n\nnanopart\u00edculas com di\u00e2metro menor que 100 nm, o revestimento \u00e9 provavelmente o fator mais \n\nimportante e determina muita das\n\nocupam alternadamente s\u00edtios octa\u00e9dricos (Figura 6a). Como existe o mesmo n\u00famero \n\ntetra\u00e9dricos e octa\u00e9dricos, o momento resultante em um cristal de magnetita surge \n\nocta\u00e9dricos n\u00e3o compensados (Figura 6b). As propriedades magn\u00e9ticas da \n\nmaghemita s\u00e3o devidas aos \u00edons Fe3+ octa\u00e9dricos n\u00e3o compensados (CORNELL e \n\ninversa da magnetita. (a) ilustra\u00e7\u00e3o de c\u00e9lula unit\u00e1ria c\u00fabica; (b) organiza\u00e7\u00e3o \nReproduzido de CORNELL e SCHWERTMANN, 2003. \n\nSuspens\u00f5es aquosas est\u00e1veis de nanopart\u00edculas de magnetita (ou maghemita) s\u00e3o ditas ser \n\nsuperparamagn\u00e9ticas por que elas n\u00e3o mostram remanesc\u00eancia, ou seja, quando elas\n\nao campo magn\u00e9tico, seu momento magn\u00e9tico global alinha na dire\u00e7\u00e3o do campo, mas quando o \n\ncampo \u00e9 zero, o momento magn\u00e9tico da amostra tamb\u00e9m retorna a zero. Este comportamento \u00e9 o \n\nmesmo do paramagn\u00e9tico, mas com um momento magn\u00e9tico de part\u00edcula imenso (comparado \n\naquele de um \u00edon paramagn\u00e9tico, por exemplo): este fen\u00f4meno \u00e9 chamado de superparamagnetismo \n\n(CORNELL e SCHWERTMANN, 2003). \n\nPor sua biocompatibilidade, a magnetita, incluindo outras formas de nanopart\u00edculas de \u00f3\n\nde ferro, tem sido ressaltada para aplica\u00e7\u00f5es biom\u00e9dicas (HUBER, 2005)\n\npart\u00edculas usualmente se refere ao di\u00e2metro total destas incluindo o n\u00facle\n\n. Part\u00edculas com tamanhos maiores e/ou agregados de part\u00edculas pequenas podem ser \n\naprisionadas, causando embolia dentro dos capilares pulmonares (KREUTER\n\nnanopart\u00edculas com di\u00e2metro menor que 100 nm, o revestimento \u00e9 provavelmente o fator mais \n\nimportante e determina muita das propriedades das part\u00edculas (KONCRACK\u00c1\n\n12 \n\n). Como existe o mesmo n\u00famero \n\ntetra\u00e9dricos e octa\u00e9dricos, o momento resultante em um cristal de magnetita surge \n\nAs propriedades magn\u00e9ticas da \n\nocta\u00e9dricos n\u00e3o compensados (CORNELL e \n\n \n\nunit\u00e1ria c\u00fabica; (b) organiza\u00e7\u00e3o \n\nSuspens\u00f5es aquosas est\u00e1veis de nanopart\u00edculas de magnetita (ou maghemita) s\u00e3o ditas ser \n\nou seja, quando elas s\u00e3o submetidas \n\nao campo magn\u00e9tico, seu momento magn\u00e9tico global alinha na dire\u00e7\u00e3o do campo, mas quando o \n\ncampo \u00e9 zero, o momento magn\u00e9tico da amostra tamb\u00e9m retorna a zero. Este comportamento \u00e9 o \n\nnto magn\u00e9tico de part\u00edcula imenso (comparado \n\naquele de um \u00edon paramagn\u00e9tico, por exemplo): este fen\u00f4meno \u00e9 chamado de superparamagnetismo \n\nPor sua biocompatibilidade, a magnetita, incluindo outras formas de nanopart\u00edculas de \u00f3xido \n\n2005). O tamanho dessas \n\npart\u00edculas usualmente se refere ao di\u00e2metro total destas incluindo o n\u00facleo de ferro e o \n\ns pequenas podem ser \n\nKREUTER, 1983). Em \n\nnanopart\u00edculas com di\u00e2metro menor que 100 nm, o revestimento \u00e9 provavelmente o fator mais \n\nKONCRACK\u00c1 et al., 2002). O \n\n\n\n13 \n\n \n\ntamanho da part\u00edcula \u00e9 um fator importante no desempenho destas e uma redu\u00e7\u00e3o neste tamanho \n\nassegura uma maior magnetiza\u00e7\u00e3o quando aplicado um campo magn\u00e9tico externo (O\u2019HANDLEY, \n\n2000). \n\n \n\n2.4.  Estabilidade de part\u00edculas magn\u00e9ticas \n\n As nanopart\u00edculas de \u00f3xido de ferro apresentam alta sensibilidade magn\u00e9tica e baixa \n\ntoxicidade. No entanto, devido \u00e0 sua baixa estabilidade coloidal na fase aquosa (tend\u00eancia de se \n\nagregar), a modifica\u00e7\u00e3o apropriada da superf\u00edcie dessas part\u00edculas representa um ponto-chave para \n\nimpedir a agrega\u00e7\u00e3o e para torn\u00e1-las altamente monodispersas (SAWANT et al., 2009).  \n\nEm geral, um revestimento polim\u00e9rico pode reduzir a agrega\u00e7\u00e3o e melhorar a estabilidade \n\ncoloidal das nanopart\u00edculas magn\u00e9ticas. Contudo, em alguns casos, a camada de pol\u00edmero pode \n\naumentar significativamente o tamanho total das nanopart\u00edculas, levando a limitadas distribui\u00e7\u00e3o \n\ntecidual, penetra\u00e7\u00e3o e depura\u00e7\u00e3o metab\u00f3lica das part\u00edculas. O desenvolvimento de nanopart\u00edculas \n\nmagn\u00e9ticas revestidas com pequenas mol\u00e9culas pode ser promissor para obter nanopart\u00edculas \n\nrevestidas de pequeno tamanho (CHENG et al., 2005; YANG et al., 2010). \n\nPara melhorar a estabilidade e biocompatibilidade, nanopart\u00edculas de \u00f3xido de ferro \n\nsuperparamagn\u00e9ticas s\u00e3o frequentemente modificadas com alguns surfactantes ou pol\u00edmeros \n\n(BERRY et al., 2003). As nanopart\u00edculas de magnetita superparamagn\u00e9ticas revestidas com \n\npol\u00edmeros s\u00e3o usualmente formadas por n\u00facleos magn\u00e9ticos respons\u00e1veis por uma resposta \n\nmagn\u00e9tica forte e uma camada polim\u00e9rica para fornecer grupos funcionaliz\u00e1veis e caracter\u00edsticos \n\n(WUNDERBALDINGER et al., 2002). \n\nAlguns autores sugerem a substitui\u00e7\u00e3o do \u00e1cido ol\u00e9ico por um pol\u00edmero sol\u00favel em \u00e1gua, \n\nrevestimento individual das nanopart\u00edculas com pol\u00edmeros anfif\u00edlicos e incorpora\u00e7\u00e3o dessas \n\nnanopart\u00edculas em micelas lip\u00eddicas para obter nanopart\u00edculas sol\u00faveis em \u00e1gua monodispersas \n\n(TROMSDORF et al., 2007).   \n\n Revestimento de materiais polim\u00e9ricos pode ser classificado em sint\u00e9tico e natural. \n\nPol\u00edmeros baseados em poli(etileno-co-vinil acetato), poli(vinilpirrolidona) (PVP), poli(\u00e1cido \n\nl\u00e1tico-co-glic\u00f3lico) (PLGA), poli(etilenoglicol) (PEG), poli(\u00e1lcool vin\u00edlico) (PVA), etc. S\u00e3o \n\nexemplos t\u00edpicos de sistemas polim\u00e9ricos sint\u00e9ticos (NUNES et al., 2006). Sistemas de pol\u00edmero \n\nnatural incluem o uso de gelatina, dextrana, quitosana, pululana. A modifica\u00e7\u00e3o de pol\u00edmeros \n\nnaturais oferece vantagens significativas em aplica\u00e7\u00f5es biom\u00e9dicas devido a sua boa \n\nbiocompatibilidade e degradabilidade (MASSIA et al., 2000). \n\n Em muitos estudos, conduzidos principalmente sobre nanopart\u00edculas de maghemita, uma \n\ndiminui\u00e7\u00e3o no valor da magnetiza\u00e7\u00e3o de satura\u00e7\u00e3o tem sido observado e atribu\u00eddo ao efeito do \n\ntamanho finito, \u00e0 desordem estrutural em toda a part\u00edcula e aos efeitos de superf\u00edcie (DAOU et al., \n\n\n\n \n\n2008). \u00c9 bem estabelecido que as propriedades das nanopart\u00edculas s\u00e3o fortemente dependentes do \n\nseu tamanho, mas diferentes rotas sint\u00e9ticas podem fornecer nanopart\u00edcul\n\ncom diferentes propriedades magn\u00e9ticas. De fato, a distin\u00e7\u00e3o entre o tamanho finito e as \n\ncontribui\u00e7\u00f5es do efeito de superf\u00edcie n\u00e3o \u00e9 f\u00e1cil. Al\u00e9m disso, pode\n\nespec\u00edfica da liga\u00e7\u00e3o org\u00e2nica sobre as propried\n\naplica\u00e7\u00f5es tecnol\u00f3gicas de nanopart\u00edculas magn\u00e9ticas requerem a compreens\u00e3o da infuencia de \n\nmodifica\u00e7\u00f5es qu\u00edmicas de superf\u00edcie sobre as propriedades magn\u00e9ticas (DAOU et al., 2008).\n\nDAOU et al. (2008) observaram \n\nnanopart\u00edculas de magnetita, na qual mol\u00e9culas funcionais foram ligadas, depende da natureza do \n\nagente de liga\u00e7\u00e3o atrav\u00e9s do qual as mol\u00e9culas s\u00e3o ligadas \u00e0 superf\u00edcie. O agente de liga\u00e7\u00e3o \n\ncarboxilato induz um spin inclinado na camada oxidada, reduzindo a magnetiza\u00e7\u00e3o de satura\u00e7\u00e3o. \n\nPelo contr\u00e1rio, n\u00e3o existe estrutura de superf\u00edcie inclinada quando mol\u00e9culas fosfonatadas s\u00e3o \n\nligadas covalentemente \u00e0s nanopart\u00edculas de \u00f3xido de ferro. Isto \u00e9 de especial i\n\nmanter as propriedades magn\u00e9ticas inalteradas quando nanopart\u00edculas forem revestidas com uma \n\ncamada org\u00e2nica (Figura 7). \n\n \n\nFigura 7. Representa\u00e7\u00e3o esquem\u00e1tica da superf\u00edcie de nanopart\u00edculas magn\u00e9ticas (Fe\norg\u00e2nico na presen\u00e7a de um campo magn\u00e9tico aplicado. As setas representam o momento ferrimagn\u00e9tico resultante. \nFonte: DAOU et al., 2008. \n \n \n A \u00e1rea de superf\u00edcie, o tamanho e a forma das nanopart\u00edculas s\u00e3o respons\u00e1veis pelas \n\npropriedades f\u00edsicas e qu\u00edmicas dessas part\u00edculas em grande extens\u00e3o, que por sua vez s\u00e3o \n\nrespon\u00e1veis pelo desempenho em v\u00e1rias aplica\u00e7\u00f5es (TARTAJ et al., 2003). O tamanho das \n\npart\u00edculas, e sua distribui\u00e7\u00e3o, as propriedades magn\u00e9ticas e de fluxo do fluido influen\n\naplica\u00e7\u00e3o dos par\u00e2metros especialmente em biomedicina. A forma esf\u00e9rica e monodispersibilidade \n\nde nanopart\u00edculas de \u00f3xido de ferro s\u00e3o frequentemente requeridas para aplica\u00e7\u00e3o em tecidos vivos \n\n2008). \u00c9 bem estabelecido que as propriedades das nanopart\u00edculas s\u00e3o fortemente dependentes do \n\nseu tamanho, mas diferentes rotas sint\u00e9ticas podem fornecer nanopart\u00edculas de tamanhos similares \n\ncom diferentes propriedades magn\u00e9ticas. De fato, a distin\u00e7\u00e3o entre o tamanho finito e as \n\ncontribui\u00e7\u00f5es do efeito de superf\u00edcie n\u00e3o \u00e9 f\u00e1cil. Al\u00e9m disso, pode-se notar que a influencia \n\nespec\u00edfica da liga\u00e7\u00e3o org\u00e2nica sobre as propriedades magn\u00e9ticas tem sido pouco estudada. As \n\naplica\u00e7\u00f5es tecnol\u00f3gicas de nanopart\u00edculas magn\u00e9ticas requerem a compreens\u00e3o da infuencia de \n\nmodifica\u00e7\u00f5es qu\u00edmicas de superf\u00edcie sobre as propriedades magn\u00e9ticas (DAOU et al., 2008).\n\nDAOU et al. (2008) observaram que a estrutura magn\u00e9tica da camada  de superf\u00edcie de \n\nnanopart\u00edculas de magnetita, na qual mol\u00e9culas funcionais foram ligadas, depende da natureza do \n\nagente de liga\u00e7\u00e3o atrav\u00e9s do qual as mol\u00e9culas s\u00e3o ligadas \u00e0 superf\u00edcie. O agente de liga\u00e7\u00e3o \n\nnduz um spin inclinado na camada oxidada, reduzindo a magnetiza\u00e7\u00e3o de satura\u00e7\u00e3o. \n\nPelo contr\u00e1rio, n\u00e3o existe estrutura de superf\u00edcie inclinada quando mol\u00e9culas fosfonatadas s\u00e3o \n\nligadas covalentemente \u00e0s nanopart\u00edculas de \u00f3xido de ferro. Isto \u00e9 de especial i\n\nmanter as propriedades magn\u00e9ticas inalteradas quando nanopart\u00edculas forem revestidas com uma \n\nRepresenta\u00e7\u00e3o esquem\u00e1tica da superf\u00edcie de nanopart\u00edculas magn\u00e9ticas (Fe3O4) com e sem revestimento \norg\u00e2nico na presen\u00e7a de um campo magn\u00e9tico aplicado. As setas representam o momento ferrimagn\u00e9tico resultante. \n\nA \u00e1rea de superf\u00edcie, o tamanho e a forma das nanopart\u00edculas s\u00e3o respons\u00e1veis pelas \n\ndades f\u00edsicas e qu\u00edmicas dessas part\u00edculas em grande extens\u00e3o, que por sua vez s\u00e3o \n\nrespon\u00e1veis pelo desempenho em v\u00e1rias aplica\u00e7\u00f5es (TARTAJ et al., 2003). O tamanho das \n\npart\u00edculas, e sua distribui\u00e7\u00e3o, as propriedades magn\u00e9ticas e de fluxo do fluido influen\n\naplica\u00e7\u00e3o dos par\u00e2metros especialmente em biomedicina. A forma esf\u00e9rica e monodispersibilidade \n\nde nanopart\u00edculas de \u00f3xido de ferro s\u00e3o frequentemente requeridas para aplica\u00e7\u00e3o em tecidos vivos \n\n14 \n\n2008). \u00c9 bem estabelecido que as propriedades das nanopart\u00edculas s\u00e3o fortemente dependentes do \n\nas de tamanhos similares \n\ncom diferentes propriedades magn\u00e9ticas. De fato, a distin\u00e7\u00e3o entre o tamanho finito e as \n\nse notar que a influencia \n\nades magn\u00e9ticas tem sido pouco estudada. As \n\naplica\u00e7\u00f5es tecnol\u00f3gicas de nanopart\u00edculas magn\u00e9ticas requerem a compreens\u00e3o da infuencia de \n\nmodifica\u00e7\u00f5es qu\u00edmicas de superf\u00edcie sobre as propriedades magn\u00e9ticas (DAOU et al., 2008). \n\nque a estrutura magn\u00e9tica da camada  de superf\u00edcie de \n\nnanopart\u00edculas de magnetita, na qual mol\u00e9culas funcionais foram ligadas, depende da natureza do \n\nagente de liga\u00e7\u00e3o atrav\u00e9s do qual as mol\u00e9culas s\u00e3o ligadas \u00e0 superf\u00edcie. O agente de liga\u00e7\u00e3o \n\nnduz um spin inclinado na camada oxidada, reduzindo a magnetiza\u00e7\u00e3o de satura\u00e7\u00e3o. \n\nPelo contr\u00e1rio, n\u00e3o existe estrutura de superf\u00edcie inclinada quando mol\u00e9culas fosfonatadas s\u00e3o \n\nligadas covalentemente \u00e0s nanopart\u00edculas de \u00f3xido de ferro. Isto \u00e9 de especial import\u00e2ncia para \n\nmanter as propriedades magn\u00e9ticas inalteradas quando nanopart\u00edculas forem revestidas com uma \n\n \n\n) com e sem revestimento \norg\u00e2nico na presen\u00e7a de um campo magn\u00e9tico aplicado. As setas representam o momento ferrimagn\u00e9tico resultante. \n\nA \u00e1rea de superf\u00edcie, o tamanho e a forma das nanopart\u00edculas s\u00e3o respons\u00e1veis pelas \n\ndades f\u00edsicas e qu\u00edmicas dessas part\u00edculas em grande extens\u00e3o, que por sua vez s\u00e3o \n\nrespon\u00e1veis pelo desempenho em v\u00e1rias aplica\u00e7\u00f5es (TARTAJ et al., 2003). O tamanho das \n\npart\u00edculas, e sua distribui\u00e7\u00e3o, as propriedades magn\u00e9ticas e de fluxo do fluido influenciam a \n\naplica\u00e7\u00e3o dos par\u00e2metros especialmente em biomedicina. A forma esf\u00e9rica e monodispersibilidade \n\nde nanopart\u00edculas de \u00f3xido de ferro s\u00e3o frequentemente requeridas para aplica\u00e7\u00e3o em tecidos vivos \n\n\n\n \n\n(PETRI-FINK e HOFMANN, 2007). Ent\u00e3o, a otimiza\u00e7\u00e3o da s\u00edn\n\nconjuga\u00e7\u00e3o com mol\u00e9culas org\u00e2nicas sobre a superf\u00edcie torna\n\n Nanopart\u00edculas magn\u00e9ticas sem revestimento tem superf\u00edcies hidrof\u00f3bicas com uma grande \n\n\u00e1rea de superf\u00edcie em rela\u00e7\u00e3o ao volume e uma tend\u00eancia a aglomerar (LU et al., 2007). O uso de \n\num revestimento de superf\u00edcie adequado permite que nanopart\u00edculas de \u00f3xid\n\ndispersas dentro de fluidos homog\u00eaneos e melhorem sua estabilidade. V\u00e1rios grupos de materiais de \n\nrevestimento s\u00e3o usados para modificar a superf\u00edcie qu\u00edmica de nanopart\u00edculas magn\u00e9ticas \n\n(SHUBAYEV et al., 2009): \n\na. Pol\u00edmeros org\u00e2nicos, tais c\n\nb. Surfactantes org\u00e2nicos, tais como oleato de s\u00f3dio e dodecilamina\n\nc. Metais inorg\u00e2nicos, tais como ouro\n\nd. \u00d3xidos inorg\u00e2nicos, tais como s\u00edlica e carbono\n\ne. Mol\u00e9culas e estruturas bioativas, tais como lipossomas, pept\u00eddeos e \n\n \n\n2.4.1. Polissacar\u00eddeos como revestimento: levana\n\n A levana (Figura 8) \u00e9 um polissacar\u00eddeo constitu\u00eddo por res\u00edduos de D\n\nliga\u00e7\u00f5es ?(2?6), podendo apresentar pontos de ramifica\n\nesp\u00e9cies de plantas e bact\u00e9rias (KANG et al., 1998). Segundo alguns autores (\n\nDERYCKE, 1983; FUCHS et al., 1985; FUCHS, 1991\n\nglicose terminal, enquanto que as de origem bacteriana s\u00f3 possuem unidades de f\n\n(CALAZANS, 1997).  \n\n \n\nFigura 8. Estrutura qu\u00edmica de uma \n \n \n\nAs levanas podem ser produzidas por diversas esp\u00e9cies de plantas e de bact\u00e9rias, onde a \n\ndistribui\u00e7\u00e3o do peso molecular e \n\nbiopol\u00edmero. Aquelas produzidas por vegetais apresentam baixo peso molecular e poucas \n\nramifica\u00e7\u00f5es; enquanto as produzidas por s\u00edntese microbiana ou enzim\u00e1tica exibem peso molecular \n\nelevado, da ordem de 2,5 x 106 daltons, e podem conter numerosas ramifica\u00e7\u00f5es\n\nBEKERS et al., 2005). A hidr\u00f3lise \u00e1cida parcial de levana produz uma s\u00e9rie de oligossacar\u00eddeos e \n\nFINK e HOFMANN, 2007). Ent\u00e3o, a otimiza\u00e7\u00e3o da s\u00edntese de nanopart\u00edculas e sua \n\nconjuga\u00e7\u00e3o com mol\u00e9culas org\u00e2nicas sobre a superf\u00edcie torna-se muito mais essencial.\n\nNanopart\u00edculas magn\u00e9ticas sem revestimento tem superf\u00edcies hidrof\u00f3bicas com uma grande \n\n\u00e1rea de superf\u00edcie em rela\u00e7\u00e3o ao volume e uma tend\u00eancia a aglomerar (LU et al., 2007). O uso de \n\num revestimento de superf\u00edcie adequado permite que nanopart\u00edculas de \u00f3xid\n\ndispersas dentro de fluidos homog\u00eaneos e melhorem sua estabilidade. V\u00e1rios grupos de materiais de \n\nrevestimento s\u00e3o usados para modificar a superf\u00edcie qu\u00edmica de nanopart\u00edculas magn\u00e9ticas \n\nPol\u00edmeros org\u00e2nicos, tais como dextrana, quitosana, polianilina \n\nSurfactantes org\u00e2nicos, tais como oleato de s\u00f3dio e dodecilamina \n\nMetais inorg\u00e2nicos, tais como ouro \n\n\u00d3xidos inorg\u00e2nicos, tais como s\u00edlica e carbono \n\nMol\u00e9culas e estruturas bioativas, tais como lipossomas, pept\u00eddeos e ligantes/receptores.\n\nPolissacar\u00eddeos como revestimento: levana \n\n) \u00e9 um polissacar\u00eddeo constitu\u00eddo por res\u00edduos de D\n\n6), podendo apresentar pontos de ramifica\u00e7\u00e3o ?(2?1) e ser produzida por diversas \n\nsp\u00e9cies de plantas e bact\u00e9rias (KANG et al., 1998). Segundo alguns autores (\n\net al., 1985; FUCHS, 1991), as levanas de origem vegetal possuem uma \n\nglicose terminal, enquanto que as de origem bacteriana s\u00f3 possuem unidades de f\n\n \n\nEstrutura qu\u00edmica de uma levana de origem vegetal, mostrando a mol\u00e9cula de glicose terminal\n\nAs levanas podem ser produzidas por diversas esp\u00e9cies de plantas e de bact\u00e9rias, onde a \n\ndistribui\u00e7\u00e3o do peso molecular e do grau de ramifica\u00e7\u00e3o depende da fonte produtora deste \n\nbiopol\u00edmero. Aquelas produzidas por vegetais apresentam baixo peso molecular e poucas \n\nramifica\u00e7\u00f5es; enquanto as produzidas por s\u00edntese microbiana ou enzim\u00e1tica exibem peso molecular \n\ndaltons, e podem conter numerosas ramifica\u00e7\u00f5es\n\nA hidr\u00f3lise \u00e1cida parcial de levana produz uma s\u00e9rie de oligossacar\u00eddeos e \n\n15 \n\ntese de nanopart\u00edculas e sua \n\nse muito mais essencial. \n\nNanopart\u00edculas magn\u00e9ticas sem revestimento tem superf\u00edcies hidrof\u00f3bicas com uma grande \n\n\u00e1rea de superf\u00edcie em rela\u00e7\u00e3o ao volume e uma tend\u00eancia a aglomerar (LU et al., 2007). O uso de \n\num revestimento de superf\u00edcie adequado permite que nanopart\u00edculas de \u00f3xido de ferro sejam \n\ndispersas dentro de fluidos homog\u00eaneos e melhorem sua estabilidade. V\u00e1rios grupos de materiais de \n\nrevestimento s\u00e3o usados para modificar a superf\u00edcie qu\u00edmica de nanopart\u00edculas magn\u00e9ticas \n\nligantes/receptores. \n\n) \u00e9 um polissacar\u00eddeo constitu\u00eddo por res\u00edduos de D-frutose unidos por \n\n1) e ser produzida por diversas \n\nsp\u00e9cies de plantas e bact\u00e9rias (KANG et al., 1998). Segundo alguns autores (VANDAMME e \n\n), as levanas de origem vegetal possuem uma \n\nglicose terminal, enquanto que as de origem bacteriana s\u00f3 possuem unidades de frutose \n\nde origem vegetal, mostrando a mol\u00e9cula de glicose terminal. \n\nAs levanas podem ser produzidas por diversas esp\u00e9cies de plantas e de bact\u00e9rias, onde a \n\ndo grau de ramifica\u00e7\u00e3o depende da fonte produtora deste \n\nbiopol\u00edmero. Aquelas produzidas por vegetais apresentam baixo peso molecular e poucas \n\nramifica\u00e7\u00f5es; enquanto as produzidas por s\u00edntese microbiana ou enzim\u00e1tica exibem peso molecular \n\ndaltons, e podem conter numerosas ramifica\u00e7\u00f5es (BARROS, 2002; \n\nA hidr\u00f3lise \u00e1cida parcial de levana produz uma s\u00e9rie de oligossacar\u00eddeos e \n\n\n\n16 \n\n \n\nlevulanas (levanas degradadas) (FEINGOLD e GEHATIA, 1957). Levanas de pesos moleculares \n\nelevados s\u00e3o sorologicamente ativas e estimulam a forma\u00e7\u00e3o de anticorpos; aquelas hidrolisadas ou \n\npurificadas n\u00e3o s\u00e3o antig\u00eanicas. A levana \u00e9 eliminada do corpo lentamente e n\u00e3o \u00e9 t\u00f3xica (HAN, \n\n1990). \n\nAs levanas s\u00e3o um dos poucos pol\u00edmeros naturais em que o carboidrato existe na forma de \n\nfuranose. Esta caracter\u00edstica estrutural tem um importante papel na conforma\u00e7\u00e3o final das mol\u00e9culas \n\nem solu\u00e7\u00e3o (MARCHESSAULT et al., 1980). Al\u00e9m disso, a maior flexibilidade do anel de \n\nfuranose, em compara\u00e7\u00e3o com o relativamente r\u00edgido anel de piranose da maioria dos \n\npolissacar\u00eddeos de reserva, confere uma flexibilidade adicional \u00e0 mol\u00e9cula de frutana inteira.  \n\nAs propriedades gerais das levanas assemelham-se aquelas das dextranas. As levanas s\u00e3o \n\nlevorotat\u00f3rias, amorfas ou microcristalinas, de solubilidade variada em \u00e1gua fria, muito sol\u00favel em \n\n\u00e1gua quente e insol\u00favel em \u00e1lcool et\u00edlico absoluto. As levanas s\u00e3o geralmente mais sol\u00faveis do que \n\na inulina, a qual \u00e9 quase insol\u00favel (&lt;0,5%) em \u00e1gua \u00e0 temperatura ambiente (HAN, 1990). A \n\nelevada solubilidade das levanas pode ser uma caracter\u00edstica da liga\u00e7\u00e3o ?(2? 6) comparada \u00e0 \n\nliga\u00e7\u00e3o ?(2? 1). A ramifica\u00e7\u00e3o deve ser apenas um fator secund\u00e1rio. As levanas s\u00e3o n\u00e3o-redutoras, \n\nn\u00e3o-hidrolisadas por invertase de levedura e amilase, mas s\u00e3o muito suscept\u00edveis \u00e0 hidr\u00f3lise por \n\n\u00e1cidos. Elas n\u00e3o s\u00e3o coradas por iodo, mas cloreto de hidrog\u00eanio confere uma cor p\u00farpura que \n\ndistingue a levana de outros polissacar\u00eddeos que n\u00e3o cont\u00e9m frutose. O peso molecular e a \n\nviscosidade das levanas variam de acordo com a fonte produtora (HAN, 1990). \n\nCertas propriedades da levana, tais como efeito antineopl\u00e1sico (CALAZANS et al., 1997), \n\naumento da permeabilidade celular para um agente citot\u00f3xico (LEIBOVICI e STARK, 1986), \n\npurifica\u00e7\u00e3o de glicoprote\u00ednas (ANGELI et al., 2009) e imobiliza\u00e7\u00e3o de enzimas (VINA et al., 2001; \n\nMACIEL et al., 2012) t\u00eam atra\u00eddo aten\u00e7\u00e3o. Maciel et al. (2012) estabilizaram part\u00edculas magn\u00e9ticas \n\nproduzidas por co-precipita\u00e7\u00e3o utilizando levana de Zymomonas mobilis, apresentando bons \n\nresultados ao imobilizarem a enzima tripsina. \n\n \n\n2.4.2. Pol\u00edmeros org\u00e2nicos sint\u00e9ticos como revestimento: polianilina \n\n Os pol\u00edmeros que apresentam propriedade el\u00e9trica s\u00e3o chamados de \u201cpol\u00edmeros condutores\u201d \n\nou \u201cmetais sint\u00e9ticos\u201d, pois possuem propriedades el\u00e9tricas, magn\u00e9ticas e \u00f3pticas de metais e \n\nsemicondutores. Entre os principais pol\u00edmeros condutores, est\u00e3o o poliacetileno, polianilina e \n\npolipirrol. A oxida\u00e7\u00e3o/redu\u00e7\u00e3o da cadeia polim\u00e9rica pode ser efetuada por agentes de transfer\u00eancia \n\nde carga (aceptores/doadores de el\u00e9trons), convertendo o pol\u00edmero de isolante em condutor ou \n\nsemicondutor. Esses agentes s\u00e3o chamados de dopantes. Na maioria dos pol\u00edmeros condutores, \n\ncomo o polipirrol, o processo de dopagem ocorre simultaneamente com a oxida\u00e7\u00e3o da cadeia. J\u00e1 a \n\npolianilina e seus derivados formam outra classe de pol\u00edmeros condutores, pois ela pode ser dopada \n\n\n\n17 \n\n \n\npor protona\u00e7\u00e3o, isto \u00e9, sem que ocorra altera\u00e7\u00e3o do n\u00famero de el\u00e9trons associados \u00e0 cadeia \n\npolim\u00e9rica (FAEZ et al., 2000).  \n\nOs pol\u00edmeros condutores s\u00e3o materiais extremamente vers\u00e1teis e est\u00e3o sendo amplamente \n\nutilizados em diversas aplica\u00e7\u00f5es, tais como tintas anticorrosivas, dispositivos eletrocr\u00f4micos e \n\ndispositivos emissores de luz (LEDs) (HEEGER, 2002). Como citado em Gizdavic-Nikolaidis et al. \n\n(2004), estes pol\u00edmeros s\u00e3o utilizados no desenvolvimento de m\u00fasculos artificiais, na libera\u00e7\u00e3o \n\ncontrolada de drogas e como est\u00edmulo para a regenera\u00e7\u00e3o de nervos. Considerando-se as aplica\u00e7\u00f5es \n\nna \u00e1rea biom\u00e9dica, a efici\u00eancia dos dispositivos constru\u00eddos a partir dos pol\u00edmeros condutores \u00e9 \n\ndeterminada atrav\u00e9s de duas caracter\u00edsticas: a habilidade de o material desempenhar uma fun\u00e7\u00e3o \n\nespec\u00edfica e apropriada dentro do organismo e, a compatibilidade do material dentro do corpo.  \n\nComo a polianilina (PANI) pode ser utilizada em biomateriais, \u00e9 necess\u00e1rio um melhor \n\nentendimento a respeito da toxicidade deste material. O mon\u00f4mero (anilina) e os subprodutos da \n\ns\u00edntese (compostos arom\u00e1ticos, a maioria aminas) s\u00e3o altamente t\u00f3xicos (SOUZA et al., 2003).  No \n\nentanto, estudos in vivo mostraram que ambas as formas de polianilina, condutora (sal de \n\nesmeraldina) e n\u00e3o-condutora (base esmeraldina), n\u00e3o provocaram respostas inflamat\u00f3rias em \n\nmodelos animais (roedores), sugerindo uma boa toler\u00e2ncia e bio/histocompatibilidade (WANG et \n\nal., 1999; KAMALESH et al., 2000). Yslas et al. (2012) verificaram que nanofibras de polianilina \n\nn\u00e3o exibiram qualquer efeito t\u00f3xico (morte ou teratog\u00eanese) em embri\u00f5es de anf\u00edbios. Resultados \n\nsemelhantes foram observados por Villalba et al. (2012) ao realizarem estudos utilizando c\u00e9lulas \n\nembrion\u00e1rias humanas (rim). Por outro lado, Oh et al. (2011) reportaram o efeito t\u00f3xico de \n\nnanomaterias de polianilina em c\u00e9lulas humanas (fibroblastos) e que essa toxicidade foi dependente \n\nda forma. \n\n A polianilina (PANI) \u00e9 um dos pol\u00edmeros condutores mais estudados devido a suas \n\npropriedades eletr\u00f4nica e \u00f3ptica, excelente estabilidade ambiental (JARAMILLO-TABARES et al., \n\n2012), f\u00e1cil polimeriza\u00e7\u00e3o por s\u00edntese qu\u00edmica (NERI et al., 2011), eletroqu\u00edmica (TAKASHIMA et \n\nal., 1995), fotoqu\u00edmica (ARA\u00daJO et al., 2010) e mais recentemente atrav\u00e9s de condi\u00e7\u00f5es extremas \n\nou n\u00e3o cl\u00e1ssicas (AZEVEDO et al., 2008; BARROS e AZEVEDO, 2008) e baixo custo do \n\nmon\u00f4mero (UMARE et al., 2010). A PANI pode ocorrer em diferentes estados de oxida\u00e7\u00e3o \n\n(Tabela 2), dos quais a forma sal de esmeraldina, 50% oxidada, \u00e9 a mais est\u00e1vel. A forma base \n\nesmeraldina (isolante) do pol\u00edmero pode reagir com \u00e1cidos (ex: HCl) resultando na forma sal de \n\nesmeraldina (condutora). A rea\u00e7\u00e3o de protona\u00e7\u00e3o ocorre principalmente nos nitrog\u00eanios im\u00ednicos da \n\npolianilina (\u2013N=). Al\u00e9m da elevada condutividade el\u00e9trica, outra propriedade interessante da \n\npolianilina \u00e9 exibir diferentes colora\u00e7\u00f5es quando se variam as condi\u00e7\u00f5es de pH ou o potencial \n\nel\u00e9trico (FAEZ et al., 2000). \n\n\n\n18 \n\n \n\nDevido as suas diferentes propriedades f\u00edsico-qu\u00edmicas e a presen\u00e7a de grupos qu\u00edmicos \n\nfuncionaliz\u00e1veis, a PANI \u00e9 utilizada como revestimento de part\u00edculas magn\u00e9ticas. Um dos objetivos \n\n\u00e9 unir as propriedades el\u00e9tricas do pol\u00edmero e a propriedade magn\u00e9tica da part\u00edcula magn\u00e9tica. A \n\nmaioria dos trabalhos consiste no revestimento de nanopart\u00edculas de magnetita (APHESTEGUY e \n\nJACOBO, 2007; XIAO et al., 2007; ZHANG et al., 2010; GANDHI et al., 2011; SUN et al., 2011; \n\nBELAABED et al., 2012). \n\n \nTabela 2. Os tr\u00eas estados de oxida\u00e7\u00e3o mais importantes da polianilina: leucoesmeraldina, esmeraldina (isolante e \ncondutora) e pernigranilina. Fonte: FAEZ et al., 2000 \n \n\nEstado de \noxida\u00e7\u00e3o \n\nEstrutura Cor* Caracter\u00edstica \n\nLeucoesmeraldina \n\n \n \n\nAmarela \n310 \n\nIsolante completamente \nreduzida \n\n \n\nSal de \nesmeraldina  \n\nVerde \n320, 420, \n\n800 \n\nCondutora parcialmente \noxidada \n\n \nBase esmeraldina \n\n \n\nAzul \n320, 620 \n\nIsolante parcialmente \noxidada \n\n \nPernigranilina \n\n \n\nP\u00farpura \n320, 530 \n\nIsolante completamente \noxidada \n\n*Os valores num\u00e9ricos referem-se ao comprimento de onda (em nanometros) onde a absor\u00e7\u00e3o \u00e9 m\u00e1xima \n \n\n \n\n2.5. Aplica\u00e7\u00f5es de part\u00edculas magn\u00e9ticas na \u00e1rea biom\u00e9dica e biotecnol\u00f3gica  \n\n Em biomedicina, o revestimento polim\u00e9rico garante a estabilidade das part\u00edculas \n\nmagn\u00e9ticas, em meio fisiol\u00f3gico, fornecendo n\u00e3o-toxicidade por evitar a liga\u00e7\u00e3o do ferro e permite \n\na modifica\u00e7\u00e3o qu\u00edmica para ligar componentes biologicamente ativos. N\u00e3o somente as \n\ncaracter\u00edsticas da superf\u00edcie, mas primariamente o tamanho das part\u00edculas, s\u00e3o fatores cruciais que \n\ndeterminam o sucesso das part\u00edculas in vivo (HOR\u00c1K et al., 2007). \n\nEm biotecnologia, essas part\u00edculas magn\u00e9ticas t\u00eam encontrado aplica\u00e7\u00f5es em diagn\u00f3sticos \n\nm\u00e9dicos como pesquisa gen\u00e9tica (SCHERER et al., 2002) e tecnologias baseadas em separa\u00e7\u00e3o \n\nmagn\u00e9tica imune de c\u00e9lulas, prote\u00ednas, DNA/RNA, bact\u00e9rias, v\u00edrus e outras biomol\u00e9culas, como \n\nadsorventes de bioafinidade, tratamento de \u00e1gua polu\u00edda via adsor\u00e7\u00e3o eletrost\u00e1tica, suportes para \n\nimobiliza\u00e7\u00e3o ou adsor\u00e7\u00e3o de enzimas e prote\u00ednas (HALLING e DUNNILL, 1980; MOFFAT et al., \n\n1994; ANSELL e MOSBACH, 1998; DUNNILL e LILLY, 2000).  \n\n \n\n \n\n \n\n\n\n19 \n\n \n\n2.5.1. Imagem por resson\u00e2ncia magn\u00e9tica (IRM) \n\n A imagem por resson\u00e2ncia magn\u00e9tica \u00e9 baseada em sinal de resson\u00e2ncia magn\u00e9tica nuclear \n\nde pr\u00f3tons atrav\u00e9s do efeito combinado de um forte campo magn\u00e9tico e um campo de \n\nradiofreq\u00fc\u00eancia (PANKHURST et al., 2003). As part\u00edculas magn\u00e9ticas melhoram o contraste das \n\nimagens obtidas por resson\u00e2ncia magn\u00e9tica (WEISSLEDER et al., 1991; WEISSLEDER et al., \n\n1992; KRESSE et al., 1998; BACHGANSMO, 1993).  \n\nOs agentes de contraste, constitu\u00eddos por nanopart\u00edculas magn\u00e9ticas, podem ser administrados \n\npor diferentes vias (a\u00e9rea, oral, intersticial ou intravenosa) (SAIYED et al., 2003). Em compara\u00e7\u00e3o \n\naos \u00edons paramagn\u00e9ticos, part\u00edculas de \u00f3xido de ferro superparamagn\u00e9ticas t\u00eam relaxitividades \n\nmaiores (SAINI et al., 1987; STARK et al., 1988).  \n\nOs ferrofluidos, usados como contraste para IRM, s\u00e3o formados por magnetita e estabilizados \n\nmais comumente por um polissacar\u00eddeo (ex: dextrana). O di\u00e2metro m\u00e9dio desses agentes varia de \n\n10 nm a 1 \u00b5 m (WEISSLEDER et al., 1991; KRESSE et al., 1998; WEISSLEDE et al., 1992). \n\n \n\n2.5.2. Separa\u00e7\u00e3o magn\u00e9tica \n\n As t\u00e9cnicas de separa\u00e7\u00e3o magn\u00e9tica possibilitam a separa\u00e7\u00e3o de compostos alvo \n\nbiologicamente ativos e c\u00e9lulas de uma variedade de materiais (extratos brutos, meios de cultivo, \n\nsangue, fluidos corporais, amostras ambientais, etc.) (\u0160AFA??K, e \u0160AFA??KOV\u00c1, 1999; \n\n\u0160AFA??K e \u0160AFA??KOV\u00c1, 2000). V\u00e1rias part\u00edculas magn\u00e9ticas t\u00eam sido desenvolvidas como \n\ncarreadores magn\u00e9ticos em processos de separa\u00e7\u00e3o incluindo purifica\u00e7\u00e3o e imunoensaios (HUBER, \n\n2005). Adsorventes de afinidade t\u00eam sido usados para a separa\u00e7\u00e3o de prote\u00ednas (enzimas, \n\nanticorpos, ant\u00edgenos, receptores, etc.), \u00e1cidos nucl\u00e9icos (DNA, RNA, etc.), compostos \n\nbiologicamente ativos de baixo peso molecular (drogas) e xenobi\u00f3ticos (corantes sol\u00faveis em \u00e1gua, \n\nmetais pesados, radionucl\u00eddeos, etc.) (\u0160AFA??K e \u0160AFA??KOV\u00c1, 2000). O uso de colunas \n\ncromatogr\u00e1ficas convencionais pode consumir muito tempo e \u00e9 neste campo que o uso de \n\nadsorventes magn\u00e9ticos ou magnetiz\u00e1veis ganha import\u00e2ncia.  \n\n \n\n2.5.3. Imobiliza\u00e7\u00e3o de enzimas \n\nA suscetibilidade das enzimas \u00e0 a\u00e7\u00e3o de fatores externos e \u00e0s dificuldades de regenera\u00e7\u00e3o \n\ncatal\u00edtica limita a aplica\u00e7\u00e3o das mesmas em larga escala. Alguns m\u00e9todos de estabiliza\u00e7\u00e3o s\u00e3o \n\ncomumente empregados para preservar a atividade da enzima, incluindo t\u00e9cnicas de imobiliza\u00e7\u00e3o \n\nf\u00edsica e/ou qu\u00edmica, que abrem possibilidades para aplica\u00e7\u00f5es industriais. Entre estes, a liga\u00e7\u00e3o \n\ncovalente de enzimas em matrizes insol\u00faveis em \u00e1gua \u00e9 o m\u00e9todo mais atrativo para estabiliza\u00e7\u00e3o, \n\nreutiliza\u00e7\u00e3o e recupera\u00e7\u00e3o de enzimas (ENGASSER e COULET, 1977; MARTINEK et al., 1977; \n\nBRYJAK e KOLARZ, 1998; XI et al., 2005). As enzimas imobilizadas podem substituir as enzimas \n\n\n\n \n\nnativas em v\u00e1rios processos, resultando em rea\u00e7\u00f5es mais r\u00e1pidas, menor contamina\u00e7\u00e3o da amostra e \n\nmelhorando o interfaciamento para procedimentos modernos, como espectrometria de ma\n\n(KROGH et al., 1999). \n\nA escolha da matriz (propriedades qu\u00edmicas e magn\u00e9ticas, tamanho da part\u00edcula e \n\ndistribui\u00e7\u00e3o, porosidade) \u00e9 um fator chave que influencia na qualidade da imobiliza\u00e7\u00e3o e na \n\nconquista das aplica\u00e7\u00f5es finais (B\u00cdLKOV\u00c1 et al., 2002\n\nser magnetizadas pelo tratamento com materiais magn\u00e9ticos sem qualquer perda de atividade da \n\nliga\u00e7\u00e3o subsequente. Uma variedade de materiais magn\u00e9ticos \n\nproduzir part\u00edculas magn\u00e9ticas (AMARAL et al., 2006; ANGELI et al., 2009; NERI et al., 2009; \n\nNERI et al, 2011; MACIEL et al., 2012). \n\n \n\nFigura 9. Desenho esquem\u00e1tico de um \u201cnanobead\u201d magn\u00e9tico que aprisiona mol\u00e9culas de enzima em sua camada de \ns\u00edlica. Reproduzido de http://seeds.kyushu\n \n\n2.5.4. Hipertermia magn\u00e9tica \n\nA t\u00e9cnica de hipertermia magn\u00e9tica se baseia na teoria que qualquer objeto met\u00e1lico, quando \n\ncolocado em um campo magn\u00e9tico alternado, tem induzida uma corrente el\u00e9trica. A quantidade de \n\ncorrente \u00e9 proporcional \u00e0 intensidade do campo magn\u00e9tico e ao tamanho do objeto. Como essas \n\ncorrentes fluem dentro do metal, o metal resiste ao fluxo da corrente e assim se aquece um processo \n\ndenominado de aquecimento indutivo, se o metal \u00e9 magn\u00e9tico, como o ferro, o\n\nampliado. Portanto, quando um fluido magn\u00e9tico \u00e9 exposto a um campo magn\u00e9tico alternado, as \n\npart\u00edculas tornam-se poderosas fontes de calor\n\n(BABINCOVA et al., 2000).  \n\nEssa t\u00e9cnica destr\u00f3i especificamente tumores sem danificar tecidos normais pelo \n\naquecimento seletivo das c\u00e9lulas tumorais. Portanto, a hipertermia magn\u00e9tica \u00e9 uma terapia \n\npromissora contra o c\u00e2ncer (HAYASHI et al., 2009).\n\ncl\u00ednica da hipertermia magn\u00e9tica \u00e9 que as nanopart\u00edculas devem apresentar baixos n\u00edveis de \n\ntoxicidade, assim como um elevado momento de satura\u00e7\u00e3o magn\u00e9tica que permita minimizar as \n\ndoses eletromagn\u00e9ticas requeridas quando a radioterapia \u00e9 utili\n\n \n\nnativas em v\u00e1rios processos, resultando em rea\u00e7\u00f5es mais r\u00e1pidas, menor contamina\u00e7\u00e3o da amostra e \n\nmelhorando o interfaciamento para procedimentos modernos, como espectrometria de ma\n\nA escolha da matriz (propriedades qu\u00edmicas e magn\u00e9ticas, tamanho da part\u00edcula e \n\ndistribui\u00e7\u00e3o, porosidade) \u00e9 um fator chave que influencia na qualidade da imobiliza\u00e7\u00e3o e na \n\nB\u00cdLKOV\u00c1 et al., 2002). Matrizes (suportes) convencionais podem \n\nser magnetizadas pelo tratamento com materiais magn\u00e9ticos sem qualquer perda de atividade da \n\nliga\u00e7\u00e3o subsequente. Uma variedade de materiais magn\u00e9ticos (Figura 9) \n\n(AMARAL et al., 2006; ANGELI et al., 2009; NERI et al., 2009; \n\nNERI et al, 2011; MACIEL et al., 2012).  \n\n \nDesenho esquem\u00e1tico de um \u201cnanobead\u201d magn\u00e9tico que aprisiona mol\u00e9culas de enzima em sua camada de \n\nReproduzido de http://seeds.kyushu-u.ac.jp/en/seed/d382.html \n\nA t\u00e9cnica de hipertermia magn\u00e9tica se baseia na teoria que qualquer objeto met\u00e1lico, quando \n\ncolocado em um campo magn\u00e9tico alternado, tem induzida uma corrente el\u00e9trica. A quantidade de \n\nproporcional \u00e0 intensidade do campo magn\u00e9tico e ao tamanho do objeto. Como essas \n\ncorrentes fluem dentro do metal, o metal resiste ao fluxo da corrente e assim se aquece um processo \n\ndenominado de aquecimento indutivo, se o metal \u00e9 magn\u00e9tico, como o ferro, o\n\nampliado. Portanto, quando um fluido magn\u00e9tico \u00e9 exposto a um campo magn\u00e9tico alternado, as \n\nse poderosas fontes de calor (Figura 10), destruindo as c\u00e9lulas tumorais \n\nEssa t\u00e9cnica destr\u00f3i especificamente tumores sem danificar tecidos normais pelo \n\naquecimento seletivo das c\u00e9lulas tumorais. Portanto, a hipertermia magn\u00e9tica \u00e9 uma terapia \n\npromissora contra o c\u00e2ncer (HAYASHI et al., 2009). Um pr\u00e9-requisito importante para a\n\ncl\u00ednica da hipertermia magn\u00e9tica \u00e9 que as nanopart\u00edculas devem apresentar baixos n\u00edveis de \n\ntoxicidade, assim como um elevado momento de satura\u00e7\u00e3o magn\u00e9tica que permita minimizar as \n\ndoses eletromagn\u00e9ticas requeridas quando a radioterapia \u00e9 utilizada (CASTRO et al., 2010).\n\n20 \n\nnativas em v\u00e1rios processos, resultando em rea\u00e7\u00f5es mais r\u00e1pidas, menor contamina\u00e7\u00e3o da amostra e \n\nmelhorando o interfaciamento para procedimentos modernos, como espectrometria de massa \n\nA escolha da matriz (propriedades qu\u00edmicas e magn\u00e9ticas, tamanho da part\u00edcula e \n\ndistribui\u00e7\u00e3o, porosidade) \u00e9 um fator chave que influencia na qualidade da imobiliza\u00e7\u00e3o e na \n\n. Matrizes (suportes) convencionais podem \n\nser magnetizadas pelo tratamento com materiais magn\u00e9ticos sem qualquer perda de atividade da \n\n) tem sido usada para \n\n(AMARAL et al., 2006; ANGELI et al., 2009; NERI et al., 2009; \n\n \nDesenho esquem\u00e1tico de um \u201cnanobead\u201d magn\u00e9tico que aprisiona mol\u00e9culas de enzima em sua camada de \n\nA t\u00e9cnica de hipertermia magn\u00e9tica se baseia na teoria que qualquer objeto met\u00e1lico, quando \n\ncolocado em um campo magn\u00e9tico alternado, tem induzida uma corrente el\u00e9trica. A quantidade de \n\nproporcional \u00e0 intensidade do campo magn\u00e9tico e ao tamanho do objeto. Como essas \n\ncorrentes fluem dentro do metal, o metal resiste ao fluxo da corrente e assim se aquece um processo \n\ndenominado de aquecimento indutivo, se o metal \u00e9 magn\u00e9tico, como o ferro, o fen\u00f4meno \u00e9 muito \n\nampliado. Portanto, quando um fluido magn\u00e9tico \u00e9 exposto a um campo magn\u00e9tico alternado, as \n\ndestruindo as c\u00e9lulas tumorais \n\nEssa t\u00e9cnica destr\u00f3i especificamente tumores sem danificar tecidos normais pelo \n\naquecimento seletivo das c\u00e9lulas tumorais. Portanto, a hipertermia magn\u00e9tica \u00e9 uma terapia \n\nrequisito importante para a utiliza\u00e7\u00e3o \n\ncl\u00ednica da hipertermia magn\u00e9tica \u00e9 que as nanopart\u00edculas devem apresentar baixos n\u00edveis de \n\ntoxicidade, assim como um elevado momento de satura\u00e7\u00e3o magn\u00e9tica que permita minimizar as \n\nzada (CASTRO et al., 2010). \n\n\n\n \n\n2.5.5. Carreador de f\u00e1rmacos \n\nA tecnologia de libera\u00e7\u00e3o controlada caracteriza o sistema capaz de prover algum controle \n\nterap\u00eautico, seja de natureza temporal, espacial ou ambos. Os sistemas de libera\u00e7\u00e3o de drogas \n\n(\u201cdrug delivery systems\u201d) oferecem in\u00fameras vantagens quando comparados a outros de dosagem \n\nconvencional, tais como: maior efic\u00e1cia terap\u00eautica, libera\u00e7\u00e3o progressiva e controlada do f\u00e1rmaco, \n\ndiminui\u00e7\u00e3o significativa da toxicidade e maior tempo de perman\u00eancia na circula\n\nn\u00famero de doses devido \u00e0 libera\u00e7\u00e3o progressiva e possibilidade de direcionamento a alvos \n\nespec\u00edficos s\u00e3o alguns exemplos (DUR\u00c1N e AZEVEDO, 2003). \n\nMuitos sistemas nanoparticulados est\u00e3o sendo usados atualmente e, entre eles, os baseados \n\nnas nanopart\u00edculas magn\u00e9ticas assumem um papel importante devido \u00e0 propriedade de serem \n\nconduzidas e retidas em uma regi\u00e3o espec\u00edfica do corpo por meio de gradiente de campo magn\u00e9tico \n\nexterno. Com o objetivo de aumentar a especificidade, o conjugado nanopa\n\npode ser associado \u00e0 outra mol\u00e9cula capaz de reconhecer e se ligar especificamente ao s\u00edtio alvo. \n\nTais mol\u00e9culas podem ser anticorpos, prote\u00ednas, lectinas, horm\u00f4nios, entre outros\n\n \n\nFigura 10. Aplica\u00e7\u00f5es m\u00e9dicas de nanopart\u00edculas magn\u00e9ticas. \n \n\n \n\n2.5.6. Chips de c\u00e9lulas \n\n Os sensores de c\u00e9lulas s\u00e3o \u00fateis para estudar os efeitos de drogas e\n\nest\u00edmulos externos e as c\u00e9lulas (CHOI et\n\nimportante processo na fabrica\u00e7\u00e3o de \u201cchips de c\u00e9lulas\u201d\n\ndessas c\u00e9lulas \u00e0 superf\u00edcie do chip constitui uma carcater\u00edstica importante para a imobiliza\u00e7\u00e3o \n\nA tecnologia de libera\u00e7\u00e3o controlada caracteriza o sistema capaz de prover algum controle \n\nterap\u00eautico, seja de natureza temporal, espacial ou ambos. Os sistemas de libera\u00e7\u00e3o de drogas \n\ny systems\u201d) oferecem in\u00fameras vantagens quando comparados a outros de dosagem \n\nconvencional, tais como: maior efic\u00e1cia terap\u00eautica, libera\u00e7\u00e3o progressiva e controlada do f\u00e1rmaco, \n\ndiminui\u00e7\u00e3o significativa da toxicidade e maior tempo de perman\u00eancia na circula\n\nn\u00famero de doses devido \u00e0 libera\u00e7\u00e3o progressiva e possibilidade de direcionamento a alvos \n\nespec\u00edficos s\u00e3o alguns exemplos (DUR\u00c1N e AZEVEDO, 2003).  \n\nMuitos sistemas nanoparticulados est\u00e3o sendo usados atualmente e, entre eles, os baseados \n\nnas nanopart\u00edculas magn\u00e9ticas assumem um papel importante devido \u00e0 propriedade de serem \n\nconduzidas e retidas em uma regi\u00e3o espec\u00edfica do corpo por meio de gradiente de campo magn\u00e9tico \n\nexterno. Com o objetivo de aumentar a especificidade, o conjugado nanopart\u00edcula magn\u00e9tica\n\npode ser associado \u00e0 outra mol\u00e9cula capaz de reconhecer e se ligar especificamente ao s\u00edtio alvo. \n\nTais mol\u00e9culas podem ser anticorpos, prote\u00ednas, lectinas, horm\u00f4nios, entre outros\n\nAplica\u00e7\u00f5es m\u00e9dicas de nanopart\u00edculas magn\u00e9ticas. Reproduzido de http://www.madrimasd.org/ \n\nensores de c\u00e9lulas s\u00e3o \u00fateis para estudar os efeitos de drogas e \n\ns externos e as c\u00e9lulas (CHOI et al., 2005). A imobiliza\u00e7\u00e3o de c\u00e9lulas \n\nbrica\u00e7\u00e3o de \u201cchips de c\u00e9lulas\u201d, e a intera\u00e7\u00e3o entre as c\u00e9lulas e a ades\u00e3o \n\ndessas c\u00e9lulas \u00e0 superf\u00edcie do chip constitui uma carcater\u00edstica importante para a imobiliza\u00e7\u00e3o \n\n21 \n\nA tecnologia de libera\u00e7\u00e3o controlada caracteriza o sistema capaz de prover algum controle \n\nterap\u00eautico, seja de natureza temporal, espacial ou ambos. Os sistemas de libera\u00e7\u00e3o de drogas \n\ny systems\u201d) oferecem in\u00fameras vantagens quando comparados a outros de dosagem \n\nconvencional, tais como: maior efic\u00e1cia terap\u00eautica, libera\u00e7\u00e3o progressiva e controlada do f\u00e1rmaco, \n\ndiminui\u00e7\u00e3o significativa da toxicidade e maior tempo de perman\u00eancia na circula\u00e7\u00e3o, diminui\u00e7\u00e3o do \n\nn\u00famero de doses devido \u00e0 libera\u00e7\u00e3o progressiva e possibilidade de direcionamento a alvos \n\nMuitos sistemas nanoparticulados est\u00e3o sendo usados atualmente e, entre eles, os baseados \n\nnas nanopart\u00edculas magn\u00e9ticas assumem um papel importante devido \u00e0 propriedade de serem \n\nconduzidas e retidas em uma regi\u00e3o espec\u00edfica do corpo por meio de gradiente de campo magn\u00e9tico \n\nrt\u00edcula magn\u00e9tica-droga \n\npode ser associado \u00e0 outra mol\u00e9cula capaz de reconhecer e se ligar especificamente ao s\u00edtio alvo. \n\nTais mol\u00e9culas podem ser anticorpos, prote\u00ednas, lectinas, horm\u00f4nios, entre outros (Figura 10).  \n\n \nReproduzido de http://www.madrimasd.org/  \n\n de intera\u00e7\u00f5es entre os \n\nal., 2005). A imobiliza\u00e7\u00e3o de c\u00e9lulas in vitro constitui um \n\n, e a intera\u00e7\u00e3o entre as c\u00e9lulas e a ades\u00e3o \n\ndessas c\u00e9lulas \u00e0 superf\u00edcie do chip constitui uma carcater\u00edstica importante para a imobiliza\u00e7\u00e3o \n\n\n\n22 \n\n \n\ncelular sem perda de viabilidade. Os fatores que t\u00eam um papel essencial nos mecanismos de ades\u00e3o \n\ncelular s\u00e3o: a composi\u00e7\u00e3o qu\u00edmica da superf\u00edcie e a morfologia do suporte e as intera\u00e7\u00f5es deste com \n\nprote\u00ednas (LAKARD et al., 2004). Os pol\u00edmeros condutores s\u00e3o amplamente utilizados no \n\ndesenvolvimento de tecnologias de biosensores, sendo as enzimas, os anticorpos e as c\u00e9lulas os \n\nprincipais elementos de bioreconhecimento dentro desses pol\u00edmeros condutores (MORRIN et al., \n\n2005). Entre os pol\u00edmeros condutores, a PANI \u00e9 um dos mais empregados, em especial devido ao \n\nf\u00e1cil processo de s\u00edntese, ao baixo custo e \u00e0 estabilidade ambiental (CAMALET et al., 1998). El-\n\nSaid et al. (2009) imobilizaram c\u00e9lulas HeLa em filme de PANI depositado em eletrodo de \u00edndio-\n\nestanho. Esses autores verificaram a viabilidade dessas c\u00e9lulas para diferentes concentra\u00e7\u00f5es de \n\ndrogas antic\u00e2ncer. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n23 \n\n \n\n3. Refer\u00eancias bibliogr\u00e1ficas \n\n \n\nAGUILAR-ARTEAGA, K., RODRIGUEZ, J.A., BARRADO, E. Magnetic solids in analytical \n\nchemistry: a review. Analytica Chimica Acta, 674, 157\u2013165, 2010. \n\n \n\nAH, L., SALABAS, E.L., SCHUTH, F. Magnetic nanoparticles: synthesis, protection, \n\nfunctionalization, and application. Angewandte Chemie International  Edition, 46, 1222\u20131244, \n\n2007. \n\n \n\nAMARAL, I.P.G., CARNEIRO-DA-CUNHA, M.G., CARVALHO JR., L.B., BEZERRA, R.S. \n\nFish trypsin immobilized on ferromagnetic Dacron.  Process Biochemistry, 41, 1213\u20131216, 2006. \n\n \n\nANGELI, R., DA PAZ, N.V. N., MACIEL, J.C., ARA\u00daJO, F.F.B., PAIVA, P.M.G., CALAZANS, \n\nG.M.T., VALENTE, A.P., ALMEIDA, F.C.L., COELHO, L.C.B.B., CARVALHO JR., L.B., \n\nSILVA, M.P.C., CORREIA, M.T.S. Ferromagnetic Levan Composite: An Affinity Matrix to Purify \n\nLectin. Journal of Biomedicine and Biotechnology, 200, 1-7, 2009. \n\n \n\nANSELL, R.J., MOSBACH, K. Magnetic molecularly imprinted polymer beads for drug \n\nradioligand binding assay.  Analyst, 123, 1611\u20131616, 1998. \n\n \n\nAPHESTEGUY, J.C., JACOBO, S.E. Synthesis of a soluble polyaniline-ferrite composite: \n\nmagnetic and electric properties. Journal of Materials Science, 42, 7062\u20137068, 2007. \n\n \n\nARA\u00daJO, A.C.V., OLIVEIRA, R.J., ALVES J\u00daNIOR, S., RODRIGUES, A.R., MACHADO, \n\nF.L.A., CABRAL, F.A.O., AZEVEDO, W.M. Synthesis, characterization and magnetic properties \n\nof polyaniline-magnetite nanocomposites. Synthetic Metals, 160, 685\u2013690, 2010. \n\n \n\nARIAS, J.L., GALLARDO, V., G\u00d3MEZ-LOPERA, S.A., PLAZA, R.D., DELGADO, A.V. \n\nSynthesis and characterization of poly(ethyl-2-cyanoacrylate) nanoparticles with a magnetic core. \n\nJournal of Controlled Release, 77, 309 \u2013 321, 2001. \n\n \n\nARIAS, J.L., L\u00d3PEZ-VIOTA, M., L\u00d3PEZ-VIOTA, J. DELGADO, \u00c1.I.V. Development of \n\niron/ethylcellulose (core/shell) nanoparticles loaded with diclofenac sodium for arthritis treatment. \n\nInternational Journal of Pharmaceutics, 382, 270\u2013276, 2009. \n\n \n\n\n\n24 \n\n \n\nARIAS, J.L., L\u00d3PEZ-VIOTA, M., L\u00d3PEZ-VIOTA, J. DELGADO, \u00c1.I.V. Development of \n\niron/ethylcellulose (core/shell) nanoparticles loaded with diclofenac sodium for arthritis treatment. \n\nInternational Journal of Pharmaceutics, 382, 270\u2013276, 2009. \n\n \n\nAZEVEDO, W.M., BARROS, R.A., DA SILVA JR., E.F. Conductive polymer preparation under \n\nextreme or non-classical conditions. Journal of Materials Science, 43, 1400\u20131405, 2008. \n\n \n\nBABINCOVA, M., LESZCZYNSKA, D., SOURIVONG, P., BABINEC, P. Selective treatment of \n\nneoplastic cells using ferritin-mediated electromagnetic hyperthermia. Medical Hypotheses, 54, \n\n177\u2013179, 2000. \n\n \n\nBACHGANSMO, T. Ferrimagnetic Susceptibility Contrast Agents. Acta Radiologica, 34, 1\u201313, \n\n1993.   \n\n \n\nBANUMATHI, E., HARIBALAGANESH, R., BABU, S., KUMAR, N., SANGILIYANDI, G.: \n\nHigh-yielding Enzymatic Method for Isolation and Culture of Microvascular Endothelial Cells from \n\nBovine Retinal Blood Vessels. Microvascular Research, 77, 377\u2013381, 2009. \n\n \n\nBARROS, V.V.R. Utiliza\u00e7\u00e3o de levana como suporte para imobiliza\u00e7\u00e3o de gentamicina. 2002. \n\nDisserta\u00e7\u00e3o (Mestrado em Bioqu\u00edmica), Universidade Federal de Pernambuco, Recife.  \n\n \n\nBARROS, R.A., AZEVEDO, W.M. Polyaniline/silver nanocomposite preparation under extreme or \n\nnon-classical conditions. Synthetic Metals, 158, 922\u2013926, 2008. \n\n \n\nBAYRAMO?LU, G., YILMAZ, M., ?ENEL, A.\u00dc., ARICA, M.Y. Preparation of nanofibrous \n\npolymer grafted magnetic poly(GMA-MMA)-g-MAA beads for immobilization of trypsin via \n\nadsorption. Biochemical Engineering Journal, 40, 262\u2013274, 2008. \n\n \n\nBEKERS, M., UPITE, D., KAMINSKA, E., LAUKEVICS, J., GRUBE, M., VIGANTS, A., \n\nLINDE, R. Stability of levan produced by Zymomonas mobilis. Process Biochemistry, 40, 1535\u2013\n\n1539, 2005. \n\n \n\nBELAABED, B., WOJKIEWICZ, J.L., LAMOURI, S., KAMCHI, N.E., LASRI, T. Synthesis and \n\ncharacterization of hybrid conducting composites based on polyaniline/magnetite fillers with \n\n\n\n25 \n\n \n\nimproved microwave absorption properties. Journal of Alloys and Compounds, 527, 137\u2013144, \n\n2012. \n\n \n\nBERRY, C.C., WELLS, S., CHARLES, S., CURTIS, A.S.G. Dextran and albumin derivatised iron \n\noxide nanoparticle: influence on fibroblasts in vitro. Biomaterials, 24, 4551\u20134557, 2003. \n\n \n\nB?LKOV\u00c1, Z., SLOV\u00c1KOV\u00c1, M., LY?KA, A., HORAK, D., LENFELD, J., TURKOVA, J., \n\nCHURACEK, J. Oriented immobilization of galactose oxidase to bead and magnetic bead cellulose \n\nand poly(HEMA-co-EDMA) and magnetic poly(HEMA-co-EDMA) microspheres. Journal of \n\nChromatography B: Analytical Technologies in the Biomedical and Life Sciences, 770, 25\u201334, \n\n2002.  \n\n \n\nBON, E.P.S., FERRARA, M.A., CORVO, M.L. Enzimas em biotecnologia: produ\u00e7\u00e3o, aplica\u00e7\u00f5es \n\ne mercado. Rio de Janeiro, Editora Interci\u00eancia, 2008. \n\n \n\nBRANDL, M., MAYER, M., HARTMANN, J., POSNICEK, T., FABIAN, C., FALKENHAGEN, \n\nD. Theoretical analysis of ferromagnetic microparticles in streaming liquid under the influence of \n\nexternal magnetic forces. Journal of Magnetism and Magnetic Materials, 322, 2454\u20132464, 2010. \n\n \n\nBRYJAK, J., KOLARZ, B.N. Immobilisation of trypsin on acrylic copolymers. Process \n\nBiochemistry, 33, 4, 409\u2013417, 1998.  \n\n \n\nCALAZANS, G.M.T. Produ\u00e7\u00e3o de levana para uso cl\u00ednico. 1997. Tese (Doutorado em Tecnologia \n\nde processos qu\u00edmicos e bioqu\u00edmicos), Escola de Qu\u00edmica, Universidade Federal do Rio de \n\nJaneiro, Rio de Janeiro. \n\n \n\nCAMALET, J.L., LACROIX, J.C., AEIYACH, S., CHANE-CHING, K., LACAZE, P.C. \n\nElectrosynthesis of adherent polyaniline films on iron and mild steel in aqueous oxalic acid \n\nm\u00e9dium. Synthetic Metals, 93, 133\u2013142, 1998. \n\n \n\nCASTRO, V.F., CELESTINO, J., DE QUEIROZ, A.A.A., GARCIA, F.G. Propriedades magn\u00e9ticas \n\ne biocompat\u00edveis de nanocomp\u00f3sitos para utiliza\u00e7\u00e3o em magneto-hipertermia. Revista Brasileira de \n\nF\u00edsica M\u00e9dica, 4, 79\u201382, 2010. \n\n \n\n\n\n26 \n\n \n\nCHENG, F.Y., SU, C.H., YANG, Y.S., YEH, C.S., TSAI, C.Y., WU, C.L. Characterization of \n\naqueous dispersions of Fe3O4 nanoparticles and their biomedical applications. Biomaterials, 26, \n\n729\u2013738, 2005. \n\n \n\nCHEN, L., WANG, T., TONG, J. Application of derivatized magnetic materials to the separation \n\nand the preconcentration of pollutants in water samples. Trends in Analytical Chemistry, 30, 1095\u2013\n\n1108, 2011. \n\n \n\nCHEN, N., ZOU, J., WANG, S., YE, Y., HUANG, Y., GADDA, G., YANG, J. Designing Protease \n\nSensors for Real-time Imaging of Trypsin Activation in Pancreatic Cancer Cells. Biochemistry, 48, \n\n3519\u20133526, 2009. \n\n \n\nCHOI, W., PARK, K.W., LEE, D.B., LEE, W., LEE, W.H. Cell immobilization using self-\n\nassembled synthetic oligopeptide and its application to biological toxicity detection using surface \n\nPlasmon resonance. Biosensors and Bioelectronics, 20, 2300\u20132305, 2005. \n\n \n\nCHOMOUCKA, J., DRBOHLAVOVA, J., HUSKA, D., ADAM, V., KIZEK, R., HUBALEK, J. \n\nMagnetic nanoparticles and targeted drug delivering. Pharmacological Research, 62, 144\u2013149, \n\n2010. \n\n \n\nCORNELL, R.M., SCHWERTMANN, U. The iron oxides: structure, properties, reactions, \n\noccurrences and uses. Weinheim: Wiley-VCH, 2003. \n\n \n\nDAOU, T.J., GREN\u00c8CHE, J.M., POURROY, G., BUATHONG, S., DERORY, A., ULHAQ-\n\nBOUILLET, C., DONNIO, B., GUILLON, D., BEGIN-COLIN, S. Coupling agent effect on \n\nmagnetic properties of functionalized magnetite-based nanoparticles. Chemistry of Materials, 20, \n\n5869\u20135875, 2008. \n\n \n\nDE CASTRO, H.F., ANDERSON, W.A. Fine chemicals by biotransformation using lipases. \n\nQu\u00edmica Nova, 18, 544\u2013554, 1995. \n\n \n\nDRBOHLAVOVA, J., HRDY, R., ADAM, V., KIZEK, R., SCHNEEWEISS, O., HUBALEK, J. \n\nPreparation and properties of various magnetic nanoparticles. Sensors, 9, 2352\u20132362, 2009. \n\n \n\n\n\n27 \n\n \n\nDUNNILL, P., LILLY, M.D. Purification of enzymes using. magnetic bioaffinity materials.  \n\nBiotechnology and Bioengineering, 16, 987\u2013990, 1974. \n\n \n\nDUR\u00c1N, N., AZEVEDO, M.M.M. O que \u00e9 nanotecnologia? Atualidades e perspectivas. Instituto \n\nde Qu\u00edmica, UNICAMP, 2003 em: RUTH LUQUEZE CAMILO, S\u00edntese e caracteriza\u00e7\u00e3o de \n\nnanopart\u00edculas magn\u00e9ticas de ferrita de cobalto recobertas por 3-aminopropiltrietoxissilano para uso \n\ncomo material h\u00edbrido em nanotecnologia. Tese (Doutorado em Ci\u00eancias na \u00c1rea de Tecnologia \n\nNuclear \u2013 Materiais), Instituto de Pesquisas Energ\u00e9ticas e Nucleares/ Universidade de S\u00e3o Paulo, \n\nSP, 2006. \n\n  \n\nEL-SAID, W.A., YEA, C.-H., CHOI, J.-W., KWON, I.-K. Ultrathin polyaniline film coated on an \n\nindium\u2013tin oxide cell-based chip for study of anticancer effect. Thin Solid Films, 518, 661\u2013667, \n\n2009. \n\n \n\nELIF BOYUKBAYRAM, A., KIRALP, S., TOPPARE, L., YAGCI, Y. Preparation of biosensors \n\nby immobilization of polyphenol oxidase in conducting co-polymers and their use in determination \n\nof phenolic compounds in red wine. Bioelectrochemistry, 69, 164\u201371, 2006. \n\n \n\nENGASSER, J.M., COULET, P.R. Comparison of intrinsic stabilities of free and bound enzyme by \n\ngraphical removal of diffusional effects. Biochimica et Biophysica Acta, 485, 29\u201336, 1977.  \n\n \n\nFAEZ, R., REIS, C., FREITAS, P.S. DE, KOSIMA, O.K., RUGGERI, G., DE PAOLI, M.-A. \n\nPol\u00edmeros condutores. Qu\u00edmica Nova na Escola, 11, 13\u201318, 2000. \n\n \n\nFEINGOLD, D.S., GEHATIA, M. The structure and properties of levan, a polymer of D- fructose \n\nproduced by cultures and cell-free extracts of Aerobacter levanicum. Journal of Polymer Science, \n\n23, 783\u2013790, 1957.  \n\n \n\nFIGUEROLA, A., DI CORATO, R., MANNA, L., PELLEGRINO, T. From iron oxide \n\nnanoparticles towards advanced iron-based inorganic materials designed for biomedical \n\napplications. Pharmacological Research, 62, 126\u2013143, 2010. \n\n \n\nFUCHS, A. Current and potencial food and non-food application of fructans. In: 686th Meeting \n\nReading of Biochemical Society Transactions, 19, 555\u2013560, 1991.  \n\n \n\n\n\n28 \n\n \n\nFUCHS, A., BRUIJN, J.M., NIEDEVELD, C.J. Bacteria and yeasts as possible candidates for the \n\nproduction of inulinases and levanases. Antonie van Leeuwenhoek, Delft, 5, 333\u2013351, 1985. \n\n \n\nGANDHI, N., SINGH, K., OHLAN, A., SINGH, D.P., DHAWAN, S.K. Thermal, dielectric and \n\nmicrowave absorption properties of polyaniline\u2013CoFe2O4 nanocomposites. Composites Science \n\nand Technology, 71, 1754\u20131760, 2011. \n\n \n\nGIZDAVIC-NIKOLAIDIS, M., TRAVAS-SEJDIC, J., BOWMAKER, G.A., COONEY, R.P., \n\nTHOMPSON, C., KILMARTIN, P.A. The antioxidant activity of conducting polymers in \n\nbiomedical applications. Current Applied Physics, 4, 347\u2013350, 2004. \n\n \n\nH\u00c4FELI, U.O., PAUER, G.J. In vitro and in vivo toxicity of magnetic microspheres. Journal of \n\nMagnetism and Magnetic Materials, 194, 76\u201382, 1999. \n\n \n\nHALLING, P.J., DUNNILL, P. Magnetic supports for immobilized enzymes and bioaffinity \n\nadsorbents. Enzyme and Microbial Technology, 2, 2\u201310, 1980.  \n\n \n\nHAN, Y.W. Microbial levan. Advances in Applied Microbiology, 35, 171\u2013194, 1990.  \n\n \n\nHAO, R., XING, R.J., XU, Z.C., HOU, Y.L., GAO, S., SUN, S.H. Synthesis, functionalization, and \n\nbiomedical applications of multifunctional magnetic nanoparticles. Advanced Materials, 25, 2729\u2013\n\n2742, 2010. \n\n \n\nHAYASHI, K., MORIYA, M., SAKAMOTO, W., YOGO, T. Chemoselective synthesis of folic \n\nacid functionalized magnetite nanoparticles via click chemistry for magnetic hyperthermia. \n\nChemistry of Materials, 21, 1318\u20131325, 2009. \n\n \n\nHEEGER, A.J. Semiconducting and metallic polymers: the fourth generation of polymeric \n\nmaterials. Synthetic Metals, 125, 23\u201342, 2002. \n\n \n\nHERMANSON, G.T., MALLIA, A. K., SMITH, P. K. The matrix. In: Immobilized Affinity Ligand \n\nTechniques. New York: Academic Press, 1992. \n\n \n\nHERMANSON, G.T. In: Bioconjugate techniques. New York:  Academic Press, 134-185, 1996. \n\n \n\n\n\n29 \n\n \n\nHOR\u00c1K, D., PETROVSK\u00dd, E., KAPI?KA, A., FREDERICHS, T. Synthesis and characterization \n\nof magnetic poly(glycidyl methacrylate) microspheres. Journal of Magnetism and Magnetic \n\nMaterials, 311, 500\u2013506, 2007.  \n\n \n\nHUBER, D.L. Synthesis, properties, and applications of iron nanoparticles. Small, 1, 482\u2013501, \n\n2005.  \n\n \n\nITO, A., SHINKAI, M., HONDA, H., KOBAYASHI, T. Medical application of functionalized \n\nmagnetic nanoparticles. Journal of Bioscience and Bioengineering, 100, 1\u201311, 2005. \n\n \n\nJARAMILLO-TABARES, B.E., JARAMILO, F.I, TORRESI, S.I.C. Stabilization of polyaniline by \n\nthe incorporation of magnetite nanoparticles. Materials Chemistry and Physics, 132, 529\u2013533, \n\n2012.  \n\n \n\nKAMALESH, S., TAN, P., WANG, J., LEE, T., KANG, E., WANG, C. Biocompatibility of \n\nelectroactive polymers in tissues. Journal of Biomedical Materials Research, 52, 467\u2013478, 2000. \n\n \n\nKANG, S.K., LEE, S.O., LIM, Y.S., JANG, K.L., LEE, T.H. Purification and characterization of \n\nnovel levanoctaose-producing levanase from Pseudomonas strain K-52. Biotechnology Applied \n\nBiochemistry, 27, 159\u2013166, 1998. \n\n \n\nKANG, Y.S., RISBUD, S., RABOLT, J.F., STROEVE, P. Synthesis and characterization of \n\nnanometer-size Fe3O4 and gamma-Fe2O3 particles. Chemistry of Materials, 8, 2209\u20132211, 1996. \n\n \n\nKENNEDY, J.F., ROIG, M.G. Principles of immobilization of enzymes. In: Handbook of enzyme \n\nbiotechnology. London: T.P. Press, 1995. \n\n \n\nKONCRACK\u00c1, M., KOP?ANSK\u00dd, P., TIMKO, M., RAMCHAND, C.N. Direct binding \n\nprocedure of proteins and enzymes to fine magnetic particles. Journal of Magnetism and Magnetic \n\nMaterials, 252, 409\u2013411, 2002. \n\n \n\nKRESSE, M., WAGNER, S., PFEFFERER, D., LAWACZECK, R., ELSTE, V., SEMMLER, D.W. \n\nTargeting of ultrasmall superparamagnetic iron oxide (uspio) particles to tumor cells in vivo by \n\nusing transferrin receptor pathways. Magnetic Resonance in Medicine, 40, 236\u2013242, 1998. \n\n \n\n\n\n30 \n\n \n\nKREUTER, J. Evaluation of nanoparticles as drug-delivery systems. III: materials, stability, \n\ntoxicity, possibilities of targeting, and use. Pharmaceutica Acta Helvetiae, 58, 242\u2013250, 1983. \n\n \n\nKROGH, T.N., BERG, T., H\u00d8JRUP, P. Protein analysis using enzymes immobilized to \n\nparamagnetic beads. Analytical Biochemistry, 274, 153\u2013162, 1999. \n\n \n\nLAKARD, S., HERLEM, G., PROPPER, A., KASTNER, A., MICHEL, G., VALL\u00c8S-\n\nVILLARREAL, N., GHARBI, T., FAHYS, B. Adhesion and proliferation of cells on new polymers \n\nmodified biomaterials. Bioelectrochemistry, 62, 19\u201327, 2004. \n\n \n\nLEIBOVICI, J., STARK, Y. Slow citotoxicity of the polysaccharide levan on tumor cells in vitro. \n\nChemico-Biological Interactions, 60, 191\u2013200, 1986. \n\n \n\nLIU, J., LIN, S., QI, D., DENG, C., YANG, P., ZHANG, X. On-chip enzymatic microreactor using \n\ntrypsin-immobilized superparamagnetic nanoparticles for highly efficient proteolysis. Journal of \n\nChromatography A, 1176, 169\u2013177, 2007. \n\n \n\nLU, A.H., SALABAS, E.L., SCHUTH, F. Magnetic nanoparticles: synthesis, protection, \n\nfunctionalization, and application. Angewandte Chemie International Edition in English, 46, \n\n1222\u20131244, 2007. \n\n \n\nMACIEL, J.C.,  ANDRADE, P.L., NERI, D.F.M., CARVALHO JR., L.B., CARDOSO, C.A., \n\nCALAZANS, G.M.T.,  AGUIAR, J. ALBINO,  SILVA, M.P.C. Preparation and characterization of \n\nmagnetic levan particles as matrix for trypsin immobilization.  Journal of Magnetism and \n\nMagnetic Materials, 324, 1312\u20131316, 2012. \n\n \n\nMALMSTEN, M., XING, K., LJUNGL\u00d6F, A. Confocal microscopy studies of trypsin \n\nimmobilization on porous glycidyl methacrylate beads. Journal of Colloid and Interface Science, \n\n220, 436-442, 1999. \n\n \n\nMARCHESSAULT, R.H., BLEHA, T., DESLENDES, Y., REVOL, J.T. Canadian Journal of \n\nChemistry, 58, 2415\u20132417, 1980. \n\n \n\nMARTINEK, K., KLIBANOV, A.M., GOLDMACHER, V.S., BEREZIN, I.V. The principles of \n\nenzyme stabilization. Biochimica et Biophysica Acta, 485, 1\u201312, 1977.  \n\n\n\n31 \n\n \n\nMASSIA, S.P., STARK, J., LETBETTER, D.S. Surface immobilized dextran limits cell adhesion \n\nand spreading. Biomaterials, 21, 2253\u20132261, 2000. \n\n \n\nMOFFAT, G., WILLIAMS, R.A., WEBB, C., STIRLING, R. Selective separations in \n\nenvironmental and industrial processes using magnetic carrier technology.  Minerals Engineering, \n\n7, 1039\u20131056, 1994. \n\n \n\nMORRIN, A., NGAMNA, O., KILLARD, A.J., MOULTON, S.E., SMYTH, M.R., WALLACE, \n\nG.G. An amperometric polyaniline enzyme biosensor fabricated from nanoparticles. \n\nElectroanalysis, 17, 423\u2013430, 2005. \n\n \n\nMUNSHI, N., DE, T.K., MAITRA, A. Size modulation of polymeric nanoparticles under controlles \n\ndynamics of microemulsion droplets. Journal of Colloid and Interface Science, 190, 387\u2013391, \n\n1997. \n\n \n\nNERI, D.F.M., BALC\u00c3O, V.M., DOURADO, F.O.Q., OLIVEIRA, J.M.B., CARVALHO JR., \n\nL.B., TEIXEIRA, J.A. Galactooligosaccharides production by ?-galactosidase immobilized onto \n\nmagnetic polysiloxane-polyaniline particles. Reactive &amp; Functional Polymers, 69, 246\u2013251, 2009.  \n\n \n\nNERI, D.F.M., BALC\u00c3O, V.M., DOURADO, F.O.Q., OLIVEIRA, J.M.B., CARVALHO JR., \n\nL.B., TEIXEIRA, J.A. Immobilized ?-galactosidase onto magnetic particles coated with \n\npolyaniline: support characterization and galactooligosaccharides production. Journal of Molecular \n\nCatalysis B: Enzymatic, 70, 74\u201380, 2011.  \n\n \n\nNIKOLIC, T., KOSTIC, M., PRASKALO, J., PEJIC, B., PETRONIJEVIC, Z., SKUNDRIC, P. \n\nSodium periodate oxidized cotton yarn as carrier for immobilization of trypsin. Carbohydrate \n\nPolymers, 82, 976 \u2013 981, 2010.  \nNUNES, J.S., VASCONCELOS, C.L., CABRAL, F.A.O., ARA\u00daJO, J.H., PEREIRA, M.R., \n\nFONSECA, J.L.C. Synthesis and characterization of poly(ethyl methacrylate-co-methacrylic acid) \n\nmagnetic particles via miniemulsion polymerization. Polymer, 47, 7646\u20137652, 2006. \n\n \n\nOH, W.K., KIM, S., KWON, O., JANG, J. Shape-dependent cytotoxicity of polyaniline \n\nnanomaterials in human fibroblast cells. Journal of Nanoscience and Nanotechnology, 11, 4254\u2013\n\n4260, 2011. \n\n\n\n32 \n\n \n\nO\u2019HANDLEY, R.C. Modern Magnetic Materials: Principles and Applications. New York: John \n\nWiley, 2000. \n\n \n\nPANKHURST, Q.A., CONNOLLY, J., JONES, S.K., DOBSON, J. The underlying physics of \n\nbiomedical applications of magnetic nanoparticles.  Journal of Physics D: Applied Physics, 36, \n\n167\u2013181, 2003.  \n\n \n\nPARK, A.K., HWANG, Y., PARK, J.G., NOH, H.J., KIM, J.Y., PARK, J.H., HWANG, N.M., \n\nHYEON, T. Ultra-large-scale syntheses of monodisperse nanocrystals. Nature Materials, 3, 891\u2013\n\n895, 2004.  \n\n \n\nPEREIRA, A.R.P. Forma\u00e7\u00e3o e transforma\u00e7\u00e3o qu\u00edmico-mineral\u00f3gica de hematita em um \n\ngeodom\u00ednio do quadril\u00e1tero ferr\u00edfero, Minas Gerais. 2010. Tese (Doutorado em Ci\u00eancias \u2013 \n\nQu\u00edmica), Universidade Federal de Minas Gerais, Belo Horizonte. \n\n \n\nPETRI-FINK, A., HOFMANN, H. Superparamagnetic iron oxide nanoparticles (SPIONs): from \n\nsynthesis to in vivo studies \u2013 A summary of the synthesis, characterization, in vitro, and in vivo \n\ninvestigations of SPIONs with particular focus on surface and colloidal properties. IEEE \n\nTransactions on Nanobioscience, 6, 289\u2013297, 2007. \n\n \n\nPOWELL, L.W. Immobilized biocatalyst technology. In: Forgat W.M. &amp; Kelly C.T., eds. \n\nMicrobial Enzyme and Biotechnology. London: Elsevier Science Publishers, 1990. \n\n \n\nQU, S.C., YANG, H.B., REN, D.W., KAN, S.H., ZOU, G.T., LI, D.M. Magnetite nanoparticles \n\nprepared by precipitation from partially reduced ferric chloride aqueous solutions. Journal of \n\nColloid and Interface Science, 215, 190\u2013192, 1999. \n\n \n\nROCHA, C., GON\u00c7ALVES, M.P., TEIXEIRA, J.A. Immobilization of trypsin on spent grains for \n\nwhey protein hydrolysis. Process Biochemistry, 46, 505\u2013511, 2011. \n\n \n\nROSEVEAR, A., KENNEDY, J.F., CABRAL, J.M.S. Immobilized enzymes and cells. Bristol: \n\nAdam Hilger, 1987.  \n\n \n\n\u0160AFA??K, I., \u0160AFA??KOV\u00c1, M. Use of magnetic techniques for the isolation of cells. Journal of \n\nChromatography B, 722, 33\u201353, 1999.  \n\n\n\n33 \n\n \n\n\u0160AFA??K, I., \u0160AFA??KOV\u00c1, M. One-step partial purification of Solanum tuberosum tuber lectin \n\nusing magnetic chitosan particles. Biotechnology Letters, 22, 941\u2013945, 2000. \n\n \n\nSAINI, S., STARK, D.D., HAHN, P.F., WITTENBERG, J., BRADY, T.J., FERRUCCI, J.T. Ferrite \n\nparticles: a superparamagnetic MR contrast agent for the reticuloendothelial system. Radiology, \n\n162, 211\u2013216, 1987. \n\n \n\nSAIYED, Z.M., TELANG, S.D., RACNCHAND, C.N. Application of magnetic techniques in the \n\nfield of drug discovery and biomedicine. BioMagnetic Research and Technology, 1, 23\u201333, 2003. \n\n \n\nSAWANT, R.M., SAWANT, R.R., GULTEPE, E., NAGESHA, D., BRIGITTE, P.S., SRIDHAR, \n\nS., TORCHILIN, V.P. Nanosized cancer cell-targeted polymeric immunomicelles loaded with \n\nsuperparamagnetic iron oxide nanoparticles. Journal of Nanoparticle Research, 11, 1777\u20131785, \n\n2009. \n\n \n\nSCHERER, F., ANTON, M., SCHILLINGER, U., HENKE J., BERGEMANN C., KR\u00dcGER A., \n\nG\u00c4NSBACHER B., PLANK C. Magnetofection: enhancing and targeting gene delivery by \n\nmagnetic force in vitro and in vivo. Gene Therapy, 9, 102\u2013109, 2002.  \n\n \n\nSCHUCHERT-SHI, A., HAUSER, P.C. Peptic and tryptic digestion of peptides and proteins \n\nmonitored by capillary electrophoresis with contactless conductivity detection.  Analytical \n\nBiochemistry: Methods in the Biological Sciences, 387, 202\u2013207, 2009.  \n\n \n\nSHUBAYEV, V.I., PISANIC II, T.R., JIN, S. Magnetic nanoparticles for theragnostics. Advanced \n\nDrug Delivery Reviews, 61, 467\u2013477, 2009. \n\n \n\nSOLEIMANI, M., NADRI, S. A protocol for isolation and culture of mesenchymal stem cells from \n\nmouse bone marrow. Nature Protocols, 4, 102\u2013106, 2009. \n\n \n\nSOUZA, R.A., ARA\u00daJO, O.A., FREITAS, P.S., DEPAOLI, M.A. Tratamento de res\u00edduos gerados \n\nna s\u00edntese de polianilina em escala pr\u00e9-piloto. Qu\u00edmica Nova, 26, 938\u2013942, 2003. \n\n \n\nSTARK, D.D., WEISSLEDER, R., ELIZONDO, G., HAHN, P.F., SAINI, S., TODD, L.E., \n\nWITTENBERG, J., FERRUCCI, J.T. Superparamagnetic iron oxide: clinical application as a \n\ncontrast agent for MR imaging of the liver. Radiology, 168, 297\u2013301, 1988.  \n\n\n\n34 \n\n \n\nSUN, L., LI, Q., WANG, W., PANG, J., ZHAI, J. Synthesis of magnetic and lightweight hollow \n\nmicrospheres/polyaniline/Fe3O4 composite in one-step method. Applied Surface Science, 257, \n\n10218\u201310223, 2011. \n\n \n\nTAKASHIMA, W., KANEKO, M., KANETO, K., MACDIARMID, A.G. The electrochemical \n\nactuator using electrochemically-deposited polyaniline film. Synthetic Metals, 71, 2265\u20132266, \n\n1995. \n\n \n\nTARTAJ, P., MORALES, M.P., VEINTEMILLAS-VERDAGUER, S., GONZ\u00c1LEZ-CARRE\u00d1O, \n\nT., SERNA, C.J. Preparation of magnetic nanoparticles for applications in biomedicine. Journal of \n\nPhysics D: Applied Physics, 36, 182\u2013197, 2003. \n\n \n\nTISCHER, W., KASCHE, V. Immobilized enzymes: crystals or carriers. Trends in Biotechnology, \n\n17, 326\u2013335, 1999.  \n\n \n\nTOKORO, H., NAKABAYASHI, T., FUJII, S., ZHAO, H., H\u00c4FELI, U.O. Magnetic iron particles \n\nwith high magnetization useful for immunoassay. Journal of Magnetism and Magnetic Materials, \n\n321, 1676\u20131678, 2009. \n\n \n\nTROMSDORF, U.I., BIGALL, N.C., KAUL, M.G., BRUNS, O.T., NIKOLIC, M.S., MOLLWITZ, \n\nB. Size and surface effects on the MRI relaxivity of manganese ferrite nanoparticle contrast agents. \n\nNano Letters, 7, 2422\u20132427, 2007. \n\n \n\nTZETIS, M., KALIAKATSOS, M., FOTOULAKI, M., PAPATHEODOROU, A., \n\nDOUDOUNAKIS, S., TSEZOU, A., MAKRYTHANASIS, P., KANAVAKIS, E., NOUSIA-\n\nARVANITAKIS, S. Contribution of the CFTR gene, the pancreatic secretory trypsin inhibitor gene \n\n(SPINK1) and the cationic trypsinogen gene (PRSS1) to the etiology of recurrent pancreatitis. \n\nClinical Genetics, 71, 451\u2013457, 2007. \n\n \n\nTUCEK, J., ZBORIL, R., PETRIDIS, D. Maghemite nanoparticles by view of Mossbauer \n\nspectroscopy. Journal of Nanoscience Nanotechnol, 6, 926\u2013947, 2006. \n\n \n\nUMARE, S.S., SHAMBHARKAR, B.H., NINGTHOUJAM, R.S. Synthesis and characterization of \n\npolyaniline-Fe3O4 nanocomposite: electrical conductivity, magnetic, electrochemical studies. \n\nSynthetic Metals, 160, 1815\u20131821, 2010. \n\n\n\n35 \n\n \n\nVANDAMME, E.J., DERYCKE, D.G. Microbial inulinases: fermentation process, properties and \n\napplications. Advances in Applied Microbiology, 29, 139\u2013176, 1983. \n\n \n\nVIETH, W.R. Bioprocess engineering \u2013 kinetic, mass transport, reactors and gene expression. \n\nNew York: John Wiley &amp; Sons, 1994. \n\n \n\nVILLALBA, P., RAM, M.K., GOMEZ, H., BHETHANABOTLA, V., HELMS, M.N., KUMAR, \n\nA., KUMAR, A. Cellular and in vitro toxicity of nanodiamond-polyaniline composites in \n\nmammalian and bacterial cell. Materials Science and Engineering: C, 32, 594\u2013598, 2012. \n\n \n\nVILLALONGA, R., VILLALONGA, M.L., G\u00d3MEZ, L. Preparation and functional properties of \n\ntrypsin modified by carboxymethylcelulose. Journal of Molecular Catalysis B: Enzymatic, 10, \n\n483\u2013490, 2000. \n\n \n\nVILLENEUVE, P., MUDERHWA, J.M., GRAILLE, J., HAAS, M.J. Customizing lipases for \n\nbiocatalysis: a survey of chemical, physical and molecular biological approaches. Journal of \n\nMolecular Catalysis B: Enzymatic, 9, 113\u2013148, 2000. \n\n \n\nVINA, I., KARSAKEVICH, A., BEKERS, M. Stabilization of anti-leukemic enzyme L-\n\nasparaginase by immobilization on polysaccharide levan. Journal of Molecular Catalysis B: \n\nEnzymatic, 11, 551\u2013558, 2001.  \n\n \n\nWANG, X., ZHUANG, J., PENG, Q., LI, Y.D. A general strategy for nanocrystal synthesis. \n\nNature, 437, 121\u2013124, 2005.  \n\n \n\nWANG, C.H., DONG, Y.Q., SENGOTHI, K., TAN, K.L., KANG, E.T. In vivo tissue response to \n\npolyaniline. Synthetic Metals, 102, 1313\u20131314, 1999. \n\n \n\nWANG, S., BAO, H., YANG, P., CHEN, G. Immobilization of trypsin in polyaniline-coated nano-\n\nFe3O4/carbon nanotube composite for protein digestion. Analytica Chimica Acta, 612, 182\u2013189, \n\n2008. \n\n \n\nWEISSLEDER, R., BOGDANOV, A., NEUWELT, E.A., PAPISOV, M. Long-circulating iron \n\noxides for MR imaging. Advanced Drug Delivery Reviews, 16, 321\u2013334, 1995. \n\n\n\n36 \n\n \n\nWEISSLEDER, R., LEE, A.S., FISCHMAN, A.J., REIMER, P., SHEN, T., WILKINSON, R., \n\nCALLAHAN, R.J., BRADY, T.J. Polyclonal human immunoglobulin-G labeled with polymeric \n\niron oxide antibody MR imaging. Radiology, 181, 245\u2013249, 1991. \n\n \n\nWEISSLEDER, R., LEE, A.S., KHAW, B.A., SHEN, T., BRADY, T.J. Antimyosin-labeled \n\nmonocrystalline iron-oxide allows detection of myocardial infarct \u2013 MR antibody imaging. \n\nRadiology, 182, 381-385, 1992.  \n\n \n\nWILLIS, A.L., TURRO, N.J., O\u2019BRIEN, S. Spectroscopic characterization of surface of iron oxide \n\nnanocrystals. Chemistry of Materials, 17, 5970\u20135975, 2005. \n\n \n\nWINGARD JR., L.B. Enzyme Engineering. New York: Interscience Publishers, 1972. \n\n \n\nWU, W., HE, Q.G., JIANG, C.Z. Magnetic iron oxide nanoparticles: synthesis and surface \n\nfunctionalization strategies. Nanoscale Research Letters, 3, 397\u2013415, 2008.  \n\n \n\nWUNDERBALDINGER, P., JOSEPHSON, L., WEISSLEDER, R. Tat peptide directs enhanced \n\nclearance and hepatic permeability of magnetic nanoparticles. Bioconjugate Chemistry, 13, 264\u2013\n\n268, 2002. \n\n \n\nXI, F., WU, J., JIA, Z., LIN, X. Preparation and characterization of trypsin immobilized on silica \n\ngel supported macroporous chitosan bead. Process Biochemistry, 40, 2833\u20132840, 2005.  \n\n \n\nXIAO, Q., TAN, X., JI, L., XUE, J. Preparation and characterization of polyaniline/nano-Fe3O4 \n\ncomposites via a novel Pickering emulsion route. Synthetic Metals, 157, 784\u2013791, 2007. \n\n \n\nYANG, H., ZHANG, C.X., SHI, X.Y., HU, H., DU, X.X., FANG, Y., MA, Y.B., WU, H.X., \n\nYANG, S.P. Water-soluble superparamagnetic manganese ferrite nanoparticles for magnetic \n\nresonance imaging. Biomaterials, 31, 3667\u20133673, 2010.  \n\n \n\nYANG, M., CHEN, C., WANG, X., ZHU, Y., GU, Y. Favorable Effects of the Detergent and \n\nEnzyme Extraction Method for Preparing Decellularized Bovine Pericardium Scaffold for Tissue \n\nEngineered Heart Valves. Journal of Biomedical Materials Research Part A, 91, 354\u2013361, 2009. \n\n \n\n\n\n37 \n\n \n\nYSLAS, E.I., IBARRA, L.E., PERALTA, D.O., BARBERO, C.A., RIVAROLA, V.A., \n\nBERTUZZI, M.L. Polyaniline nanofibers: acute toxicity and teratogenic effect on Rhinella \n\narenarum embryos. Chemosphere, 87, 1374\u20131380, 2012. \n\n \n\nZABORSKY, O.R. Immobilized enzymes. Cleveland: CRC Press, 1973. \n\n \n\nZABORSKY, O.R. Immobilized enzymes \u2013 Miscellaneous methods and general classification. In: \n\nImmobilized enzymes \u2013 Methods in Enzymology. New York: Academic Press, 1976. \n\n \n\nZANIN, G.M., MORAES, F.F. Enzimas como agentes biotecnol\u00f3gicos.  Ribeir\u00e3o Preto: Legis \n\nSumma, 2004. \n\n \n\nZBORIL, R., MASHLAN, M., PETRIDIS, D. Iron(iii) oxides from thermal processes-synthesis, \n\nstructural and magnetic properties, Mossbauer spectroscopy characterization, and applications. \n\nChemistry of Materials, 14, 969\u2013982, 2002. \n\n \n\nZHANG, Y.-J., LIN, Y.-W., CHANG, C.-C., WU, T.-M. Magnetic properties of hydrophilic iron \n\noxide/polyaniline nanocomposites synthetisized by in situ chemical oxidative polymerization. \n\nSynthetic Metals, 160, 1086\u20131091, 2010. \n\n \n\nZHU, L., MA, J., JIA, N., ZHAO, Y., SHEN, H. Chitosan-coated magnetic nanoparticles as carriers \n\nof 5-fluorouracil: preparation, characterization and cytotoxicity studies. Colloids and Surfaces B-\n\nBiointerfaces, 68, 1\u20136, 2009. \n\n \n\n \n\n  \n\n\n\n38 \n\n \n\nCap\u00edtulo 2 \n\n \n\n4. Artigo submetido ao peri\u00f3dico Analytica Chimica Acta \n\n \n\nT\u00edtulo: Magnetic particles coated with polyaniline: effect of the polymerization conditions on the \nactivity of immobilized trypsin for protein digestion \n \n\nAutores: Jackeline C. Maciel, Mariana Cabrera, David F.M. Neri, Maria da Paz C. Silva, Luiz B. \nCarvalho Jr. \n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n39 \n\n \n\nMagnetic particles coated wtih polyaniline: effect of the polymerization conditions on the \n\nactivity of immobilized trypsin for protein digestion \n\n \n\nJackeline C. Maciela, Mariana Cabreraa, David F.M. Nerib, Maria da Paz C. Silvaa, Luiz B. \n\nCarvalho Jr.a \n \n\naDepartamento de Bioqu\u00edmica and Laborat\u00f3rio de Imunopatologia Keizo Asami, Universidade \n\nFederal de Pernambuco, Cidade Universit\u00e1ria, Recife-PE CEP 50670-901, Brazil \nbUniversidade Federal do Vale do S\u00e3o Francisco, Centro, Petrolina-PE CEP 56304-205, Brazil \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n*Corresponding author: \n\nLuiz Bezerra de Carvalho J\u00fanior \n\nLaborat\u00f3rio de Imunopatologia Keizo Asami (LIKA) \n\nUniversidade Federal de Pernambuco \n\nCidade Universit\u00e1ria, Recife \u2013 PE CEP 50670\u2013901, Brazil \n\nTelephone number: + 55-81-21268485/ Fax: +55-81-21268485 \n\nE-mail address: lbcj@hotlink.com.br  \n\n\n\n40 \n\n \n\nAbstract \n\nThe main objective of this work was to produce an enzymatic derivative with higher retention \n\nactivity to be used the protein digestion. The proteolytic enzyme trypsin was immobilized on \n\ncomposite of magnetic nanoparticles-polyaniline and the influence of coating on residual specific \n\nactivity of the enzyme was studied using two 23 complete factorial designs. The 1st factorial design \n\nresults showed that the best conditions for the KMnO4 concentration, aniline concentration and \n\npolymerization time were 0.1 M; 0.5 M and 1 h, respectively, with a maximum residual specific \n\nactivity of 70% of the initial activity of the free enzyme solution. In the sequence, the best result in \n\nthe 2nd factorial design for the contact time of KMnO4, polymerization temperature and offered \n\nprotein were 1 h; 4\u00b0C and 50 \u00b5 g mL-1, respectively, with a maximum residual specific activity of \n\n79%. Under the optimized conditions, the immobilized trypsin exhibited higher thermal stability \n\n(35\u00b0C\u201365\u00b0C); higher apparent affinity for the substrate (Kmapp was 1.4-fold lower than that of the \n\nsoluble enzyme) and after 48 days of storage at 4\u00b0C retained 89% of its initial activity. The \n\nfeasibility and performance of this enzymatic derivative offers a wide range of applications in the \n\nbiomedical sciences including proteome research due the simple method and low cost of production \n\nof the enzymatic derivative. \n\n \n\nKeywords: magnetic composite, magnetic nanoparticles, PANI, enzyme \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n41 \n\n \n\n1. Introduction \n\nImmobilization of biomolecules onto insoluble supports is an important tool for the fabrication of a \n\ndiverse range of functional materials or devices [1]. It provides many distinct advantages including \n\nenhanced stability, easy separation from reaction mixture, possible modulation of the catalytic \n\nproperties, and easier prevention of microbial growth [2]. Numerous approaches had been taken to \n\nimmobilize bioactive molecules onto solid substrates including adsorption, covalent coupling and \n\ntethering via an intermediate linker molecule [3].  \n\nThe typical protocol for protein digestion is accomplished by enzymatic hydrolysis [4]. However, \n\nthe traditional digestion (in solution) has drawbacks, because often produces autoproteolysis of the \n\nenzyme, leading to non-substrate related background peaks [5]. Different types of enzymes can be \n\nused in this step, depending of the purpose of the analysis [6]. Trypsin is by far the most common \n\nenzyme used, this enzyme cleaves peptide bonds predominantly at the carboxyl side of amino acids \n\nlysine and arginine [7].  \n\nMagnetite (Fe3O4) or maghemite (?- Fe2O3) are usually used as magnetic materials [8], especially as \n\nsupports for immobilization. The magnetite particles are preferred because of their greater \n\nsaturation magnetization [9].  These magnetite beads are generally of core-shell type: the biological \n\nspecies cells, nucleic acids, and proteins are connected to the magnetite core through an organic or \n\npolymeric shell [10].  \n\nIn our lab a composite has been proposed including polyaniline (PANI) to the magnetite [11,12]. \n\nPANI is one of the most investigated conducting polymers. It has been studied frequently because \n\nof its low cost, its ease in preparation, good thermal and environmental stabilities, its versatile \n\napplications [13\u201316], its diverse structures, good solution processability and high conductivity [17]. \n\nFor the optimization of process, factorial designs are widely used to investigate the effects of \n\nexperimental factors and the interactions between those factors, that is, how the effect of one factor \n\nvaries with the level of the other factors in a response [18]. The advantages of factorial experiments \n\ninclude the relatively low cost, a reduced number of experiments, and increased possibilities to \n\nevaluate interactions among the variables [19]. \n\nIn this work, were optimized the aniline polymerization conditions. Two factorial designs were used \n\nto investigate the effects of experimental factors and the interactions between those factors. The \n\nproperties of immobilized trypsin were characterized and compared with those of the soluble \n\ntrypsin. Finally, the applicability of this enzymatic derivative shows advantages due to its low cost \n\nand simple method, specially. \n\n \n\n \n\n \n\n\n\n42 \n\n \n\n2. Materials and methods \n\n \n\n2.1. Materials \n\nTrypsin (E.C.3.4.21.4) from porcine pancreas, N-benzoyl-D-L-arginine-p-nitroanilide (BAPNA), \n\naniline (ACS reagent), potassium permanganate (ACS reagent) and glutaraldehyde were all \n\nproducts from Sigma-Aldrich (USA). Dimethylsulfoxide (DMSO) and sodium hydroxide were from \n\nVetec Chemical (Brazil). Ferric chloride hexahydrate and ferrous chloride tetrahydrate were from \n\nMerck (Germany). All other reagents were of analytical grade. \n\n \n\n2.2. Magnetic particles preparation \n\nSolutions of 1.1 M FeCl3 .6H2O (5 mL) and of 0.6 M FeCl2 .4H2O (5 mL) were added to 50 mL of \n\ndistilled water, under magnetic agitation, then 5.0 M NaOH was added dropwise up to pH 10 when \n\nblack particles precipitate were being produced. The mixture was heated at 50\u00b0C for 30 min with \n\nvigorous stirring. The magnetic particles were thoroughly washed with distilled water until pH was \n\nneutral. The material was dried up and kept at room temperature.  \n\n \n\n2.3. Polymerization of aniline \n\nThe oxidative polymerization of aniline was carried out in the presence of magnetic particles (0.01 \n\ng) by treating them with KMnO4 solution at 25\u00b0C and washing with distilled water (in the 1st \n\ndesign, contact time of KMnO4 with magnetic particles was overnight; whereas in the 2nd design it \n\nwas in agreement with the Table 3). Then magnetic-KMnO4 particles were immersed into aniline \n\nsolution in 1.0 M HNO3. After polymerization, the magnetic nanoparticles-polyaniline (mPANI) \n\nwere successively washed with distilled water, 0.1 M citric acid and rewashed with distilled water, \n\nand finally the material was dried up and kept at 25\u00b0C. \n\n \n\n2.4. Immobilization of trypsin \n\nmPANI (0.01g) was incubated with 2.0% w/v glutaraldehyde (1.0 mL) at 25\u00b0C for 2 h under mild \n\nstirring, washed with distilled water and Tris-HCl buffer to remove the excess of glutaraldehyde. \n\nmPANI activated with glutaraldehyde (mPANIG) was kept in buffer at 4\u00b0C until use. mPANIG was \n\nincubated with trypsin solution ranging from 50\u2013200 \u00b5 g mL-1 (Table 3) for 16 h at 4\u00b0C under mild \n\nstirring. The enzymatic derivative (mPANIG-Trypsin) was collected by a magnetic field (Ciba \n\nCorning; 0.6 T) and the supernatant and washings were used for protein determination.  \n\n \n\n \n\n \n\n\n\n43 \n\n \n\n2.5. Activity assay  \n\nAmidase activity of the trypsin was measured by using the artificial substrate BAPNA (4.0 mM \n\nBAPNA in DMSO). The mixture of reaction was incubated at 25\u00b0C for 15 min. The hydrolyzed p-\n\nnitroanilide was monitored in spectrophotometer at 440 nm and the activity of enzyme was \n\ncalculated. All assays were carried out in replicates and the results are expressed as mean \u00b1 standard \n\ndeviation. One unit of proteolytic activity of trypsin was defined as 1\u00b5mol of BAPNA hydrolyzed \n\nper minute using an absorption coefficient of 9.100 M-1 cm-1. The specific activity was calculated by \n\ndividing the enzymatic activity (U) by the amount of protein (mg). For the residual specific activity \n\nwas considered  the specific activity of the free enzyme as 100%.  \n\n \n\n2.6. Protein determination \n\nThe retained protein was estimated by the difference between the offered protein and that found in \n\nthe supernatant and washing solutions measured according to the method of Lowry et al. [20] using \n\nbovine serum albumin (BSA) as a standard. \n\n \n\n2.7. Experimental design \n\nAccording to literature data, the synthesis of PANI is influenced for experimental factors, such as \n\naniline concentration and polymerization temperature for example. Therefore based in an \n\nexperimental protocol routinely in our laboratory [11,12] were carried out two 23 complete factorial \n\ndesigns in this study, requiring 10 experiments for  1st factorial design and 20 experiments for 2nd \n\nfactorial design. The central point was run in replicates to provide an estimate of the pure error \n\nvariance in the experimental responses. Experimental errors of the effects were estimated and used \n\nto assess the significance of the effects and interactions of the independent variables. The variables \n\nand their levels selected for study were: KMnO4 concentration (0.1\u20130.3 M), aniline concentration \n\n(0.5\u20131.0 M), polymerization time (1\u20133 h), contact time of KMnO4 (1\u20135 h), polymerization \n\ntemperature (4\u201350\u00baC), and offered protein amount (50\u2013200 \u00b5 g mL-1). Table 1 and 3 show the \n\nindependent factors, levels and experimental design. The results were statistically analyzed by \n\nvariance analysis (ANOVA) at a significance level of p ? 0.05. All statistical and graphical analyses \n\nwere carried out with the \u201cStatistical 8.0\u201d software (StatSoft, Inc., 2004, USA).  \n\n \n\n2.8. Characterization of mPANIG-Trypsin \n\n2.8.1. Thermal stability  \n\nThe thermal stability was evaluated by incubating samples of soluble trypsin and mPANIG-Trypsin \n\nin Tris-HCl buffer for 30 min at temperatures ranging from 25oC to 65oC. The heated samples were \n\n\n\n44 \n\n \n\nkept at 25oC for temperature equilibration and their activities measured. All activity assays were \n\ncarried out as described in the item 2.5.  \n\n \n\n2.8.2. Kinetic constants  \n\nThe Km for soluble trypsin and mPANIG-Trypsin was calculated from initial rate data using \n\nBAPNA as substrate (0.15\u20133.75 mM). The Michaelis constant (Km) and the maximum reaction \n\nvelocity (Vmax) of the soluble trypsin and mPANIG-Trypsin were determined mathematically using \n\nthe Michaelis-Menten equation. \n\n \n\n2.8.3. Stability during storage  \n\nThe mPANIG-Trypsin was stored in Tris-HCl buffer at 4\u00b0C. The remaining activity of immobilized \n\ntrypsin was evaluated during 48 days, by measurements of its activity, followed by washing with \n\nTris-HCl buffer and storage again in the buffer at 4\u00b0C.  \n\n \n\n2.9. Protein digestion  \n\nmPANIG-Trypsin was used for digestion of bovine serum albumin (BSA). The stock solution of \n\nBSA (2.0 \u00b5 g mL-1) was prepared in Tris-HCl buffer. Before tryptic digestion, it was denatured in a \n\n95\u00b0C water bath for 5 min. Then, 100 \u00b5 L of stock solution and 800 \u00b5 L of Tris-HCl buffer were \n\ntransferred into an tube containig mPANIG-Trypsin (10 \u00b5 g of protein/mg of mPANI). After the \n\nmixture solution was incubated in 37\u00b0C water bath for 15 min, mPANIG-Trypsin was separated by \n\nan external field. The supernatant was transferred to an Eppendorf tube and lyophilized. For \n\ncomparison, 0.2 mg mL-1 BSA was digested by conventional in-solution proteolysis in Tris-HCl \n\nbuffer for 12 h at 37\u00b0C (trypsin/substrate ratio, 1:40 w/w). \n\n \n\n2.10. MALDI-TOF MS procedure \n\nMatrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) \n\nmeasurements were performed in positive ion mode using an Autoflex III proteomics analyzer \n\n(Bruker Daltonics Inc., Billerica, MA, USA). The samples were prepared using the dried-droplet \n\nmethod [21]. They were dissolved in 100 \u00b5 L of 0.1% TFA. A volume of 1.0 \u00b5 L of matrix solution \n\n(10 \u00b5 g mL-1 CHCA dissolved in 50% aqueous ACN containing 0.3% TFA) was mixed to 1.0 \u00b5 L of \n\nthe sample and 0.5 \u00b5 L of mixture was deposited on a MALDI plate. The MS instrument was \n\noperated at an accelerating voltage of 19 kV. A 100 Hz pulsed Nd:YAG laser at 355 nm was used. \n\n\u201cFlexAnalysis\u201d software obtained from Bruker Daltonics was used to identify proteins using the \n\npeptide fingerprint mass spectra (PMF). For PMF data, 1000 laser shots were accumulated for each \n\n\n\n45 \n\n \n\nspectrum. Data obtained were searched using MASCOT (Matrix Sciences, London, UK) as the \n\nsearch engine.  \n\n \n\n3. Results and discussion \n\n3.1. KMnO4 concentration, aniline concentration and polymerization time effect in the mPANIG-\n\nTrypsin activity (1st factorial design) \n\nThe main effects represent deviations of the average between the high and low levels for each \n\nfactor. When the effect of a factor is positive, the response increase as the factor changes from low \n\nto high levels, for example [22]. The results of the 1st complete factorial design are presented in the \n\nTable 1.  \n\nTable 1. Matrix of experiments and results for 1st factorial design \n \n\nRun    Response \n KMnO4 \n\nconcentration \n(M) \n\nAniline \nconcentration \n\n(M) \n\nPolymerization \ntime \n(h) \n\nResidual \nspecific activity  \n\n(%) \n1 0.1 0.5 1 70.05 \n2 0.3 0.5 1 47.09 \n3 0.1 1.0 1 26.37 \n4 0.3 1.0 1 32.86 \n5 0.1 0.5 3 69.49 \n6 0.3 0.5 3 53.46 \n7 0.1 1.0 3 33.04 \n8 0.3 1.0 3 39.98 \n9 0.2 0.75 2 37.09 \n\n10 0.2 0.75 2 36.75 \n \n\n \n\nThe KMnO4 concentration and aniline concentration showed significant negative effect, suggesting \n\nthat the decrease of the parameter values increase the residual specific activity of mPANIG-Trypsin \n\n(Table 2). Moreover, the polymerization time factor showed significant positive effect, suggesting \n\nthat the increase of the parameter values increase the residual specific activity of enzyme. Alone the \n\naniline and KMnO4 concentrations interaction between was statistically significant have positive \n\neffect (Table 2).  \n\nTable 2. Main and interaction effects for the 1st complete factorial design \n \n\nFactors Effects on residual \nspecific activity \n\n(a) KMnO4 concentration    \u20136.39 \n(b) Aniline concentration   \u201326.96 \n(c) Polymerization time      4.90 \na*b  13.10 \na*c     1.84* \nb*c    1.99* \na*b*c  \u20131.61* \n\n                                        *Not significant (p<0.05) \n\n\n\n \n\nAccording to the results shown in Table \n\ncorresponded to lowest levels (0.5 M aniline, 0.1 M KMnO\n\nresults are similar to the conditions used in our research group [11,12], except by reduction in the \n\npolymerization time of 2 h to 1 h, thus an advantage in this study. \n\nAs shown in Pareto chart (Figure \n\nand polymerization time) and their interactions that extend beyond the reference line were \n\nsignificant at the level of the 0.05. These results can be corroborated by data showed in the Table \n\nThe aniline concentration represented the main effect most significant on residual specific activity \n\nof mPANIG-Trypsin, ie, it was what exerted a greater influence in the response.  This 1st design \n\nallowed obtaining an enzymatic derivative with 70.05% residual spec\n\n \n\nFigure 1. Pareto chart for the effects of \npolymerization time (c) on residual specific activity of mPANIG\n \n\n \n\n3.2. Contact time of KMnO4, polymerization temperature and offered protein effects in the \n\nmPANIG-Trypsin activity (2nd factorial design) \n\nA 2nd complete factorial design was carried out to produce an enzymatic derivative with greater \n\nactivity than that observed in the 1st design done in this work. The results of this 2nd design can be \n\nseen in the Table 3.  \n\nIt is possible to see that the leve\n\n(76.01%). According to data from Table 3\n\n5 h, maintaining the polymerization temperature at 4\u00b0C and 50 \u00b5 g mL\n\ndecreased about 15%. This result shows the advantage of the optimization of original protocol, that \n\nuses a contact time of KMnO4 overnight [11,12].\n\n \n\nAccording to the results shown in Table 1, the highest residual specific activity (70.05%) \n\ncorresponded to lowest levels (0.5 M aniline, 0.1 M KMnO4 and polymerization time of 1 h). These \n\nresults are similar to the conditions used in our research group [11,12], except by reduction in the \n\npolymerization time of 2 h to 1 h, thus an advantage in this study.  \n\nAs shown in Pareto chart (Figure 1), the main factors (KMnO4 concentration, aniline concentration \n\nand polymerization time) and their interactions that extend beyond the reference line were \n\nsignificant at the level of the 0.05. These results can be corroborated by data showed in the Table \n\nne concentration represented the main effect most significant on residual specific activity \n\nTrypsin, ie, it was what exerted a greater influence in the response.  This 1st design \n\nallowed obtaining an enzymatic derivative with 70.05% residual specific activity.\n\nPareto chart for the effects of the variables KMnO4 concentration (a), aniline concentration (\n) on residual specific activity of mPANIG-Trypsin from the 1st factorial design.\n\n, polymerization temperature and offered protein effects in the \n\nTrypsin activity (2nd factorial design)  \n\nA 2nd complete factorial design was carried out to produce an enzymatic derivative with greater \n\nactivity than that observed in the 1st design done in this work. The results of this 2nd design can be \n\nIt is possible to see that the levels inferiors are the best conditions observed in this design also \n\nAccording to data from Table 3, when the contact time of KMnO4 was elevated from 1 to \n\n5 h, maintaining the polymerization temperature at 4\u00b0C and 50 \u00b5 g mL-1 offered protein, the act\n\ndecreased about 15%. This result shows the advantage of the optimization of original protocol, that \n\novernight [11,12]. \n\n46 \n\n, the highest residual specific activity (70.05%) \n\nand polymerization time of 1 h). These \n\nresults are similar to the conditions used in our research group [11,12], except by reduction in the \n\nconcentration, aniline concentration \n\nand polymerization time) and their interactions that extend beyond the reference line were \n\nsignificant at the level of the 0.05. These results can be corroborated by data showed in the Table 2.  \n\nne concentration represented the main effect most significant on residual specific activity \n\nTrypsin, ie, it was what exerted a greater influence in the response.  This 1st design \n\nific activity. \n\n \n\n), aniline concentration (b) and \n1st factorial design. \n\n, polymerization temperature and offered protein effects in the \n\nA 2nd complete factorial design was carried out to produce an enzymatic derivative with greater \n\nactivity than that observed in the 1st design done in this work. The results of this 2nd design can be \n\nls inferiors are the best conditions observed in this design also \n\nwas elevated from 1 to \n\noffered protein, the activity \n\ndecreased about 15%. This result shows the advantage of the optimization of original protocol, that \n\n\n\n \n\nTable 3. Matrix of experiments and results for 2nd factorial design\n \n\nRun  \n Time of\n\nKMnO\n(h) \n\n1 (1) 1 \n2 (1) 5 \n3 (1) 1 \n4 (1) 5 \n5 (1) 1 \n6 (1) 5 \n7 (1) 1 \n8 (1) 5 \n9 (1) 3 \n10 (1) 3 \n11 (2) 1 \n12 (2) 5 \n13 (2) 1 \n14 (2) 5 \n15 (2) 1 \n16 (2) 5 \n17 (2) 1 \n18 (2) 5 \n19 (2) 3 \n20 (2) 3 \n\n       \n \n\n \n\nThe Pareto chart represents the estimated effects of the variables, and their interactions on residual \n\nspecific activity in decreasing order of magnitude. It can be seen in Figure \n\n(polymerization temperature, contact time of KMnO\n\nconfidence level of 95%. Thus the values of the effects indicate that, on average, higher activities \n\nwere obtained when factors contact time of\n\nprotein were at their lowest levels. \n\n \n\nFigure 2. Pareto chart for the effects of \noffered protein (f) on residual specific activity \n \n\nMatrix of experiments and results for 2nd factorial design\n\n  Response\nof \n\nKMnO4 \n \n\nPolymerization \ntemperature \n\n(\u00b0C) \n\nOffered protein \namount \n\n(\u00b5g mL-1) \n\nResidual \nspecifica \n\n(%)\n4 50 72.70\n4 50 60.45\n\n50 50 34.85\n50 50 32.38\n4 200 37.01\n4 200 41.61\n\n50 200 31.51\n50 200 30.74\n27 125 44.41\n27 125 43.80\n4 50 79.05\n4 50 60.87\n\n50 50 30.07\n50 50 30.63\n4 200 38.32\n4 200 36.70\n\n50 200 33.35\n50 200 31.93\n27 125 45.33\n27 125 39.69\n\nThe Pareto chart represents the estimated effects of the variables, and their interactions on residual \n\nspecific activity in decreasing order of magnitude. It can be seen in Figure 2\n\n(polymerization temperature, contact time of KMnO4, offered protein) are significant at a \n\nconfidence level of 95%. Thus the values of the effects indicate that, on average, higher activities \n\nwere obtained when factors contact time of KMnO4, polymerization temperature a\n\nat their lowest levels.  \n\nPareto chart for the effects of the variables contact time of KMnO4 (d), polymerization temperature (\n) on residual specific activity of mPANIG-Trypsin from the 2nd factorial design.\n\n47 \n\nMatrix of experiments and results for 2nd factorial design \n\nResponse \nResidual \n\nspecifica ctivity \n(%) \n\n72.70 \n60.45 \n34.85 \n32.38 \n37.01 \n41.61 \n31.51 \n30.74 \n44.41 \n43.80 \n79.05 \n60.87 \n30.07 \n30.63 \n38.32 \n36.70 \n33.35 \n31.93 \n45.33 \n39.69 \n\nThe Pareto chart represents the estimated effects of the variables, and their interactions on residual \n\n2 that all main effects \n\n, offered protein) are significant at a \n\nconfidence level of 95%. Thus the values of the effects indicate that, on average, higher activities \n\n, polymerization temperature and offered \n\n \n\n), polymerization temperature (e) and \n2nd factorial design. \n\n\n\n48 \n\n \n\nRaising the polymerization temperature from 4 to 50\u00b0C with contact time of KMnO4 of 1 h and 50 \n\n\u00b5 g mL-1 offered protein, the activity was reduced about 44%. The polymerization of aniline showed \n\nbest results when carried out at 4\u00b0C than at higher temperatures as in the original protocol [11,12].   \n\nIncreasing offered protein from 50 to 200 \u00b5 g mL-1 with contact time of KMnO4 of 1 h and \n\npolymerization temperature of 4\u00b0C, the activity decreased about 38%. Among these, the \n\npolymerization temperature represented the main effect most significant on residual specific activity \n\nof mPANIG-Trypsin, it is corroborated by data showed in the Table 4. The results observed in these \n\nexperiments show the influence of the conditions of coating on the catalytic performance of the \n\nmPANIG-Trypsin. In addition, the advantages of using a factorial design to obtain an enzymatic \n\nderivative with good retention of the activity when compared to the enzyme in its soluble form.  \n\n \n\nTable 4. Main and interaction effects for the 2nd complete factorial design \n \n\nFactors Effects on residual \nspecific activity \n\n(d) Contact time of KMnO4   \u20133.94 \n(e) Polymerization temperature  \u201321.41 \n(f) Offered protein amount  \u201314.98 \nd*e    2.92 \nd*f   4.14 \ne*f  14.88 \nd*e*f  \u20134.21 \n\n                                         *Not significant (p<0.05) \n\n \n\n3.3. mPANIG-Trypsin characterization \n\n \n\n3.3.1. Thermal stability \n\nThe second goal this study was the mPANIG-Trypsin characterization with respect to temperature, \n\nsubstrate concentration and stored stability. The presence of the coating has an important role in the \n\nproperties of the immobilized enzyme, in particular their catalytic performance as observed by \n\nMaciel et al. [23]. Activity of retention on the support is one of the most important aspects in the \n\nenzyme immobilization process. \n\nFig. 3 shows the higher thermal stability of the immobilized trypsin at temperatures higher than \n\n35oC. This results were similar to those obtained by Bryjak and Kolarz [24], using trypsin \n\nimmobilized on acrylic carrier.  \n\nThe link of a molecule of an enzyme to rigid support by several strong chemical bonds makes the \n\nstructure of the protein molecule much more rigid, and hence unfolding and inactivation (for \n\nexample, on heating) of such immobilized enzyme will be much more difficult occur than that of \n\nthe starting, native enzyme [24]. At 45\u00b0C, the activity of mPANIG-Trypsin was 77%, compared to \n\n\n\n \n\nsoluble trypsin which was 44%. An increase in thermal stability was observed when trypsin was \n\nimmobilized on vermiculite [26], on  carboxymethylcellulose [27] and ferromagnetic Dacron [28]. \n\nThese results suggest that the immobilized enzyme was more stable compared to \n\nenzyme.  \n\nThermal deactivation of soluble enzyme is caused by disruption of weak intra\n\nsubsequent unfolding of the protein chain. Immobilization of trypsin on composite of magnetic \n\nnanoparticles-polyaniline increased the the\n\nhydrogen bonds, there by increasing the range of operating temperatures. Increase in thermal \n\nstability of the mPANIG-Trypsin was also due to multipoint attachment of the enzyme to PANI via \n\nglutaraldehyde  and prevention of autolysis.\n\n \n\nFigure 3. Thermal stability of the mPANIG\n(100%). \n \n\n3.3.2. Kinetic constants \n\nThe affinity of the enzyme for substrate is characterized by the \n\nKm for soluble trypsin and mPANIG\n\nKm of soluble trypsin (2.96 \u00b1 0.23 mM) \n\n\u00b1 0.19 mM. In this amidolytic reacti\n\nconstant Km was 1.4-fold lower than that of the soluble enzyme, a clear sign of higher \u201capparent\u201d \n\naffinity of BAPNA to the bound enzyme. This indicates an alteration in the affinity of the enzyme\n\ntowards to the substrate upon covalent\n\nGupta [29] and, Koreck\u00e1 et al. [30] reported \n\nthe catalytic efficiency of an enzyme\n\nof the soluble trypsin and mPANIG\n\nsin which was 44%. An increase in thermal stability was observed when trypsin was \n\nimmobilized on vermiculite [26], on  carboxymethylcellulose [27] and ferromagnetic Dacron [28]. \n\nThese results suggest that the immobilized enzyme was more stable compared to \n\nThermal deactivation of soluble enzyme is caused by disruption of weak intra\n\nsubsequent unfolding of the protein chain. Immobilization of trypsin on composite of magnetic \n\npolyaniline increased the thermal stability by stabilizing the weak ionic forces and \n\nhydrogen bonds, there by increasing the range of operating temperatures. Increase in thermal \n\nTrypsin was also due to multipoint attachment of the enzyme to PANI via \n\nyde  and prevention of autolysis. \n\n \n\n \n\nThermal stability of the mPANIG-Trypsin (B). The obtained activities were referred to the highest activity \n\nThe affinity of the enzyme for substrate is characterized by the constant of Michaelis\n\nfor soluble trypsin and mPANIG-Trypsin were determined using BAPNA. In comparison with \n\nof soluble trypsin (2.96 \u00b1 0.23 mM) Km of mPANIG-Trypsin has decreased to the value of 2.13 \n\n\u00b1 0.19 mM. In this amidolytic reaction catalyzed by immobilized trypsin, the value of saturation \n\nfold lower than that of the soluble enzyme, a clear sign of higher \u201capparent\u201d \n\naffinity of BAPNA to the bound enzyme. This indicates an alteration in the affinity of the enzyme\n\ncovalent  immobilization on mPANIG. Amaral et al [28], Kumar and \n\nGupta [29] and, Koreck\u00e1 et al. [30] reported similar results. The ratio Kcat/Km\n\nthe catalytic efficiency of an enzyme-substrate pair. In this study, the catalytic efficiencies (\n\nof the soluble trypsin and mPANIG-Trypsin were found to be 645 and 580, respectively. The \n\n49 \n\nsin which was 44%. An increase in thermal stability was observed when trypsin was \n\nimmobilized on vermiculite [26], on  carboxymethylcellulose [27] and ferromagnetic Dacron [28]. \n\nThese results suggest that the immobilized enzyme was more stable compared to the soluble \n\nThermal deactivation of soluble enzyme is caused by disruption of weak intra-molecular forces and \n\nsubsequent unfolding of the protein chain. Immobilization of trypsin on composite of magnetic \n\nrmal stability by stabilizing the weak ionic forces and \n\nhydrogen bonds, there by increasing the range of operating temperatures. Increase in thermal \n\nTrypsin was also due to multipoint attachment of the enzyme to PANI via \n\nTrypsin (B). The obtained activities were referred to the highest activity \n\nconstant of Michaelis\u2013Menten (Km). \n\nTrypsin were determined using BAPNA. In comparison with \n\nTrypsin has decreased to the value of 2.13 \n\non catalyzed by immobilized trypsin, the value of saturation \n\nfold lower than that of the soluble enzyme, a clear sign of higher \u201capparent\u201d \n\naffinity of BAPNA to the bound enzyme. This indicates an alteration in the affinity of the enzyme \n\non mPANIG. Amaral et al [28], Kumar and \n\nm defines a measure of \n\nsubstrate pair. In this study, the catalytic efficiencies (Kcat/Km) \n\nTrypsin were found to be 645 and 580, respectively. The \n\n\n\n \n\ncatalytic efficiency of trypsin was de\n\nthe conclusion that the immobilization apparently did not introduce mass\n\nlimitations. According to Amaral et al. [28] such phenomenon could also be attributed to eventual\n\nnegatively charged matrix attraction for the positively charged substrate \n\ncatalytic efficiency were similar to those obtained by Bayramo\n\n \n\n3.3.3. Stability during storage \n\nData of operational stability showed that \n\nTrypsin maintained 89% of its initial activity (Fig.\n\nduring this period. The immobilized trypsin on polyaniline supports retained 50% its original \n\nactivity after 21days when stored at 4\u00b0C in phosphate buffer [32], 58% its original activity after 49 \n\ndays when stored at 4\u00b0C in glycine buffer containing CaCl\n\n44 days (approximately) when stored in glycine buffer containing CaC\n\nobserved better results. Moreover, Chellapandian [26] reported that immobilized trypsin on \n\nvermiculite retained 84% its original activity after 60 days when stored in borate buffer. \n\nenzymatic derivative obtained this study was\n\nactivity after 55 days was 77% of initial value. This result indicates that the mPANIG\n\nbe stored in buffer only (no stabilizer, e.g. CaCl\n\nof its initial activity.  \n\n \n\nFigure 4. Shelf life of mPANIG\n\n \n\n3.4. Model protein substrate digestion \n\nThe main application of the mPANIG\n\nfor protein identification. The procedure included the digestion of BSA with mPANIG\n\ncatalytic efficiency of trypsin was decreased about 1.1-fold upon immobilization. These data lead to \n\nthe conclusion that the immobilization apparently did not introduce mass-\n\nlimitations. According to Amaral et al. [28] such phenomenon could also be attributed to eventual\n\nnegatively charged matrix attraction for the positively charged substrate BAPNA. The results of the \n\nsimilar to those obtained by Bayramo?lu et al. [31]. \n\nData of operational stability showed that after 5 cycles combining storage and reuse, mPANIG\n\nTrypsin maintained 89% of its initial activity (Fig.4). An 11% decrease in activity was detected \n\nduring this period. The immobilized trypsin on polyaniline supports retained 50% its original \n\n21days when stored at 4\u00b0C in phosphate buffer [32], 58% its original activity after 49 \n\ndays when stored at 4\u00b0C in glycine buffer containing CaCl2 [33] and 80% its original activity after \n\n44 days (approximately) when stored in glycine buffer containing CaCl2 [34]. In our study, we \n\nobserved better results. Moreover, Chellapandian [26] reported that immobilized trypsin on \n\nvermiculite retained 84% its original activity after 60 days when stored in borate buffer. \n\nenzymatic derivative obtained this study was more stable during the period of 48 days, however its \n\nactivity after 55 days was 77% of initial value. This result indicates that the mPANIG\n\nbe stored in buffer only (no stabilizer, e.g. CaCl2) for approximately 50 days, retaining about 90% \n\n \n\nShelf life of mPANIG-Trypsin at 4\u00b0C stored in Tris-HCl buffer.\n\n3.4. Model protein substrate digestion  \n\nThe main application of the mPANIG-Trypsin is residue-specific proteolysis to generate fragments \n\nidentification. The procedure included the digestion of BSA with mPANIG\n\n50 \n\nfold upon immobilization. These data lead to \n\n-transfer and diffusion \n\nlimitations. According to Amaral et al. [28] such phenomenon could also be attributed to eventual \n\nBAPNA. The results of the \n\n \n\nafter 5 cycles combining storage and reuse, mPANIG-\n\nAn 11% decrease in activity was detected \n\nduring this period. The immobilized trypsin on polyaniline supports retained 50% its original \n\n21days when stored at 4\u00b0C in phosphate buffer [32], 58% its original activity after 49 \n\n[33] and 80% its original activity after \n\n[34]. In our study, we \n\nobserved better results. Moreover, Chellapandian [26] reported that immobilized trypsin on \n\nvermiculite retained 84% its original activity after 60 days when stored in borate buffer. The \n\nmore stable during the period of 48 days, however its \n\nactivity after 55 days was 77% of initial value. This result indicates that the mPANIG-Trypsin may \n\n) for approximately 50 days, retaining about 90% \n\nHCl buffer. \n\nspecific proteolysis to generate fragments \n\nidentification. The procedure included the digestion of BSA with mPANIG-Trypsin in \n\n\n\n51 \n\n \n\n15 min digestion. The resulting fragments were determined using MALDI-TOF MS and the \n\nanalyses of these MS spectra were made using a Mascot database search as showed in the Table 5.  \n\n \n\n \nTable 5. Identified peptide residues obtained from 15 min digestion using mPANIG-Trypsin \n\n \nPeptide sequence MW Missed  \n\ncleavages \nPosition \n\nBSA, 28% sequence coverage    \nDTHKSEIAHR 1193.66 1 25\u201334 \nSEIAHR  712.37 0 29\u201334 \nFKDLGEEHFK 1249.67 1 35\u201344 \nDLGEEHFK  974.49 0 37\u201344 \nLVNELTEFAK 1163.68 0 66\u201375 \nVASLR  545.25 0 101\u2013105 \nQEPER  658.29 0 118\u2013122 \nKFWGK  665.36 1 156\u2013160 \nFWGK  537.19 0 156\u2013160 \nGACLLPK  701.33 0 198\u2013204 \nGACLLPKIETMR 1347.58 1 198\u2013209 \nIETMR  664.28 0 205\u2013209 \nQRLR  572.23 1 219\u2013222  \nCASIQK  649.31 0 223\u2013228 \nFGER  508.15 0 229\u2013232 \nALKAWSVAR 1001.63 1 233\u2013241 \nAWSVAR  689.37 0 236\u2013241 \nRHPEYAVSVLLR 1439.88 1 360\u2013371 \nHPEYAVSVLLR 1283.77 0 361\u2013371 \nHLVDEPQNLIK 1305.77 0 402\u2013412 \nQNCDQFEK 1011.41 0 413\u2013420 \nLGEYGFQNALIVR 1479.87 0 421\u2013433 \nYTRK  568.07 1 434\u2013437  \nKVPQVSTPTLVEVSR 1640.01 1 437\u2013451 \nVPQVSTPTLVEVSR 1511.91 0 438\u2013451 \nLCVLHEK 842.56 0 483\u2013489 \nRPCFSALTPDETYVPK 1823.99 0 508\u2013523 \nAFDEK  609.24 0 524\u2013528 \nQIKK  515.23 1 545\u2013548 \nEACFAVEGPK 1050.48 0 588\u2013597 \n\n \n\nThe peptide mass fingerprinting (PMF) spectra of the in-solution tryptic digest was also measured \n\nas control (22 peptides matched, sequence coverage 30%).  As can be seen in the Table 5, a total of \n\n29 tryptic peptides from BSA were identified with the corresponding amino-acid sequence coverage \n\nof 28% for BSA using mPANIG-Trypsin. Comparing the MALDI-TOF MS results obtained from \n\n15 min digestion using mPANIG-Trypsin and 12 h in-solution digestion, the enzyme soluble \n\nexhibited higher sequence coverage (30%). The identification results of BSA are comparable to \n\nthose obtained by using in-solution digestion that required a longer reaction time. The digestion \n\ntime was significantly reduced from 12 h for in-solution digestion to 15 min for the digestion based \n\non the immobilized enzyme. The results showed that mPANIG-Trypsin offers a proteolysis similar \n\nthe in-solution digestion in relation to the sequence coverage, but the types of peptides obtained by \n\nthe immobilized enzyme has a different profile from that of the soluble enzyme. According to Wang \n\n\n\n52 \n\n \n\net al. [35] the high surface area-to-volume ratio of trypsin-immobilized on magnetic particles can \n\nlead to the risks of the adsorption of proteins and peptides that might be the reason for the large \n\nmissing parts in the coverage (e.g. 280\u2013347 and 489\u2013548 for BSA). Furthermore, the protein BSA \n\ncontain several disulfide bridges and therefore more rigid and difficult to digest [36].  \n\nA total of 28, 30 and 28 tryptic peptides from BSA were identified with the corresponding amino-\n\nacid sequence coverage 46%, 44% and 43% for BSA after digestion with Trypsin-immobilized \n\nPA/Fe3O4/CNT composite [35], Trypsin-immobilized magnetic nanoparticles on chip [37] and \n\nTrypsin-immobilized on magnetic carbonaceous microspheres [38], respectively. In this study, the \n\nresult found had a sequence coverage of 28%, much smaller than those observed by Wang et al. \n\n[35], Liu et al. [37] and Yao et al. [38]. A possible explanation for this low conversion (compared to \n\nthe authors cited) may be due to the immobilization trypsin on microparticles and nanoparticles not, \n\ndecreasing the surface area leading to a reduction in the enzyme-interaction. Another possible \n\nexplanation may be due to a reduced contact, because the enzymatic derivative is not left under \n\nstirring proteolysis.   \n\nMoreover, the digestion of specific proteins tends to be incomplete without additional pre-\n\ntreatments [39].  The reduced and alkylated BSA was generally used to obtain the digestive peptides \n\nwith reproducibility [40], confirming the results of Sun et al. [41] that after pre-treatment of BSA \n\nexhibited sequence coverage above 90%.  \n\n \n\n4. Conclusions \n\nThe uses of the factorial design allowed obtaining an enzymatic derivative with residual activity of \n\n79% of the initial activity of soluble enzyme, showing the advantages offered by the use of \n\noptimized experimental conditions. In these conditions, the enzymatic derivative mPANIG-Trypsin \n\nexhibited: increased stability at high temperatures, and retention of 89% of its initial activity after \n\nstorage at 4\u00b0C for 48 days. Furthermore, mPANIG-Trypsin showed higher affinity for the substrate \n\nBAPNA and a lower catalytic efficiency of 580. The excellent catalytic performance of mPANIG-\n\nTrypsin is the major benefits of this enzymatic derivative. It can be used in proteins digestion to be \n\nsimple method, rapid and low cost. \n\n \n\nAcknowledgements \n\nThe authors wish to acknowledge financial support from the Brazilian agencies CNPq (Conselho \n\nNacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico) and FACEPE (Funda\u00e7\u00e3o de Amparo a \n\nCi\u00eancia e Tecnologia de Pernambuco) and J\u00falia Campos (Centro de Tecnologias Estrat\u00e9gicas do \n\nNordeste, Brazil) for the analyses of mass spectra.  \n\n \n\n\n\n53 \n\n \n\nReferences \n\n[1] W. Tischer, F. Wedekind, 1999. Immobilized Enzymes: Methods and Applications, in: Fessner, \n\nW.-D. (Ed.), Topics Current Chemistry (200). Springer Verlag Berlin Heidelberg, pp. 95-126. \n\n[2] U.T. Bornscheuer, Chem. Int. Edit. 42 (2003) 3336\u20133337. \n\n[3] F. Xi, J. Wu, Z. Jia, X. Lin, Process Biochem. 40 (2005) 2833\u20132840. \n\n[4] J. Ma, L. Zhang, Z. Liang, W. Zhang, W. Zhang, Y. Zhang, Anal. Chim. Acta 632 (2009) 1\u20138. \n\n[5] E. Bonneil, K.C. Waldron, Talanta 53 (2000) 687\u2013699. \n\n[6] D. L\u00f3pez-Ferrer, B. Ca\u00f1as, J. V\u00e1zquez, C. Lodeiro, R. Rial-Otero, I. Moura, J.L. Capelo, Trends \n\nAnal. Chem. 25 (2006) 996\u20131005. \n\n[7] J.L. Capelo, R. Carreira, M. Diniz, L. Fernandes, M. Galesio, C. Lodeiro, H.M. Santos, G. Vale, \n\nAnal. Chim. Acta 650 (2009) 151\u2013159. \n\n[8] B. Tural, N. \u00d6zkan, M. Voljan, J. Phys. Chem. Solids 70 (2009) 860\u2013866. \n\n[9] K. Can, M. Ozmen, M. Ersoz, Colloid. Surface B 71 (2009) 154\u2013159. \n\n[10] B.F. Pan, F. Gao, H.C. Gu, J. Colloid Interface Sci. 284 (2005), 1\u2013 6.  \n\n[11] D.F.M. Neri, V.M. Balc\u00e3o, F.O.Q. Dourado, J.M.B. Oliveira, L.B. Carvalho Jr., \n\nJ.A. Teixeira, React. Funct. Polym. 69 (2009) 246\u2013251. \n\n[12] D.F.M. Neri, V.M. Balc\u00e3o, F.O.Q. Dourado, J.M.B. Oliveira, L.B. Carvalho Jr., J.A. Teixeira, \n\nJ. Mol. Catal. B-Enzym. 70 (2011) 74\u201380. \n\n[13] Y. Cao, P. Smith, A.J. Heeger, Synthetic Met. 48 (1992) 91\u201397. \n\n[14] A.G. MacDiarmid, J.C. Chiang, A.F. Richter, A.J. Epstein, Synthetic Met. 18 (1987) 285\u2013290. \n\n[15] S.W. Ng, K.G. Neoh, J.T. Sampanthar, E.T. Kang, K.L. Tan, J. Phys. Chem. B 105 (2001) \n\n5618\u20135625. \n\n[16] W.R. Salaneck, I. Lundstrom, W.S. Huang, A.G. MacDiarmid, Synthetic Met. 13 (1986) 291\u2013\n\n297. \n\n[17] N. Nagaraja, J. Pattar, N. Shashank, J. Manjanna, Y., Kamada, K. Rajanna, H.M. Mahesh, \n\nSynthetic Met. 159 (2009) 718\u2013722.  \n\n[18] H.-Y.Ju, C.-H. Kuo, J.-R. Too, Y.-C. Liu, C.-J. Shieh, Biocatal. Agricultural Biotechnol. 1 \n\n(2012) 20\u201324. \n\n[19] D. Bingol, N. Tekin, M. Alkan, Appl. Clay Sci. 50 (2010) 315\u2013 321. \n\n[20] O.H. Lowry, N.J. Rosebrough, A.L. Farr, R.J. Randall, J. Biol. Chem. 193 (1951) 265\u2013275. \n\n[21] M. Karas, F. Hillenkamp, Anal. Chem. 60 (1988) 2299\u20132301. \n\n[22] V. Ponnusami, F. Genoud, C. Menardo, M. Nechtschein, J. Hazard. Mater. 142 (2007) 397\u2013\n\n403.   \n\n[23] J.C. Maciel, P.L. Andrad, D.F.M. Neri, L.B. Carvalho Jr., C.A. Cardoso, G.M.T. Calazans, J. \n\nAlbino Aguiar, M.P.C. Silva, J. Magn. Magn. Mater. 324 (2012) 1312\u20131316.  \n\n\n\n54 \n\n \n\n[24] J. Bryjak, B.N. Kolarz, Process Biochem. 33 (1998) 409\u2013417. \n\n[25] F.M.F. Monteiro, G.M.M. Silva, J.B.R. Silva, C.S. Porto, L.B. Carvalho Jr., J.L. Lima-Filho, \n\nA.M.A. Carneiro-Le\u00e3o, M.G. Carneiro-da-Cunha, A.L.F. Porto, Process Biochem. 42 (2007) 884\u2013\n\n888. \n\n[26] M. Chellapandian, Process Biochem. 33 (1998) 169\u2013173. \n\n[27] R. Villalonga, M.L. Villalonga, L. G\u00f3mez, J. Mol. Catal. B-Enzym. 10 (2000) 483\u2013490. \n\n[28] I.P.G. Amaral, M.G. Carneiro-da-Cunha, L.B. Carvalho Jr., R.S. Bezerra, Process Biochem. 41 \n\n(2006) 1213\u20131216. \n\n[29] A. Kumar, M.N. Gupta, J. Mol. Catal. B-Enzym. 5 (1998) 289\u2013294. \n\n[30] L. Koreck\u00e1, J. Je\u017eov\u00e1, Z. B\u00edlkov\u00e1, M. Benes, D. Hor\u00e1k, O. Hradcov\u00e1, M. Slov\u00e1kov\u00e1, J.-L. \n\nViovy, J. Magn. Magn. Mater. 293 (2005) 349\u2013357.  \n\n[31] G. Bayramo?lu, M. Yilmaz, A.\u00dc. ?enel, M.Y. Arica, Biochem. Eng. J. 40 (2008) 262\u2013274. \n\n[32] SS. Caramori, K.F. Fernandes, Mater. Sci. Eng. C 28 (2008) 1159\u20131163. \n\n[33] L.L.A. Purcena, S.S. Caramori, S. Mitidieri, K.F. Fernandes, Mater. Sci. Eng. C 29 (2009) \n\n1077\u20131081. \n\n[34] SS. Caramori, F.N. de Faria, M.P. Viana, K.F. Fernandes, L.B. Carvalho Jr., Mater. Sci. Eng. \n\nC 31 (2011) 252\u2013257.  \n\n[35] S. Wang, H. Bao, P. Yang, G. Chen, Anal. Chim. Acta 612 (2008) 182\u2013189. \n\n[36] E.C.A. Stigter, G.J. de Jong, W.P. van Bennekom, Anal. Chim. Acta 619 (2008) 231\u2013238. \n\n[37] J. Liu, S. Lin, D. Qi, C. Deng, P. Yang, X. Zhang,  J. Chromatogr. A 1176 (2007) 169\u2013177. \n\n[38] G. Yao, D. Qi, C. Deng, X. Zhang, J. Chromatogr. A 1215 (2008) 82\u201391. \n\n[39] E. Calleri, C. Temporini, E. Perani, C. Stella, S. Rudaz, D. Lubda, G. Mellerio, J.-L. Veuthey, \n\nG. Caccialanza, G. Massolini, J. Chromatogr. A 1045 (2004) 99\u2013109. \n\n[40] S. Ota, S. Miyazaki, H. Matsuoka, K. Morisato, Y. Shintani, K. Nakanishi, J. Biochem. \n\nBiophys. Methods 70 (2007) 57\u201362. \n\n[41] L. Sun, Y. Li, P. Yang, G. Zhu, N.J. Dovichi, J. Chromatogr. A 1220 (2012) 68\u201374. \n\n \n\n \n\n \n\n\n\n55 \n\n \n\nCap\u00edtulo 3 \n\n \n\n5. Artigo submetido ao peri\u00f3dico Composites Science and Technology \n\n \n\nT\u00edtulo: Synthesis, characterization and magnetic property of composite of magnetic nanoparticles-\npolyaniline for enzyme immobilization \n \nAutores: Jackeline C. Maciel, Willian T. Shigeyosi, Maristela Olzon-Dionysio, Cl\u00e1udio A. \nCardoso, David F.M. Neri, Maria da Paz C. Silva, Luiz B. Carvalho Jr. \n\n \n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n56 \n\n \n\nSynthesis, characterization and magnetic property of composite of magnetic nanoparticles-\n\npolyaniline for enzyme immobilization \n\n \n\nJackeline C. Maciela, Willian T. Shigeyosib, Maristela Olzon-Dionysiob, Cl\u00e1udio A. Cardosob, \n\nDavid F.M. Neric, Maria da Paz C. Silvaa, Luiz B. Carvalho Jr.a \n\n \n\naDepartamento de Bioqu\u00edmica and Laborat\u00f3rio de Imunopatologia Keizo Asami, Universidade \n\nFederal de Pernambuco, 50670\u2013901 Recife, PE, Brazil \nbDepartamento de F\u00edsica, Universidade Federal de S\u00e3o Carlos, 13565\u2013905 S\u00e3o Carlos, SP, Brazil \ncUniversidade Federal do Vale do S\u00e3o Francisco, 56304\u2013205 Petrolina, PE, Brazil \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n*Corresponding author: \n\nLuiz Bezerra de Carvalho J\u00fanior \n\nLaborat\u00f3rio de Imunopatologia Keizo Asami (LIKA) \n\nUniversidade Federal de Pernambuco \n\nCidade Universit\u00e1ria, Recife \u2013 PE CEP 50670\u2013901, Brazil \n\nTelephone number: + 55-81-21268485/ Fax: +55-81-21268485 \n\nE-mail address: lbcj@hotlink.com.br  \n\n\n\n57 \n\n \n\nAbstract \n\nIn this paper, we report the preparation of magnetic nanoparticles via the chemical coprecipitation \n\nmethod. These magnetic nanoparticles were coated with polyaniline (PANI) in optimized conditions \n\nand characterized by different techniques. The electronic micrograph analysis showed nanoparticles \n\nwith about 15 nm of average diameter and apparently regular morphology. A combination of FTIR, \n\nX-ray diffraction and M\u00f6ssbauer spectroscopy techniques was used to understand the chemical \n\ncomposition of the nanoparticles, being identified as phases magnetite and maghemite. Both \n\nnanoparticles exhibited magnetic behavior and strong magnetization at room temperature. The \n\ncoated magnetic nanoparticles (mPANI) presented ability to bind to biological molecules such as \n\ntrypsin, forming the magnetic enzymatic derivative mPANIG-Trypsin. The protein amount and \n\nspecific activity of the immobilized trypsin were 12.84 \u00b1 4.95 \u00b5 g of protein/mg of mPANI (49.27% \n\nof immobilized protein) and 24.06 \u00b1 0.67 U/mg of protein, respectively. After twenty reuses, the \n\nactivity of mPANIG-Trypsin was 81% of initial activity. These results suggest that the use of this \n\nenzymatic derivative in different biomedical applications due to its excellent operational stability, \n\nhigh activity, simple method and at low cost. \n\n \n\nKeywords: magnetic nanoparticles, PANI, trypsin, biomedical applications. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n58 \n\n \n\n1. Introduction \n\nFunctionalization of magnetic iron oxides nanoparticles by organic molecules gives rise to intensive \n\nresearch for biomedical applications such as magnetic drug targeting, hyperthermia and enzyme \n\nimmobilization [1]. This attention is due to their unique catalytic, magnetic and electrical properties \n\n[2]. Within this scope, magnetite (Fe3O4) has become an important kind of magnetic material in \n\ndifferent applications. The main aspects that have given a boost to the study of magnetite \n\nnanoparticles are mainly their chemical functionality of the active surface, biocompatibility and low \n\ncost [3], and its good magnetic property and a very high saturation magnetization [4].  \n\nThe need for combining the magnetic properties with the conductive properties leads to processing \n\nnew materials such as conductive polymers with magnetic behavior, or magnetic particles \n\ncontaining a conductive polymer [5].  \n\nPolyaniline (PANI) receives a special attention among other conducting polymers due to the simple \n\nsynthetic methodology, good environmental stability, optical activity, controllable doping [6], an \n\neasy tunability of their electronic properties and high levels of electromagnetic shielding \n\nperformances at microwave frequencies with a low mass by unit of surface [4]. The electromagnetic \n\nproperties of polyaniline can be modified by the addition of inorganic fillers, such as the inclusion \n\nof magnetic particles may improve the magnetic and dielectric properties of host materials [7]. The \n\nproduction of monodisperse nanopowders and the control of their composition and size are \n\ntherefore key points to address for applications of these materials [8]. \n\nOur main objective was to produce magnetic nanoparticles coated with polyaniline (PANI) to be \n\nused as a support for immobilization of trypsin. The catalytic performance of this enzymatic \n\nderivative was evaluated by its activity (reuses). For this, magnetic nanoparticles were prepared via \n\ncoprecipitating ferrous and ferric ions in aqueous solution and then coated with PANI. These \n\nmagnetic nanoparticles were characterized by electronic micrographic observations, FTIR, X-ray \n\ndiffraction analysis, M\u00f6ssbauer spectroscopy and magnetization measurements.  \n\n \n\n2. Materials and methods \n\n2.1. Materials \n\nTrypsin (E.C.3.4.21.4) from porcine pancreas, bovine serum albumin (BSA), N-benzoyl-D-L-\n\narginine-p-nitroanilide (BAPNA), aniline (ACS reagent), potassium permanganate (ACS reagent), \n\nFolin-Ciocalteu\u2019s phenol reagent and, 25 % glutaraldehyde were purchased from Sigma-Aldrich \n\n(USA). Dimethylsulfoxide (DMSO) and sodium hydroxide were from Vetec Chemical (Brazil). \n\nFerric chloride hexahydrate and ferrous chloride tetrahydrate were from Merck (Germany). All \n\nother reagents were of analytical grade. \n\n \n\n\n\n59 \n\n \n\n2.2. Magnetic particles preparation \n\nSolutions of 1.1 M FeCl3 .6H2O (5 mL) and of 0.6 M FeCl2 .4H2O (5 mL) were added to 50 mL of \n\ndistilled water, under magnetic agitation, then 5.0 M NaOH was added dropwise up to pH 10 when \n\nblack particles precipitate were produced. The mixture was heated at 50\u00b0C for 30 min with vigorous \n\nstirring. The magnetic nanoparticles were thoroughly washed with distilled water until pH was \n\nneutral. The material was dried up and kept at room temperature.  \n\n \n\n2.3. Coating with PANI  \n\nOxidative polymerization of aniline was carried out in the presence of magnetic nanoparticles (0.5 \n\ng) by treating them with 0.1 M KMnO4 (50 mL) solution at 25\u00b0C for 1 h and washed with distilled \n\nwater. Then magnetic-KMnO4 nanoparticles were immersed into 50 mL of 0.5 M aniline solution \n\n(in 1.0 M HNO3). Polymerization was allowed to occur at 4\u00b0C for 1 h and after that the magnetic \n\nnanoparticles coated with polyaniline (mPANI) were successively washed with distilled water, 0.1 \n\nM citric acid and rewashed with distilled water, and finally the material was dried up and kept at \n\n25\u00b0C. This process was performed using the optimum conditions obtained after the full factorial \n\ndesign (results not shown). \n\n        \n\n2.4. Trypsin immobilization  \n\nmPANI (0.01g) was incubated with 2.0% w/v glutaraldehyde (1.0 mL) at 25\u00b0C for 2 h under mild \n\nstirring, washed with distilled water and Tris-HCl buffer (0.1 M, pH 8.0) to remove the excess of \n\nglutaraldehyde. mPANI activated with glutaraldehyde (mPANIG) was kept in buffer at 4\u00b0C until \n\nuse. mPANIG (0.01g) was incubated with trypsin for 16 h at 4\u00b0C under mild stirring. The \n\nenzymatic derivative (mPANIG-Trypsin) was collected by a magnetic field (Ciba corning; 0.6 T) \n\nand the supernatant and washings were used for protein determination.  \n\n \n\n2.5. Activity assay  \n\nAmidase activity of  trypsin was measured by using the artificial substrate BAPNA (4.0 mM \n\nBAPNA in DMSO). The mixture of reaction was incubated at 25\u00b0C for 15 min. The hydrolyzed p-\n\nnitroanilide was monitored in spectrophotometer at 440 nm and the activity of enzyme was \n\ncalculated. All assays were carried out in replicates and the results are expressed as mean \u00b1 SD. \n\nProteolytic activity of trypsin (unit) was defined as \u00b5mol BAPNA hydrolyzed per minute using an \n\nabsorption coefficient of 9.100 M-1 cm-1. The specific activity was calculated by dividing the \n\nenzymatic activity (U) by the amount of protein (mg). For the residual specific activity, was \n\nconsidered that the specific activity of free enzyme as 100%.  \n\n \n\n\n\n60 \n\n \n\n2.6. Protein determination \n\nThe amount of immobilized protein was estimated by the difference between the offered protein and \n\nthat found in the supernatant and washing solutions measured according to the method Lowry et al. \n\n[9] using bovine serum albumin (BSA) as a standard. \n\n \n\n2.7. Magnetic nanoparticles characterization  \n\nThe morphology and particle size of the nanoparticles were characterized using a FEI QUANTA \n\n200F scanning electron microscope (SEM) and a Jeol 1200EXII 80 transmission electron \n\nmicroscope (TEM). \n\nThe polydispersity index (PDI) was obtained in a Delsa Nano C particle analyzer (Beckman \n\nCoulter, Krefeld, North Rhine-Wetphalia, Germany). Particles were suspended in 1.0 M HCl and \n\nplaced in ultrasonic for 10 min to break aggregates. For each measurent, three analyzes were \n\nconsidered. \n\nThe Fourier transform infrared (FTIR) spectra were obtained on an IFS\u201366 FTIR spectrometer \n\n(Bruker, Billerica, MA, USA) in the range of 4000-400 cm-1 using KBr pellets. Typically, 100 scans \n\nwere recorded with a 4 cm-1 resolution.  \n\nThe BET surface area (Brunauer-Emmett-Teller) and pore volume was measured by nitrogen \n\nadsorption isotherm using an ASAP 2420 (Micromeritics, Atlanta, GA, USA).  \n\nThe structural properties of the magnetic particles were characterized by X-ray powder diffraction, \n\nwhich was carried out in a ray-X diffractometer Shimadzu model XDR 7000, using Cu K? radiation \n\n(? = 0.154 nm) at a scanning speed of 0.1\u00b0 s-1 in the range of 2? = 10\u201390\u00b0 with a step 0.02\u00b0.  \n\nM\u00f6ssbauer data collection was carried out at room temperature 298K using a 57Co (Rh-matrix) \n\nsource of initially 10 mCi strength. The cobalt source is oscillated longitudinally so that its velocity \n\nvaries between \u201310.5 and 10.5 mm s\u20131. M\u00f6ssbauer spectrometer (model MB500) was calibrated \n\nusing a thin ?-Fe foil. We performed a M\u00f6ssbauer set using three distributions. In the first and the \n\nsecond were used a magnetic hyperfine field distribution (0 T to 55 T and 1 T-by-step). The third \n\nwas using a quadrupole electric distribution (0 mm s\u20131 to 1.2 mm s\u20131 and 0.1 mm s\u20131 -by-step). Data \n\nanalysis was performed using the computer program WinNormos for IGOR Pro 6.2\u00ae \n\ncommercialized by WaveMetrics\u00a9, assuming that all the peaks are Gaussian in shape. \n\nMagnetization measurements were obtained at 298 K and 323 K in \u00b1 50 KOe (50 T) applied field \n\nusing a SQUID magnetometer (Quantum Design Model MPMS-5S).  \n\n \n\n2.8. Reuse of the enzymatic derivate \n\nTwo series of reuse was performed. The first reuse was carried out by assaying the same mPANIG-\n\nTrypsin preparation with BAPNA ten times intercalating each successive use with buffer washing \n\n\n\n61 \n\n \n\n(three times). This preparation was kept at 4\u00b0C during eight days and a second reuse was carried out \n\nas above. All of the experiments were conducted in triplicate. \n\n \n\n3. Results and discussion \n\n3.1. Synthesis of magnetic nanoparticles and PANI coating  \n\nMagnetic particles were prepared in accordance with Carneiro Le\u00e3o et al. [10] except by \n\nmodifications in the incubation time (30 min), temperature (50\u00b0C), final pH of the mixture (10) and \n\nco-precipitation agent (NaOH) in order to obtain nanoparticles. According to Sun et al. [11], the \n\nsynthesis of magnetite with sizes around 10 nm can be achieved using a reaction temperature of \n\n50\u00b0C, a solution pH of 10\u201311 and a high stirring rate (above 800 rpm). According to these authors, \n\ntemperatures above 50\u00b0C lead to production of larger particles when the temperature increase, i.e., \n\nthe growth of magnetite nucleus is easier to happen when the temperature is higher than 50\u00b0C. \n\nRegarding the pH, the reason that may explain why the size of magnetite nanoparticles is reduced \n\nwith increasing pH of the solution when the pH is lower than 11 is based on the mechanism of \n\nformation of magnetite [11]. According to previous studies, Fe2+ adsorbs at the ferric hydroxide \n\nsurface, the increase of the pH gives rise to dehydration of hydroxides and leads to the formation of \n\nmagnetite facilitated by electron hopping between Fe2+ and Fe3+ [8]. NaOH was chosen as the \n\nprecipitating agent instead of NH3\u00b7 H2O used by Carneiro Le\u00e3o et al. [10] because according to \n\nHong et al. [12], the diameter of magnetite nanoparticles by co-precipitation with NaOH is smaller \n\nand with minor agglomeration then using NH3\u00b7 H2O in water. The magnetic particles produced in \n\nthis work (around 15 nm) have dimensions much smaller than those obtained by Neri et al. [13] \n\n(10\u2013100 \u00b5 m) who followed the protocol of Carneiro Le\u00e3o et al. [10]. \n\nThe magnetic nanoparticles produced were coated with PANI (mPANI) by the oxidation of aniline \n\nwith potassium permanganate. It is well known that, under certain synthesis conditions, PANI \n\nforms a sub-micrometer film on the surface of the objects immersed into a polymerization mixture. \n\nThese films are formed on various types of substrates: conducting, insulating, hydrophobic, and \n\nhydrophilic. Thus, the polymer strongly adheres to the surface and covers even nanoparticles and \n\nnanostructure relief of the objects. The parameters of the film (its thickness, uniformity, and \n\nmorphology) depend both on the chemical nature of the coated surface and on the synthesis \n\nconditions [14]. While hydrophobic materials are covered by a more or less uniform PANI film, the \n\nfilm relief on hydrophilic microparticles has often a discontinuous patchy character [15]. In addition \n\nto the film structure, the synthesis process results in a PANI precipitate which has no adhesion and \n\nis easily washed away from the surface. The ratio between the amounts of precipitate and film \n\ndepends on the synthesis conditions [16]. Modifications of the experimental protocol [13] were \n\nmade to obtain coated nanoparticles with good binding capacity for biomolecules. The optimal \n\n\n\n \n\nconditions were obtained from an experimental design (results not s\n\ncoating. The conditions were: 0.1 M KMnO\n\npolymerization time of 1 h and polymerization temperature of 4\u00b0C. The concentrations of the \n\noxidizing agent and aniline were identical to the pr\n\nreduced from overnight to 1 h, the polymerization time from 2 h to 1 h and, the polymerization \n\ntemperature from 25\u00b0C to 4\u00b0C. As a result, it was possible to form a core\n\nwhich magnetic nanoparticles are the core and polyaniline the\n\n \n\n3.2. Transmission and scanning electron micrographs\n\nThe morphology, shape and size distribution of magnetic nanoparticles and mPANI were examined \n\nby electron micrographs observation. Typical \n\nmagnetic nanoparticles is shown in \n\n \n\nFigure 1. Electron microscopic images. TEM image of (A) magnetic nanoparticles and SEM images of (B) magnetic \nnanoparticles, (C) mPANI (lower resolution), (D) mPANI (higher resolution).\n\n \n\nconditions were obtained from an experimental design (results not shown) used for the PANI \n\ncoating. The conditions were: 0.1 M KMnO4, 0.5 M aniline, contact time of KMnO\n\npolymerization time of 1 h and polymerization temperature of 4\u00b0C. The concentrations of the \n\noxidizing agent and aniline were identical to the protocol; however, the contact time of KMnO\n\nreduced from overnight to 1 h, the polymerization time from 2 h to 1 h and, the polymerization \n\ntemperature from 25\u00b0C to 4\u00b0C. As a result, it was possible to form a core-shell structural mixture, in \n\ntic nanoparticles are the core and polyaniline the shell. \n\nTransmission and scanning electron micrographs  \n\nThe morphology, shape and size distribution of magnetic nanoparticles and mPANI were examined \n\nby electron micrographs observation. Typical transmission electron microscope (\n\nmagnetic nanoparticles is shown in Fig. 1A.  \n\nElectron microscopic images. TEM image of (A) magnetic nanoparticles and SEM images of (B) magnetic \n(lower resolution), (D) mPANI (higher resolution). \n\n \n\n62 \n\nhown) used for the PANI \n\n, 0.5 M aniline, contact time of KMnO4 of 1 h, \n\npolymerization time of 1 h and polymerization temperature of 4\u00b0C. The concentrations of the \n\notocol; however, the contact time of KMnO4 was \n\nreduced from overnight to 1 h, the polymerization time from 2 h to 1 h and, the polymerization \n\nshell structural mixture, in \n\nThe morphology, shape and size distribution of magnetic nanoparticles and mPANI were examined \n\nelectron microscope (TEM) image of \n\n \n\nElectron microscopic images. TEM image of (A) magnetic nanoparticles and SEM images of (B) magnetic \n\n\n\n63 \n\n \n\nSome magnetic nanoparticles are partially superimposed onto the agglomerate core, i.e., the \n\nboundary limit of each nanoparticle is partially diffuse; thus a precise average particle size cannot \n\nbe determined. However, according to C\u00f3tica et al. [17] a narrowed particle sizes distribution can be \n\nseen. It should be noted that generally, magnetite nanoparticles with no surface treatments tend to \n\nagglomerate with the neighboring ones, which could be due to the substantial built-up specific \n\nsurface area of the nanosized particles [18]. The presence of theses agglomerates may be due also to \n\nthe magnetic nanoparticles aggregated together to reduce their surface energy [19] and/or due to the \n\nmagnetic dipole-dipole interactions and the van der Waals forces between the nanoparticles [20,21]. \n\nIn our work, the magnetic nanoparticles exhibited agglomerates with apparently regular \n\nmorphology, nearly spherical/ellipsoidal shape, dimensions around 15 nm, and narrow particle size \n\ndistribution (Fig. 1A). The morphology of the magnetic nanoparticles and mPANI was also \n\ninvestigated using a scanning electron microscope (SEM). The micrographs were obtained on \n\nmetalized films deposited on carbon strip and results shown in Fig. 1B\u2013D. SEM images revealed \n\nthat mPANI present similar shape to the magnetic nanoparticles, a homogeneous structure and look \n\nlike small flakes, i.e., the unstructured analog of PANI were obtained [22]. The surface of mPANI \n\nbecomes rougher, which is due to the polymerization that occurred on the surface of magnetite \n\nnanoparticles and the strong interfacial interaction between the polymer matrix and magnetic \n\nnanoparticles as observed by Gu et al. [2]. \n\nThe polydispersity index (PDI) of magnetic nanoparticles and mPANI was 0.47 and 0.29, \n\nrespectively. According to Pich et al. [23], the increase in polydispersity can be explained by a \n\nsimultaneous formation of large composite microparticles and smaller particles with iron oxide core \n\nand polymeric shell which precipitate on the surface of larger particles during polymerization \n\nprocess leading also to a noticeable morphology variation.  \n\n \n\n3.3. FTIR spectra \n\nThe emeraldine salt is the partly oxidized form of polyaniline where six benzene rings and two \n\nquinoid rings are present in an eight-ring repeating unit. The conductivity of the emeraldine form of \n\npolyaniline can be changed by about 10 orders of magnitude by doping [24]. The FTIR spectra of \n\nmagnetic nanoparticles and mPANI are shown in Figure 2. It was found that mPANI had \n\ncharacteristic peaks at around 1494 cm-1 (C=C stretching of benzenoid ring), 1398 cm-1 (Q=N\u2013B  \n\nstretching deformation, Q refers to the quinoid ring and B to the benzenoid ring), 1305 and 1260 \n\ncm-1 (C\u2013N stretching benzenoid ring) and 805 cm-1 (out-of-plane deformation of C\u2013H in the 1,4-\n\ndisubstitued benzene ring), which was similar with polyaniline [13,25,26]. The low intensity of the \n\nbands of the FTIR spectra (Fig. 2A) is believed to be due to the fact that, because of the presence of \n\nmagnetic nanoparticles in the reaction system, aniline gets adsorbed on the oxide particles. \n\n\n\n \n\nPolymerization proceeds initially on the surface of these oxide particles in the presence of KMnO\n\nin the reaction system. The adsorption of polymer to the magn\n\nconstrained chain growth around the particles. Such adsorption and constrained motion of the \n\nchains will restrict the modes of vibration in polyaniline, which in turn lead to the reduction in \n\nintensity in the FTIR spectra [24,\n\nby two strong absorption bands at around 635 and 590 cm\n\nband at 570 cm-1, which corresponds to the Fe\n\nabsorption bands of Fe\u2013O bond were observed around 631 and 588 cm\n\nand 630 and 580 cm-1 for mPANI. A principal effect of finite size of nanoparticles is the breaking of \n\nlarge number of bonds for surface atoms, resulting in the\n\nsurface [28]. The FTIR spectra in the range 750\n\nare shown in the Fig. 2B. These spectra are compared with the spectrum of maghemite (not shown) \n\nconfirming the oxidation and its increase after \n\nbands around the 570 cm\u20131 characteristic of magnetite \n\nsmall shoulders in the 600\u2013750 cm\n\nintensity after coating of the magnetic particles. The appearance of the characteristic maghemite \n\npeaks shows that the relative quantify of maghemite \n\nFigure 2. FTIR spectra of magnetic nanoparticles and mPANI.\n\nPolymerization proceeds initially on the surface of these oxide particles in the presence of KMnO\n\nin the reaction system. The adsorption of polymer to the magnetic nanoparticles results in \n\nconstrained chain growth around the particles. Such adsorption and constrained motion of the \n\nchains will restrict the modes of vibration in polyaniline, which in turn lead to the reduction in \n\nintensity in the FTIR spectra [24,27]. The presence of Fe\u2013O bond in magnetite particles can be seen \n\nby two strong absorption bands at around 635 and 590 cm-1. These bands result from split of the \n\n, which corresponds to the Fe\u2013O bond of bulk magnetite [28\n\nO bond were observed around 631 and 588 cm-1 for magneti\n\nfor mPANI. A principal effect of finite size of nanoparticles is the breaking of \n\nlarge number of bonds for surface atoms, resulting in the rearrangement of electrons on the particle \n\nThe FTIR spectra in the range 750\u2013450 cm\u20131 for magnetic nanoparticles and mPANI \n\n. These spectra are compared with the spectrum of maghemite (not shown) \n\non and its increase after coating (Figure 2B). The spectra exhibit absorption \n\ncharacteristic of magnetite [8]. Although, the bandwidth increases, and \n\n750 cm\u20131 range as well as a band at 450 cm\u2013\n\nintensity after coating of the magnetic particles. The appearance of the characteristic maghemite \n\npeaks shows that the relative quantify of maghemite increases the coating. \n\n \n\nFTIR spectra of magnetic nanoparticles and mPANI. \n\n64 \n\nPolymerization proceeds initially on the surface of these oxide particles in the presence of KMnO4 \n\netic nanoparticles results in \n\nconstrained chain growth around the particles. Such adsorption and constrained motion of the \n\nchains will restrict the modes of vibration in polyaniline, which in turn lead to the reduction in \n\nO bond in magnetite particles can be seen \n\n. These bands result from split of the ?1 \n\nO bond of bulk magnetite [28\u201331]. In our work, \n\nfor magnetic nanoparticles \n\nfor mPANI. A principal effect of finite size of nanoparticles is the breaking of \n\nrearrangement of electrons on the particle \n\nfor magnetic nanoparticles and mPANI \n\n. These spectra are compared with the spectrum of maghemite (not shown) \n\nThe spectra exhibit absorption \n\nAlthough, the bandwidth increases, and \n\u20131 appear with greater \n\nintensity after coating of the magnetic particles. The appearance of the characteristic maghemite \n\n\n\n \n\n3.4. Characterization of the surface areas of magnetic nanoparticles and mPANI\n\nNitrogen sorption isotherms for magnetic nanoparticles and mPANI can be seen in Fig. 3. The \n\nnitrogen adsorption\u2013desorption isotherms of both magnetic materials produced belong to the type \n\nIV [32] with H4 hysteresis loops, according to IUPAC\n\nrepresent the adsorption of N2 gas on the surfaces of the magnetic nanoparticles and mPANI, while \n\nthe upper curve represents the progressive withdrawal; desorption, of the adsorbed N\n\nobserved by El-kharrag et al. \n\nmaterials (pores of widths between 2 nm and 50 nm) and their hysteresis loops are associated with \n\nthe filling and emptying of the mesopores by capillary condensation [35]. \n\nFor magnetic nanoparticles, the mesopores should be interparticle pores among magnetic \n\nnanoparticles. After coating such magnetic nanoparticles with polyaniline, there was a slight \n\nincrease of 154.60 m2 g\u20131 to 162.93 m\n\naverage pore diameter (Barrett\u2013Joyner\n\nwith uncoated magnetic nanoparticles. For magnetic nanoparticles, pore volume was of 0.36 cm\n\nand average pore diameter of 9.46 nm, and for mPANI, pore volume was\n\naverage pore diameter of 8.72 nm, respectively. No pronounced difference in the pore size was \n\nobserved between samples. Both samples show a broader pore distribution (results not shown) in \n\nwhich pores with different sizes coexist [35].\n\n \n\nFigure 3. Nitrogen adsorption/desorption isotherms of magnetic nanoparticles and mPANI.\n\n \n\n \n\n3.4. Characterization of the surface areas of magnetic nanoparticles and mPANI\n\nNitrogen sorption isotherms for magnetic nanoparticles and mPANI can be seen in Fig. 3. The \n\ndesorption isotherms of both magnetic materials produced belong to the type \n\nIV [32] with H4 hysteresis loops, according to IUPAC\u2013classification [33]. In the \n\ngas on the surfaces of the magnetic nanoparticles and mPANI, while \n\nthe upper curve represents the progressive withdrawal; desorption, of the adsorbed N\n\nkharrag et al. [34]. The magnetic nanoparticles and mPANI are mesoporous \n\nmaterials (pores of widths between 2 nm and 50 nm) and their hysteresis loops are associated with \n\nthe filling and emptying of the mesopores by capillary condensation [35].  \n\nthe mesopores should be interparticle pores among magnetic \n\nnanoparticles. After coating such magnetic nanoparticles with polyaniline, there was a slight \n\nto 162.93 m2 g\u20131 in BET surface area. On the other hand, pore volume and \n\nJoyner\u2013Halena, BJH method) were slightly reduced when compared \n\nwith uncoated magnetic nanoparticles. For magnetic nanoparticles, pore volume was of 0.36 cm\n\naverage pore diameter of 9.46 nm, and for mPANI, pore volume was\n\naverage pore diameter of 8.72 nm, respectively. No pronounced difference in the pore size was \n\nsamples. Both samples show a broader pore distribution (results not shown) in \n\nwhich pores with different sizes coexist [35]. \n\nNitrogen adsorption/desorption isotherms of magnetic nanoparticles and mPANI.\n \n\n65 \n\n3.4. Characterization of the surface areas of magnetic nanoparticles and mPANI \n\nNitrogen sorption isotherms for magnetic nanoparticles and mPANI can be seen in Fig. 3. The \n\ndesorption isotherms of both magnetic materials produced belong to the type \n\n[33]. In the Fig. 3, the curves \n\ngas on the surfaces of the magnetic nanoparticles and mPANI, while \n\nthe upper curve represents the progressive withdrawal; desorption, of the adsorbed N2 gas as \n\n]. The magnetic nanoparticles and mPANI are mesoporous \n\nmaterials (pores of widths between 2 nm and 50 nm) and their hysteresis loops are associated with \n\nthe mesopores should be interparticle pores among magnetic \n\nnanoparticles. After coating such magnetic nanoparticles with polyaniline, there was a slight \n\nin BET surface area. On the other hand, pore volume and \n\nHalena, BJH method) were slightly reduced when compared \n\nwith uncoated magnetic nanoparticles. For magnetic nanoparticles, pore volume was of 0.36 cm3 g\u20131 \n\naverage pore diameter of 9.46 nm, and for mPANI, pore volume was of 0.35 cm3 g\u20131 and \n\naverage pore diameter of 8.72 nm, respectively. No pronounced difference in the pore size was \n\nsamples. Both samples show a broader pore distribution (results not shown) in \n\n \n\nNitrogen adsorption/desorption isotherms of magnetic nanoparticles and mPANI. \n\n\n\n \n\n3.5. XRD analysis \n\nColors of iron oxide may be very dependent on grain size and chemical composition and this feature \n\nis a first auxiliary attribute in their \n\nmPANI are black and magnetic, suggesting that magnetite may be the dominant phase, although \n\nmaghemite may not be completely excluded.\n\nXRD patterns for magnetite and maghemite. As observed by \n\npeak due to other crystalline phase, which could occur as impurity, was observed, indicating that \n\nfinal products were pure enough, from this point of view, consisting\n\nthe two spinel magnetic iron oxides, meaning magnetite and maghemite. The differences in the \n\ncrystalline behavior of magnetic nanoparticles and mPANI are analyzed by XRD \n\nFig. 4 shows XRD patterns for magnetic\n\n35.67\u00b0, 43.37\u00b0, 53.80\u00b0, 57.35\u00b0, 62.97\u00b0, 71.43\u00b0 and 74.48\u00b0 [2,6,37,38] are attributed to the crystal \n\nplanes of magnetite at (111), (220), (311), (400), (422), (511), (440), (620) and (533) \n\nindex of magnetite nanoparticles is in accordance with the International Center for Diffraction Data \n\n(reference code: ICDD 01\u2013071\n\nunmodified magnetite in the mPANI as can be seen in \n\nbroadened lines that can be due to the magnetization relaxation from superparamagnetism and \n\nmatrix constrictions for nanosized particles [40].\n\nFigure 4. XRD patterns of magnetic nanoparticles and mPANI.\n\n \n\nAccording to Yu et al. [37], the absence\n\ncorresponding to maghemite, suggests the magnetite as phase \n\nobserved the absence of this peak. However, we cannot rule out the presence of maghemite i\n\nColors of iron oxide may be very dependent on grain size and chemical composition and this feature \n\nis a first auxiliary attribute in their identification [36]. In our work, magnetic nanoparticles and \n\nmPANI are black and magnetic, suggesting that magnetite may be the dominant phase, although \n\nmaghemite may not be completely excluded. There are typically small differences between typical \n\nterns for magnetite and maghemite. As observed by Andrade et al. [\n\npeak due to other crystalline phase, which could occur as impurity, was observed, indicating that \n\nfinal products were pure enough, from this point of view, consisting essentially of binary mixture of \n\nthe two spinel magnetic iron oxides, meaning magnetite and maghemite. The differences in the \n\ncrystalline behavior of magnetic nanoparticles and mPANI are analyzed by XRD \n\nshows XRD patterns for magnetic nanoparticles and mPANI. The 2? peaks at 18.44\u00b0, 30.30\u00b0, \n\n35.67\u00b0, 43.37\u00b0, 53.80\u00b0, 57.35\u00b0, 62.97\u00b0, 71.43\u00b0 and 74.48\u00b0 [2,6,37,38] are attributed to the crystal \n\nplanes of magnetite at (111), (220), (311), (400), (422), (511), (440), (620) and (533) \n\nindex of magnetite nanoparticles is in accordance with the International Center for Diffraction Data \n\n071\u2013636). In this study, XRD results confirmed the presence of \n\nunmodified magnetite in the mPANI as can be seen in Fig. 4. Furthermore, the results showed \n\nbroadened lines that can be due to the magnetization relaxation from superparamagnetism and \n\nmatrix constrictions for nanosized particles [40]. \n\nXRD patterns of magnetic nanoparticles and mPANI. \n\n[37], the absence of the characteristic reflection of (221) plane, \n\ncorresponding to maghemite, suggests the magnetite as phase predominant. In our w\n\nof this peak. However, we cannot rule out the presence of maghemite i\n\n66 \n\nColors of iron oxide may be very dependent on grain size and chemical composition and this feature \n\nidentification [36]. In our work, magnetic nanoparticles and \n\nmPANI are black and magnetic, suggesting that magnetite may be the dominant phase, although \n\nThere are typically small differences between typical \n\nAndrade et al. [36] no clear reflection \n\npeak due to other crystalline phase, which could occur as impurity, was observed, indicating that \n\nessentially of binary mixture of \n\nthe two spinel magnetic iron oxides, meaning magnetite and maghemite. The differences in the \n\ncrystalline behavior of magnetic nanoparticles and mPANI are analyzed by XRD measurements. \n\npeaks at 18.44\u00b0, 30.30\u00b0, \n\n35.67\u00b0, 43.37\u00b0, 53.80\u00b0, 57.35\u00b0, 62.97\u00b0, 71.43\u00b0 and 74.48\u00b0 [2,6,37,38] are attributed to the crystal \n\nplanes of magnetite at (111), (220), (311), (400), (422), (511), (440), (620) and (533) [39]. The \n\nindex of magnetite nanoparticles is in accordance with the International Center for Diffraction Data \n\nIn this study, XRD results confirmed the presence of \n\nFurthermore, the results showed \n\nbroadened lines that can be due to the magnetization relaxation from superparamagnetism and \n\n \n\nof the characteristic reflection of (221) plane, \n\ndominant. In our work, we also \n\nof this peak. However, we cannot rule out the presence of maghemite in the \n\n\n\n \n\nsamples produced, since the FTIR results, for example, suggest \n\nal. [41] and Gorski and Scherer \n\nmagnetite and magnetite\u2013maghemite mixture was claimed\n\nrecent studies  report the differentiation between magnetite and maghemite by XRD analysis of high \n\nangle peaks as (511) or (440) and its\n\n \n\n3.6. M\u00f6ssbauer spectroscopy (MS) \n\nBecause magnetite and maghemite have very similar XRD patterns, we performed further \n\ncharacterization by M\u00f6ssbauer spectroscopy to distinguish the phases of iron oxide nanoparticles. \n\nThe spectra were fitted using a two sextet model (sextet 1 and 2) \n\nadjusted M\u00f6ssbauer spectra at 298 K for magnetic nanoparticles and mPANI, where the \n\ncontribution of two magnetic subspectra corresponds to Fe\n\n[Fe3+/Fe2+] in octahedral coordination in the spinel st\n\n \n\nFigure 5. M\u00f6ssbauer spectra of (A) magnetic nanoparticles and (B) mPANI.\n\n \n\nThe Table 1 shows the hyperfine parameters calculated from \n\nsextets present an important broadening, the hyperfine magnetic fields for magnetic nanoparticles \n\nare sextet 1 equal to 48.2 T and \n\nmagnetic fields for mPANI are sexte\n\nTable 1).  These values are similar to the bulk material \n\nare slightly inferior to the ones corresponding to the bulk material [45], this deviation in\n\nratio (1:2) of the iron in tetrahedral and octahedral position obtained from the subspectra area\n\nin accordance with to the small particle size [44]. When the size is lower than 20 nm, the magnetic \n\nhyperfine structure is not resolved, cons\n\noriginating from the occurrence of superparamagnetic relaxation phenomena [8,47].  Previous work \n\nsamples produced, since the FTIR results, for example, suggest otherwise (Fig. 4).\n\nand Gorski and Scherer [42] reported that the differentiation between non\n\nmaghemite mixture was claimed to be almost impossible. However, more \n\nrecent studies  report the differentiation between magnetite and maghemite by XRD analysis of high \n\npeaks as (511) or (440) and its resolution through the deconvolution [43].\n\n. M\u00f6ssbauer spectroscopy (MS)  \n\nBecause magnetite and maghemite have very similar XRD patterns, we performed further \n\ncharacterization by M\u00f6ssbauer spectroscopy to distinguish the phases of iron oxide nanoparticles. \n\nThe spectra were fitted using a two sextet model (sextet 1 and 2) for magnetite\n\nadjusted M\u00f6ssbauer spectra at 298 K for magnetic nanoparticles and mPANI, where the \n\ncontribution of two magnetic subspectra corresponds to Fe3+ in the tetrahedral position and \n\n] in octahedral coordination in the spinel structure [38,44].  \n\nM\u00f6ssbauer spectra of (A) magnetic nanoparticles and (B) mPANI.\n\nshows the hyperfine parameters calculated from Fig. 5. The resonant lines of both \n\nsextets present an important broadening, the hyperfine magnetic fields for magnetic nanoparticles \n\nto 48.2 T and sextet 2 equal to 44.9 T (Fig. 5A and Table 1). The hyperfine \n\nmagnetic fields for mPANI are sextet 1 equal to 48.3 T and sextet 2 equal to 45.4 \n\nThese values are similar to the bulk material (sextet 1: 49.0 T and sextet 2: 46.0\n\nare slightly inferior to the ones corresponding to the bulk material [45], this deviation in\n\nratio (1:2) of the iron in tetrahedral and octahedral position obtained from the subspectra area\n\nin accordance with to the small particle size [44]. When the size is lower than 20 nm, the magnetic \n\nhyperfine structure is not resolved, consisting of broadened, overlapped, and asymmetrical lines \n\noriginating from the occurrence of superparamagnetic relaxation phenomena [8,47].  Previous work \n\n67 \n\notherwise (Fig. 4). Vandenberghe et \n\n[42] reported that the differentiation between non-stoichiometric \n\nto be almost impossible. However, more \n\nrecent studies  report the differentiation between magnetite and maghemite by XRD analysis of high \n\nresolution through the deconvolution [43]. \n\nBecause magnetite and maghemite have very similar XRD patterns, we performed further \n\ncharacterization by M\u00f6ssbauer spectroscopy to distinguish the phases of iron oxide nanoparticles. \n\nnetite. Fig. 5 shows the \n\nadjusted M\u00f6ssbauer spectra at 298 K for magnetic nanoparticles and mPANI, where the \n\nin the tetrahedral position and \n\n \n\nM\u00f6ssbauer spectra of (A) magnetic nanoparticles and (B) mPANI. \n\nThe resonant lines of both \n\nsextets present an important broadening, the hyperfine magnetic fields for magnetic nanoparticles \n\n(Fig. 5A and Table 1). The hyperfine \n\nsextet 2 equal to 45.4 T (Fig. 5B and \n\nand sextet 2: 46.0 T), but \n\nare slightly inferior to the ones corresponding to the bulk material [45], this deviation in the ideal \n\nratio (1:2) of the iron in tetrahedral and octahedral position obtained from the subspectra area can be \n\nin accordance with to the small particle size [44]. When the size is lower than 20 nm, the magnetic \n\nisting of broadened, overlapped, and asymmetrical lines \n\noriginating from the occurrence of superparamagnetic relaxation phenomena [8,47].  Previous work \n\n\n\n68 \n\n \n\nreported on magnetite nanoparticles of 39 \u00b1 5 nm in size have shown that the nanoparticles consist \n\nof a magnetite core surrounded by an oxidized layer close to maghemite [48].  \n\n \n\nTable 1. Analyzed results of M\u00f6ssbauer spectra for magnetic nanoparticles and mPANI. Bhf: hyperfine field; ?: \nquadrupole splitting; ?: isomer shift relative to the isomer shift of ?-iron at room temperature \n \n\nSample Component Bhf (T) ? (mm s-1) ? (mm s-1) Area (%) \nMagnetic nanoparticles Doublet  0.00 0.21 \u00b1 0.03 1 \n Sextet 1 48.2 \u00b1 0.56 0.08 \u00b1 0.03 0.17 \u00b1 0.02 67 \n Sextet 2 44.9 \u00b1 1.83 -0.21 \u00b1 0.04 0.36 \u00b1 0.04 32 \n      \nmPANI Doublet  0.00 0.21 \u00b1 0.04 2 \n Sextet 1 48.3 \u00b1 0.49 -0.13 \u00b1 0.03 0.31 \u00b1 0.04 49 \n Sextet 2 45.4 \u00b1 0.56 0.11 \u00b1 0.03 0.14 \u00b1 0.02 48 \n\n \n\n \n\nIn addition to the signals relating to magnetite, the Fig. 5 also shows a doublet having an isomer \n\nshift equal to 0.21 mm s-1 for both samples and an area equal to 1% and 2% for magnetic \n\nnanoparticles and mPANI, respectively. In Fig. 5A, it is possible to observe the presence of a \n\ndoublet at the center of the spectrum. Moreover, in Fig. 5B, the doublet is not well defined, possibly \n\ndue to the presence of the coating. This doublet emanates from ferric iron in a non-spherical local \n\nsurrounding, maybe coming from the rim of the iron oxide core, i.e., the magnetic relaxation effect \n\nwhich is attributed to the presence of superparamagnetic as well as the ferromagnetic nanoparticles \n\n[44]. Thus the M\u00f6ssbauer spectrum could not be fitted with two discrete tetrahedral and octahedral \n\nsites along with a doublet because of the superposition of relaxing sextet and doublet patterns. To \n\nblock the superparamagnetic relaxation effect, the M\u00f6ssbauer spectrum should be recorded at low \n\ntemperature [49]. According to M\u00f6ssbauer spectra and the hyperfine parameters, it is evident that \n\nthe process for obtaining the mPANI does not interfere significantly with the nature of the oxide \n\n[38]. However, a small percentage of maghemite must be present in the samples due to the \n\noxidation process as can be corroborated by Fig. 2B. \n\n \n\n3.7. Magnetization measurements \n\nThe magnetic properties of the magnetic nanoparticles and mPANI were investigated in the applied \n\nmagnetic field sweeping from \u201360 to 60 kOe at 298 K and 323 K as shown in Fig. 6. It is well-\n\nknown that the size [50], structure and shape may affect the magnetic properties of the products \n\n[51]. Under applied magnetic field, magnetic nanoparticles and mPANI showed the positive \n\nmagnetizations and there is no hysteresis (Fig. 6). It indicates the superparamagnetic behavior [30]. \n\nThe difference between the magnetic behavior of small and medium sized particles can also be \n\nobserved in their hysteresis loops [8]. \n\n\n\n \n\nFig. 6 shows the field dependent magnetization curves of magnetic\n\nsaturation magnetization (Ms) for the magnetic\n\nwhich is lower than that of bulk magnetite (\n\n59.05 emu g\u20131 (Fig. 6). The reduction in the saturation magnetization values signifies the decrease in \n\nthe particles size [53] and can be attributed to surface effects such as ma\n\ncontaining spins that not collinear with the magnetic field as observed by \n\nThese discrepancies in the saturation values of magnetization may be explained by variations in the \n\nmethods employed to synthesize m\n\nsurfaces and chemical compositions \n\n \n\nFigure 6. Magnetization curves of magnetic nanoparticles and mPANI at 298 K and 323 K.\n\n \n\n3.8. Reuse of the magnetic enzymatic derivative\n\nThe trypsin was immobilized on mPANIG yielding a preparation containing protein amount of \n\n12.84 \u00b1 0.49 \u00b5 g of protein/mg of \n\ntrypsin was reused ten times and presented a mean \n\nactivity (22.44 \u00b1 1.25 U/mg of protein), corresponding to 32.46 \n\nenzyme. After ten reuses, immobilized trypsi\n\nten other reuses were performed.  This immob\n\nmean specific activity of 81.26 \u00b1 1.51% of the initial activity \n\nderivative activity during these twenty assa\n\nPreviously, immobilized trypsin on \n\nactivity equal to 92.1 \u00b1 7.3% of the initial activity [56\n\nparticles after ten reuses, a specific activity equal to 84.43 \u00b1 5\n\nshows the field dependent magnetization curves of magnetic nanoparticles and mPANI. \n\nfor the magnetic nanoparticles has value equal to 60.51 emu g\n\nn that of bulk magnetite (Ms = 92 emu g\n\u20131) [52], and mPANI \n\n). The reduction in the saturation magnetization values signifies the decrease in \n\nand can be attributed to surface effects such as magnetically inactive layer \n\ncontaining spins that not collinear with the magnetic field as observed by Gu et al. (2009) \n\nThese discrepancies in the saturation values of magnetization may be explained by variations in the \n\nmethods employed to synthesize magnetite, which can generate different particle sizes, magnetite \n\nsurfaces and chemical compositions [54]. \n\nMagnetization curves of magnetic nanoparticles and mPANI at 298 K and 323 K.\n \n\nmagnetic enzymatic derivative \n\nrypsin was immobilized on mPANIG yielding a preparation containing protein amount of \n\nmg of mPANI (49.27% of immobilized protein)\n\ntrypsin was reused ten times and presented a mean specific activity of 93.63 \n\nof protein), corresponding to 32.46 \u00b1 3.11% of the activity \n\nAfter ten reuses, immobilized trypsin on mPANI was stored at 4\u00b0C for\n\nperformed.  This immobilized enzyme presented the end of these reuses\n\n\u00b1 1.51% of the initial activity (Fig. 7). The decrease in the trypsin \n\nderivative activity during these twenty assays was approximately 12% of the initial activity. \n\nPreviously, immobilized trypsin on ferromagnetic Dacron presented after eight reuses a specific \n\n7.3% of the initial activity [56] and immobilized trypsin \n\na specific activity equal to 84.43 \u00b1 5.42% of the initial activity [57\n\n69 \n\nnanoparticles and mPANI. The \n\nnanoparticles has value equal to 60.51 emu g\u20131, \n\nand mPANI has value equal to \n\n). The reduction in the saturation magnetization values signifies the decrease in \n\ngnetically inactive layer \n\nGu et al. (2009) [30]. \n\nThese discrepancies in the saturation values of magnetization may be explained by variations in the \n\nagnetite, which can generate different particle sizes, magnetite \n\n \n\nMagnetization curves of magnetic nanoparticles and mPANI at 298 K and 323 K. \n\nrypsin was immobilized on mPANIG yielding a preparation containing protein amount of \n\n(49.27% of immobilized protein). The immobilized \n\n \u00b1 4.78% of the initial \n\n\u00b1 3.11% of the activity of the free \n\nn on mPANI was stored at 4\u00b0C for one week and then \n\nilized enzyme presented the end of these reuses, a \n\nThe decrease in the trypsin \n\nys was approximately 12% of the initial activity. \n\npresented after eight reuses a specific \n\nimmobilized trypsin magnetic levan \n\n.42% of the initial activity [57]. \n\n\n\n \n\nMoreover, Neri et al. [13] showed that after ten reuses the \n\nparticles coated with PANI retained approximately 85% of\n\nenzymatic derivative in this work\n\nstability. Our goal is to use it in different applications in the biomedical field, especially in \n\nproteomics research, in the stage of p\n\nFigure 7. Specific activity of mPANIG\ninitial concentration of BAPNA and Tris\n\n4. Conclusions \n\nIn conclusion, magnetic nanoparticles were obtained from modifications of the experimental \n\nprotocol used routinely by our research group. These nanoparticles showed dimensions smaller than \n\nthose obtained by original the protocol, corroborating the advantages of the optimization process. \n\nThe FTIR, XRD and M\u00f6ssbauer spectroscopy analysis of the nanoparticles confirmed \n\nof magnetite, but suggested the presence of another phase. Therefore, \n\nconsist of a mixture of magnetite and maghemite, where maghemite is a result of oxidation of the \n\nmagnetite. Furthermore, after PANI coating, nanoparticles exhibited good magnetization, an \n\nincrease in the surface area and showed to be an excellent suppor\n\nmajor benefits of the magnetic enzymatic derivative (\n\nhigh activity, simple method and \n\n \n\nAcknowledgements \n\nThe authors wish to acknowledge financial suppo\n\nNacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico)\n\nCi\u00eancia e Tecnologia de Pernambuco)\n\n(Laborat\u00f3rio de Ultraestrutura Celular Herta Meyer, UFRJ, Brazil) for the transmission electron \n\nMoreover, Neri et al. [13] showed that after ten reuses the ?-galactosidase immobilized on magnetic \n\nparticles coated with PANI retained approximately 85% of the initial activity. Thus\n\nin this work exhibited excellent activity retention and high \n\nstability. Our goal is to use it in different applications in the biomedical field, especially in \n\nproteomics research, in the stage of protein digestion.  \n\n \n\nSpecific activity of mPANIG-Trypsin. The immobilized trypsin on mPANIG was incubated with a 4 mM \ninitial concentration of BAPNA and Tris-HCl buffer. After each cycle, the derivative were washed before new step.\n\n \n\nIn conclusion, magnetic nanoparticles were obtained from modifications of the experimental \n\nresearch group. These nanoparticles showed dimensions smaller than \n\nprotocol, corroborating the advantages of the optimization process. \n\nThe FTIR, XRD and M\u00f6ssbauer spectroscopy analysis of the nanoparticles confirmed \n\nof magnetite, but suggested the presence of another phase. Therefore, the nanoparticles produc\n\nconsist of a mixture of magnetite and maghemite, where maghemite is a result of oxidation of the \n\nmagnetite. Furthermore, after PANI coating, nanoparticles exhibited good magnetization, an \n\nincrease in the surface area and showed to be an excellent support for trypsin immobilization. T\n\nthe magnetic enzymatic derivative (mPANIG-Trypsin) are its \n\nsimple method and low cost of production. \n\nThe authors wish to acknowledge financial support from the Brazilian agency CNPq (\n\nNacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico) and FACEPE (Funda\u00e7\u00e3o de Amparo a \n\nCi\u00eancia e Tecnologia de Pernambuco). The authors would like to thank Prof. Dr. M\u00e1rcia Attias \n\n(Laborat\u00f3rio de Ultraestrutura Celular Herta Meyer, UFRJ, Brazil) for the transmission electron \n\n70 \n\ngalactosidase immobilized on magnetic \n\nl activity. Thus produced \n\nexhibited excellent activity retention and high operational \n\nstability. Our goal is to use it in different applications in the biomedical field, especially in \n\n \n\nTrypsin. The immobilized trypsin on mPANIG was incubated with a 4 mM \nHCl buffer. After each cycle, the derivative were washed before new step. \n\nIn conclusion, magnetic nanoparticles were obtained from modifications of the experimental \n\nresearch group. These nanoparticles showed dimensions smaller than \n\nprotocol, corroborating the advantages of the optimization process. \n\nThe FTIR, XRD and M\u00f6ssbauer spectroscopy analysis of the nanoparticles confirmed the presence \n\nnanoparticles produced \n\nconsist of a mixture of magnetite and maghemite, where maghemite is a result of oxidation of the \n\nmagnetite. Furthermore, after PANI coating, nanoparticles exhibited good magnetization, an \n\nt for trypsin immobilization. The \n\nare its operational stability, \n\nrt from the Brazilian agency CNPq (Conselho \n\nand FACEPE (Funda\u00e7\u00e3o de Amparo a \n\nProf. Dr. M\u00e1rcia Attias \n\n(Laborat\u00f3rio de Ultraestrutura Celular Herta Meyer, UFRJ, Brazil) for the transmission electron \n\n\n\n71 \n\n \n\nmicroscopy analysis and Prof. Dr. Adilson J.A. de Oliveira (UFSCar, SP, Brazil) for the \n\nmagnetization measurements.  \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n72 \n\n \n\nReferences \n\n[1] Daou TJ, Gren\u00e8che JM, Pourroy G, Buathong B, Derory A, Ulhaq-Bouillet C, Donnio B, \n\nGuillon D, Begin-Colin S. Coupling agent effect on magnetic properties of functionalized \n\nmagnetite-based nanoparticles. Chem Mater 2008; 20: 5869\u20135875. \n\n \n\n [2] Gu H, Huang Y,  Zhang X,  Wang Q, Zhu J, Shao L, Haldolaarachchige N, Young DP, Wei S, \n\nGuo Z. Magnetoresistive polyaniline-magnetite nanocomposites with negative dielectrical \n\nproperties. Polymer 2012; 53: 801\u2013809. \n\n \n\n[3] Salado J, Insausti M,  Lezama L,  de Muro IG,  Goikolea E,  Rojo T. Preparation and \n\ncharacterization of monodisperse Fe3O4 nanoparticles: na electron magnetic resonance study. Chem \n\nMater 2011; 23: 2879 \u2013 2885. \n\n \n\n[4] Belaabed B,  Wojkiewicz JL,  Lamouri S,  Kamchi NE, Lasri T. Synthesis and characterization \n\nof hybrid conducting composites based on polyaniline/magnetite fillers with improved microwave \n\nabsorption properties. J Alloy Compd 2012; 527: 137\u2013144. \n\n \n\n[5] Khafagy RM. Synthesis, characterization, magnetic and electrical properties of the novel \n\nconductive and magnetic Polyaniline/MgFe2O4 nanocomposite having the core\u2013shell structure. J \n\nAlloy Compd 2011; 509: 9849\u20139857. \n\n \n\n[6] Reddy KR, Lee K-P,  Gopalan AI, Kang H-D. Organosilane modified magnetite \n\nnanoparticles/poly(aniline-co-o/m-aminobenzenesulfonic acid) composites: Synthesis and \n\ncharacterization. React Funct Polym 2007; 67: 943\u2013954. \n\n \n\n[7] Gandhi N, Singh K, Ohlan A, Singh DP, Dhawan SK. Thermal, dielectric and microwave \n\nabsorption properties of polyaniline\u2013CoFe2O4 nanocomposites. Compos Sci. Technol 2011; 71: \n\n1754\u20131760. \n\n \n\n[8] Salazar JS, Perez L, Abril O, Phuoc LT, Ihiawakrim D, Vazquez M, Greneche J-M,  Begin-\n\nColin S, Pourroy G. Magnetic iron oxide nanoparticles in 10\u201340 nm range: composition in terms of \n\nmagnetite/maghemite ratio and effect on the magnetic properties. Chem Mater 2011; 23: 1379 \u2013 \n\n1386. \n\n \n\n\n\n73 \n\n \n\n[9] Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol \n\nreagent. J Biol Chem 1951; 193: 265\u2013275. \n\n \n\n[10] Carneiro Le\u00e3o AMA, Oliveira EA, Carvalho Jr. LB. Immobilization for protein on \n\nferromagnetic Dacron. Appl Biochem Biotech 1991; 32: 53\u201358. \n\n \n\n[11] Sun J, Zhou S,  Hou P, Yang Y, Weng J,  Li X,  Li M. Synthesis and characterization of \n\nbiocompatible Fe3O4 nanoparticles. J Biomed Mater Res A 2007; 80A: 333\u2013341. \n\n \n\n[12] Hong R,  Li J, Wang J, Li H. Comparison of schemes for preparing magnetic Fe3O4 \n\nnanoparticles. China Part 2007; 5: 186\u2013191. \n\n \n\n[13] Neri DFM, Balc\u00e3o VM, Dourado FOQ, Oliveira JMB, Carvalho Jr. LB, Teixeira JA. \n\nImmobilized ?-galactosidase onto magnetic particles coated with polyaniline: support \n\ncharacterization and galactooligosaccharide production. J Mol Catal B-Enzym 2011; 70: 74\u201380. \n\n \n\n[14] Stejskal J, Sapurina I, Proke\u0161 J, Zemek J. In-situ polymerization polyaniline films. Synthetic \n\nMet 1999; 105: 195\u2013202. \n\n \n\n[15] Kohut-Svelko N, Reynaud S, Dedryevre R, Martinez H, Gonbeau D, Francois J. Study of a \n\nnanocomposite based on a conducting polymer: polyaniline. Langmuir 2005; 21: 1575\u20131583. \n\n \n\n[16] Stejskal J, Trchov\u00e1 M, Fedorova S, Sapurina I, Zemek J. Surface polymerization of aniline on \n\nsilica gel. Langmuir 2003; 19: 3013\u20133018. \n\n \n\n[17] C\u00f3tica LF, Freitas VF, Dias GS, Santos IA, Vendrame SC, Khalil NM, Mainardes RM, Staruch \n\nM, Jain M. Simple and facile approach to synthesize magnetite nanoparticles and assessment of \n\ntheir effects on bloods cells. J Magn Magn Mater 2012; 324: 559\u2013563. \n\n \n\n[18] Chen DH, He XR. Synthesis of nickel ferrite nanoparticles by sol-gel method. Mater Res Bull \n\n2001; 36: 1369\u20131377. \n\n \n\n[19] Hu C, Gao Z, Yang X. Fabrication and magnetic properties of Fe3O4 octahedra. Chem Phys \n\nLett 2006; 429: 513\u2013517.  \n\n \n\n\n\n74 \n\n \n\n[20] Lalatonne Y, Richardi J, Pileni MP. van der Waals versus dipolar forces controlling \n\nmesoscopic organizations of magnetic nanocrystals. Nat Mater 2004; 3: 121\u2013125.  \n\n \n\n[21] Valenzuela R, Fuentes MC, Parra C, Baeza J, Duran N, Sharma SK, Knobel M, Freer J. \n\nInfluence of stirring velocity on the synthesis of magnetite nanoparticles (Fe3O4) by the co-\n\nprecipitation method. J Alloy Compd 2009; 488: 227\u2013231. \n\n \n\n[22] Hopkins AR, Lipeles RA, Hwang S-J. Morphology characterization of polyaniline nano- and \n\nmicrostructures. Synthetic Met 2008; 158: 594\u2013601. \n\n \n\n[23] Pich A, Bhattacharya S, Ghosh A, Adler HJP. Composite magnetic particles: 2. Encapsulation \n\nof iron oxide by surfactant-free emulsion polymerization. Polymer 2005; 46: 4596\u20134603. \n\n \n\n[24] Nagaraja N, Pattar J, Shashank N, Manjanna J, Kamada Y, Rajanna K, Mahesh HM. Electrical, \n\nstructural and magnetic properties of polyaniline/pTSA-TiO2 nanocomposites. Synthetic Met 2009; \n\n159: 718\u2013722. \n\n \n\n[25] Xiao Q, Tan X, Ji L, Xue J. Preparation and characterization of polyaniline/nano-Fe3O4 \n\ncomposites via a novel Pickering emulsion route. Synthetic Met 2007;  157: 784\u2013791. \n\n \n\n[26] Lin Y-W, Wu T-M. Synthesis and characterization of externally doped sulfonated \n\npolyaniline/multi-walled carbon nanotube composites. Compos Sci. Technol 2009; 69: 2559\u20132565. \n\n \n\n[27] Feng W, Bai XD, Lian YQ, Liang J, Wang XG, Yoshino K. Well-aligned polyaniline/carbon-\n\nnanotube composite films grown by in-situ aniline polymerization. Carbon 2003; 41: 1551\u20131557. \n\n \n\n[28] Ma M, Zhang Y, Yu W, Shen H, Zhang H, Gu N. Preparation and characterization of \n\nmagnetite nanoparticles coated by amino silane. Colloid Surface A 2003; 212: 219\u2013226. \n\n \n\n[29] Xu XQ, Shen H, Xu JR, Li XJ. Aqueous-based magnetite magnetic fluids stabilized by surface \n\nsmall micelles of oleolysarcosine. Appl Surf Sci 2004; 221: 430\u2013436. \n\n \n\n[30] Yamaura M, Camilo RL, Sampaio LC, Mac\u00eado MA, Nakamura M, Toma HE. Preparation and \n\ncharacterization of (3-aminopropyl) triethoxysilane-coated magnetite nanoparticles. J Magn Magn \n\nMater 2004; 279: 210\u2013217. \n\n\n\n75 \n\n \n\n[31] Klokkenburg M, Hilhorst J, Ern\u00e9 BH. Surface analysis of magnetite nanoparticles in \n\ncyclohexane solutions of oleic acid and oleylamine. Vib Spectrosc 2007; 43: 243\u2013248. \n\n \n\n[32] Guo S, Li D, Zhang L, Li J, Wang E. Monodisperse mesoporous superparamagnetic single-\n\ncrystal magnetite nanoparticles for drug delivery. Biomaterials 2009; 30: 1881\u20131889. \n\n \n\n[33] Sing KSW, Everett DH, Haul RAW, Moscou L, Pierotti RA, Rouqu\u00e9rol J, Siemieniewska T. \n\nReporting physisorption data for gas/solid systems with special reference to the determination of \n\nsurface area and porosity. IUPAC 1985;  57: 603\u2013619. \n\n \n\n[34] El-kharrag R, Amin A, Greish YE. Low temperature synthesis of monolithic mesoporous \n\nmagnetite nanoparticles. Ceram Int 2012; 38: 627\u2013634. \n\n \n\n[35] Yuan P, Fan M, Yang D, He H, Liu D, Yaun A, Zhu J, Chen T. Montmorillonite-supported \n\nmagnetite nanoparticles for the removal of hexavalent chromium [Cr(IV)] from aqueuos solutions. J \n\nHazard Mater 2009; 166: 821\u2013829. \n\n  \n\n[36] Andrade AL, Valente MA, Ferreira JMF, Fabris JD. Preparation of size-controlled \n\nnanoparticles of magnetite. J Magn Magn Mater 2012; 324: 1753\u20131757. \n\n \n\n[37] Yu W, Zhang T, Zhang J, Qiao X, Yang L, Liu Y. The synthesis of octahedral nanoparticles of \n\nmagnetite. Mater Lett 2006; 60: 2998\u20133001. \n\n \n\n[38] Jaramillo-Tabares BE, Isaza FJ, C\u00f3rdoba de Torresi SI. Stabilization of polyaniline by the \n\nincorporation of magnetite nanoparticles. Mater Chem Phys 2012; 132: 529\u2013533. \n\n \n\n[39] Klug HP, Alexander LE. X-ray diffraction procedures for polycrystalline and amorphous \n\nmaterials 1974, 2 ed. New York: Willey-Interscience. \n\n \n\n[40] Quin XY. The exothermal and endothermal phenomena in nanocrystalline aluminum. \n\nNanostruct Mater 1993; 2: 99\u2013106. \n\n \n\n[41] Vandenberghe RE, Barrero CA, da Costa GM, Van San E, De Grave E. M\u00f6ssbauer \n\ncharacterization of iron oxides and (oxy)hydroxides: the present state of the art. Hyperfine Interact \n\n2000; 126: 247\u2013259. \n\n\n\n76 \n\n \n\n[42] Gorski CA, Scherer MM. Influence of magnetite stoichiometry on FeII uptake and nitrobenzene \n\nreduction.  Environ Sci Techonol 2009; 43: 3675\u20133680. \n\n \n\n[43] Kim W, Suh C-Y, Cho S-W, Roh K-M, Kwon H, Song K, Shon I-J. A new method for the \n\nidentification and quantification of magnetite\u2013maghemite mixture using conventional X-ray \n\ndiffraction technique. Talanta 2012; 94: 348\u2013352. \n\n \n\n[44] Cabrera L, Gutierrez S, Menendez N, Morales MP, Herrasti P. Magnetic nanoparticles: \n\nelectrochemical synthesis and characterization. Electrochim Acta 2008; 53: 3436\u20133441. \n\n \n\n[45] Dyar MD, Agresti DG, Schaefer MW, Grant CA, Sklute EC. M\u00f6ssbauer spectroscopy of Earth \n\nand planetary materials. Annu Rev Earth Pl Sc 2006; 34: 83\u2013125. \n\n \n\n[46] Kamali-M S, Ericsson T, W\u00e4ppling R. Characterization of iron oxide nanoparticles by \n\nM\u00f6ssbauer spectroscopy. Thin Solid Films 2006; 515: 721\u2013723. \n\n \n\n[47] Santana GP, Ramos AM, Fabris JD. Uma estrat\u00e9gia adaptada para s\u00edntese de magnetita. Quim \n\nNova 2008; 31: 430\u2013432. \n\n \n\n[48] Daou TJ, Pourroy G, Begin-Colin S, Greneche JM, Ulhaq-Bouillet C, Legare P, Bernhardt P, \n\nLeuvrey C, Rogez G. Hydrothermal synthesis of monodisperse magnetite nanoparticles. Chem \n\nMater  2006; 18: 4399\u20134404. \n\n \n\n[49] Bandhu A, Mukherjee S, Acharya S, Modak S, Brahma SK, Das D, Chakrabarti PK. Dynamic \n\nmagnetic behavior and M\u00f6ssabauer effect measurements of magnetite nanoparticles prepared by a \n\nnew technique in the co-precipitation method. Solid State Commun 2009; 149: 1790\u20131794. \n\n \n\n[50] Wen X, Yang J, He B, Gu Z. Preparation of monodisperse magnetite nanoparticles under mild \n\nconditions. Curr Appl Phys 2008; 8: 535\u2013541. \n\n \n\n[51] Xu H, Shao M, Chen T, Zhuo S, Wen C, Peng M. Magnetism-assisted assembled porous Fe3O4 \n\nnanoparticles and their electrochemistry for dopamine sensing. Micropor Mesopor Mat 2012; 153: \n\n35\u201340.  \n \n\n[52] Cullity D. Introduction to Magnetic Materials 1972, Addison-Wesley, Reading, MA. \n\n\n\n77 \n\n \n\n[53] Xu L, Du J, Li P, Qian Y. In situ synthesis, magnetic property, and formation mechanism of \n\nFe3O4 particles encapsulated in ID bamboo-shaped carbon microtubes. J Phys Chem B 2006; 110: \n\n3871\u20133875. \n\n \n\n[54] Grigorova M, Blythe HJ, Blaskov V, Rusanov V, Petkov V, Masheva V,  Nihtianova D, \n\nMartinez LM, Mu\u00f1oz JS, Mikhov M. Magnetic properties and M\u00f6ssbauer spectra of nanosized \n\nCoFe2O4 powders. J Magn Magn Mater 1998; 183: 163\u2013172. \n\n \n\n[55] Wei Y, Hsueh KF. Thermal analysis of chemically synthesized polyaniline and effects of \n\nthermal aging on conductivity. J Polym Sci A1 1989; 27: 4351\u20134363.  \n\n \n\n[56] Amaral IPG, Carneiro-da-Cunha MG, Carvalho Jr. LB, Bezerra RS. Fish trypsin immobilized \n\non ferromagnetic Dacron.  Process Biochem 2006; 41: 1213\u20131216. \n\n \n\n[57] Maciel JC,  Andrad PL, Neri DFM, Carvalho Jr. LB, Cardoso CA, Calazans GMT,  Aguiar JA,  \n\nSilva MPC. Preparation and characterization of magnetic levan particles as matrix for trypsin \n\nimmobilization.  J Magn Magn Mater 2012; 324: 1312\u20131316. \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n78 \n\n \n\nCap\u00edtulo 4 \n\n \n\n6. Artigo publicado no peri\u00f3dico Journal of Magnetism and Magnetic Materials \n\n \n\nT\u00edtulo: Preparation and characterization of magnetic levan particles as matrix for trypsin \nimmobilization \n\nVolume: 324  \n\nP\u00e1ginas: 1312\u20131316 \n\nAno: 2012  \n\nAutores: J.C. Maciel, P.L. Andrade, D.F.M. Neri, L.B. Carvalho Jr., C.A. Cardoso, G.M.T. \nCalazans, J. Albino Aguiar, M.P.C. Silva \n\n \n\n \n\n\n\n79 \n\n \n\n \n\n\n\n80 \n\n \n\n \n\n\n\n81 \n\n \n\n \n\n\n\n82 \n\n \n\n \n\n\n\n83 \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n84 \n\n \n\n6. Conclus\u00f5es \n\n \n\n\u2022 Foram produzidas part\u00edculas de levana magn\u00e9tica (seguindo o protocolo de rotina em nosso \n\nlaborat\u00f3rio), por coprecipita\u00e7\u00e3o qu\u00edmica de sais de ferro (II) e (III) em meio aquoso alcalino, \n\nna presen\u00e7a do polissacar\u00eddeo levana; \n\n\u2022 As part\u00edculas de levana magn\u00e9tica apresentaram como fase cristalina predominante a \n\nmagnetita; exibiram bandas de absor\u00e7\u00e3o no infravermelho caracter\u00edsticas de liga\u00e7\u00f5es \n\nqu\u00edmicas presentes no polissacar\u00eddeo; com forma\u00e7\u00e3o de maiores agregados quando \n\ncomparada ao material sem a levana; redu\u00e7\u00e3o de dez vezes nas medidas de satura\u00e7\u00e3o da \n\nmagnetiza\u00e7\u00e3o, provavelmente devido a presen\u00e7a do pol\u00edmero durante o processo de \n\ncoprecipita\u00e7\u00e3o. A tripsina imobilizada em levana magn\u00e9tica apresentou boa capacidade de \n\nreutiliza\u00e7\u00e3o, retendo 84% de sua atividade inicial ap\u00f3s dez reutiliza\u00e7\u00f5es.  \n\n\u2022 Nanopart\u00edculas magn\u00e9ticas foram obtidas a partir de modifica\u00e7\u00f5es (temperatura, pH e agente \n\nde precipita\u00e7\u00e3o) do protocolo utilizado rotineiramente em nosso grupo de pesquisa; \n\n\u2022 As nanopart\u00edculas magn\u00e9ticas s\u00e3o constitu\u00eddas principalmente por magnetita, por\u00e9m \n\nmaghemita tamb\u00e9m foi detectada nas an\u00e1lises realizadas, indicando poss\u00edvel oxida\u00e7\u00e3o da \n\nmagnetita \u00e0 maghemita; \n\n\u2022 O processo de revestimento com polianilina n\u00e3o interferiu de forma significativa nas \n\npropriedades f\u00edsicas, qu\u00edmicas e magn\u00e9ticas do material magn\u00e9tico sintetizado; \n\n\u2022 O comp\u00f3sito mPANI foi utilizado para imobiliza\u00e7\u00e3o de tripsina de forma eficaz; \n\n\u2022 Foi observado que as condi\u00e7\u00f5es de polimeriza\u00e7\u00e3o da anilina exercem influ\u00eancia na atividade \n\nda tripsina imobilizada, dessa forma o processo foi otimizado; \n\n\u2022 O derivado enzim\u00e1tico imobilizado mostrou melhores atividades em temperaturas mais \n\nelevadas quando comparado \u00e0 enzima sol\u00favel, indicando que a presen\u00e7a do revestimento \n\nconfere estabilidade \u00e0 enzima; \n\n\u2022 Foi verificado que o derivado enzim\u00e1tico apresenta excelente estabilidade operacional \n\n(reusos) e de estocagem; \n\n\u2022 A performance do derivado enzim\u00e1tico foi demonstrada pela digest\u00e3o tr\u00edptica de albumina \n\nde soro bovino dentro de  15 min, apresentando uma sequ\u00eancia de convers\u00e3o de 28%. A \n\nvantagem desta convers\u00e3o em rela\u00e7\u00e3o \u00e0quela com a enzima sol\u00favel \u00e9 o tempo de digest\u00e3o \n\nque \u00e9 bem menor; \n\n\u2022 O derivado enzim\u00e1tico produzido (mPANIG-Trypsina) apresenta boa capacidade de \n\nreutiliza\u00e7\u00e3o, baixo custo de obten\u00e7\u00e3o, metodologia simples e grande n\u00famero de poss\u00edveis \n\naplica\u00e7\u00f5es. \n\n\n\n85 \n\n \n\n7. ANEXOS \n\n7.1. Instru\u00e7\u00f5es para autores \n\n_____________________________________________________________________________ \n\nPreparation \nUse of wordprocessing software \nIt is important that the file be saved in the native format of the wordprocessor used. The text should \nbe in single-column format. Keep the layout of the text as simple as possible. Most formatting codes \nwill be removed and replaced on processing the article. In particular, do not use the wordprocessor's \noptions to justify text or to hyphenate words. However, do use bold face, italics, subscripts, \nsuperscripts etc. When preparing tables, if you are using a table grid, use only one grid for each \nindividual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align \ncolumns. The electronic text should be prepared in a way very similar to that of conventional \nmanuscripts (see also the Guide to Publishing with Elsevier: \nhttp://www.elsevier.com/guidepublication). Note that source files of figures, tables and text \ngraphics will be required whether or not you embed your figures in the text. See also the section on \nElectronic artwork.  \nTo avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' \nfunctions of your wordprocessor. \nPlease use line numbering and double spacing for the manuscript at the time of submission. \n \nArticle structure \nSubdivision - numbered sections \nDivide your article into clearly defined and numbered sections. Subsections should be numbered 1.1 \n(then 1.1.1, 1.1.2,...), 1.2, etc. (the abstract is not included in section numbering). Use this \nnumbering also for internal cross-referencing: do not just refer to 'the text'. Any subsection may be \ngiven a brief heading. Each heading should appear on its own separate line. \nIntroduction \nState the objectives of the work and provide an adequate background, avoiding a detailed literature \nsurvey or a summary of the results. \nMaterials and methods \nExperimental The experimental methods should be described after the introductory material. \nDetailed experimental descriptions should be restricted to one section of the paper. Sufficient detail \nshould be given to allow any experienced worker to implement the procedures described. \nProcedural steps should not be numbered. \nResults \nResults should be clear and concise. \nDiscussion \nThis should explore the significance of the results of the work, not repeat them. A combined Results \nand Discussion section is often appropriate. Avoid extensive citations and discussion of published \nliterature. \nConclusions \nThis should include key findings of the research, quantitative analytical performance figures (if \nappropriate) and their significance to real sample matrices. \nAppendices \nIf there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in \n\n\n\n86 \n\n \n\nappendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent \nappendix, Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; Fig. A.1, etc. \n \nEssential title page information \n\u2022 Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid \nabbreviations and formulae where possible. \n\u2022 Author names and affiliations. Where the family name may be ambiguous (e.g., a double name), \nplease indicate this clearly. Present the authors' affiliation addresses (where the actual work was \ndone) below the names. Indicate all affiliations with a lower-case superscript letter immediately \nafter the author's name and in front of the appropriate address. Provide the full postal address of \neach affiliation, including the country name and, if available, the e-mail address of each author. \n\u2022 Corresponding author. Clearly indicate who will handle correspondence at all stages of \nrefereeing and publication, also post-publication. Ensure that telephone and fax numbers (with \ncountry and area code) are provided in addition to the e-mail address and the complete postal \naddress. Contact details must be kept up to date by the corresponding author. \n\u2022 Present/permanent address. If an author has moved since the work described in the article was \ndone, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a \nfootnote to that author's name. The address at which the author actually did the work must be \nretained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes.  \nAbstract \nA concise and factual abstract is required. The abstract should state briefly the purpose of the \nresearch, the principal results and major conclusions. An abstract is often presented separately from \nthe article, so it must be able to stand alone. For this reason, References should be avoided, but if \nessential, then cite the author(s) and year(s). Also, non-standard or uncommon abbreviations should \nbe avoided, but if essential they must be defined at their first mention in the abstract itself. \nKeywords \nImmediately after the abstract, provide a maximum of 6 keywords, using American spelling and \navoiding general and plural terms and multiple concepts (avoid, for example, 'and', 'of'). Be sparing \nwith abbreviations: only abbreviations firmly established in the field may be eligible. These \nkeywords will be used for indexing purposes. \nAbbreviations \nDefine abbreviations that are not standard in this field in a footnote to be placed on the first page of \nthe article. Such abbreviations that are unavoidable in the abstract must be defined at their first \nmention there, as well as in the footnote. Ensure consistency of abbreviations throughout the article. \nAcknowledgements \nCollate acknowledgements in a separate section at the end of the article before the references and do \nnot, therefore, include them on the title page, as a footnote to the title or otherwise. List here those \nindividuals who provided help during the research (e.g., providing language help, writing assistance \nor proof reading the article, etc.). \nNomenclature, abbreviations and symbols \nPlease use L for litres. Always leave a space between units and use superscripts rather than /. For \ninstance: use mg mL-1 and not mg/ml. Do not use ppm or ppb to denote solid/liquid concentrations.  \nDo not use abbreviations in the title or keywords. Define abbreviations that are not standard in this \nfield at their first occurrence in both the abstract and the main text. Ensure consistency of \nabbreviations throughout the remainder of the manuscript.  \nIn all other cases, the recommendations of the International Union of Pure and Applied Chemistry \n(IUPAC) should be followed, and attention should be given to the recommendations of the \nAnalytical Chemistry Division in the journal Pure and Applied Chemistry (see also IUPAC \nCompendium of Analytical Nomenclature, Definitive Rules, 1987). \nMath formulae \nPresent simple formulae in the line of normal text where possible and use the solidus (/) instead of a \nhorizontal line for small fractional terms, e.g., X/Y. In principle, variables are to be presented in \n\n\n\n87 \n\n \n\nitalics. Powers of e are often more conveniently denoted by exp. Number consecutively any \nequations that have to be displayed separately from the text (if referred to explicitly in the text). \nFootnotes \nFootnotes should be used sparingly. Number them consecutively throughout the article, using \nsuperscript Arabic numbers. Many wordprocessors build footnotes into the text, and this feature \nmay be used. Should this not be the case, indicate the position of footnotes in the text and present \nthe footnotes themselves separately at the end of the article. Do not include footnotes in the \nReference list.  \nTable footnotes \nIndicate each footnote in a table with a superscript lowercase letter. \nork \nElectronic artwork \nGeneral points \n\u2022 Make sure you use uniform lettering and sizing of your original artwork.  \n\u2022 Save text in illustrations as 'graphics' or enclose the font.  \n\u2022 Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol.  \n\u2022 Number the illustrations according to their sequence in the text.  \n\u2022 Use a logical naming convention for your artwork files.  \n\u2022 Provide captions to illustrations separately.  \n\u2022 Produce images near to the desired size of the printed version.  \n\u2022 Submit each figure as a separate file.  \nA detailed guide on electronic artwork is available on our website: \nhttp://www.elsevier.com/artworkinstructions \nYou are urged to visit this site; some excerpts from the detailed information are given here. \nFormats \nRegardless of the application used, when your electronic artwork is finalised, please 'save as' or \nconvert the images to one of the following formats (note the resolution requirements for line \ndrawings, halftones, and line/halftone combinations given below):  \nEPS: Vector drawings. Embed the font or save the text as 'graphics'.  \nTIFF: Color or grayscale photographs (halftones): always use a minimum of 300 dpi.  \nTIFF: Bitmapped line drawings: use a minimum of 1000 dpi.  \nTIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is \nrequired.  \nIf your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) \nthen please supply 'as is'.  \n \nPlease do not: \n\u2022 Supply files that are optimised for screen use (e.g., GIF, BMP, PICT, WPG); the resolution is too \nlow;  \n\u2022 Supply files that are too low in resolution;  \n\u2022 Submit graphics that are disproportionately large for the content. \nColor artwork \nPlease make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and \nwith the correct resolution. If, together with your accepted article, you submit usable color figures \nthen Elsevier will ensure, at no additional charge, that these figures will appear in color on the Web \n(e.g., ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced \nin color in the printed version. For color reproduction in print, you will receive information \nregarding the costs from Elsevier after receipt of your accepted article. Please indicate your \npreference for color: in print or on the Web only. For \nfurther information on the preparation of electronic artwork, please see \nhttp://www.elsevier.com/artworkinstructions.  \n\n\n\n88 \n\n \n\nPlease note: Because of technical complications which can arise by converting color figures to 'gray \nscale' (for the printed version should you not opt for color in print) please submit in addition usable \nblack and white versions of all the color illustrations. \n \n\nFigure captions \nEnsure that each illustration has a caption. Supply captions separately, not attached to the figure. A \ncaption should comprise a brief title (not on the figure itself) and a description of the illustration. \nKeep text in the illustrations themselves to a minimum but explain all symbols and abbreviations \nused. \n \nTables \nNumber tables consecutively in accordance with their appearance in the text. Place footnotes to \ntables below the table body and indicate them with superscript lowercase letters. Avoid vertical \nrules. Be sparing in the use of tables and ensure that the data presented in tables do not duplicate \nresults described elsewhere in the article. \n \n\nBiographies and photographs \nAuthors of reviews and tutorials will be required to upload a colour image and short biography of \neach individual author. Biographies should contain 2 to 3 sentences (max 100 words) indicating \nauthors' present affiliation, number of publications, awards, current research interests and website if \navailable. \n \nReferences \nCitation in text \nPlease ensure that every reference cited in the text is also present in the reference list (and vice \nversa). Any references cited in the abstract must be given in full. Unpublished results and personal \ncommunications are not recommended in the reference list, but may be mentioned in the text. If \nthese references are included in the reference list they should follow the standard reference style of \nthe journal and should include a substitution of the publication date with either 'Unpublished results' \nor 'Personal communication'. Citation of a reference as 'in press' implies that the item has been \naccepted for publication. \nWeb references \nAs a minimum, the full URL should be given and the date when the reference was last accessed. \nAny further information, if known (DOI, author names, dates, reference to a source publication, \netc.), should also be given. Web references can be listed separately (e.g., after the reference list) \nunder a different heading if desired, or can be included in the reference list. \nReferences in a special issue \nPlease ensure that the words 'this issue' are added to any references in the list (and any citations in \nthe text) to other articles in the same Special Issue. \nReference management software \nThis journal has standard templates available in key reference management packages EndNote \n(http://www.endnote.com/support/enstyles.asp) and Reference Manager \n(http://refman.com/support/rmstyles.asp). Using plug-ins to wordprocessing packages, authors only \nneed to select the appropriate journal template when preparing their article and the list of references \nand citations to \nthese will be formatted according to the journal style which is described below. \n \nReference style \nText: Indicate references by number(s) in square brackets in line with the text. The actual \nauthorscan be referred to, but the reference number(s) must always be given.  \n\n\n\n89 \n\n \n\nExample: '..... as demonstrated [3,6]. Barnaby and Jones [8] obtained a different result ....'  \nList: Number the references (numbers in square brackets) in the list in the order in which they \nappear in the text.  \nExamples: \nReference to a journal publication:  \n[1] J. van der Geer, J.A.J. Hanraads, R.A. Lupton, J. Sci. Commun. 163 (2010) 51\u201359.  \nReference to a book:  \n[2] W. Strunk Jr., E.B. White, The Elements of Style, fourth ed., Longman, New York, 2000.  \nReference to a chapter in an edited book:  \n[3] G.R. Mettam, L.B. Adams, in: B.S. Jones, R.Z. Smith (Eds.), Introduction to the Electronic Age, \nE-Publishing, Inc. New York, 2009, pp. 281\u2013304. \n \nJournal abbreviations source \nJournal names should be abbreviated according to  \nIndex Medicus journal abbreviations: http://www.nlm.nih.gov/tsd/serials/lji.html;  \nList of title word abbreviations: http://www.issn.org/2-22661-LTWA-online.php;  \nCAS (Chemical Abstracts Service): http://www.cas.org/sent.html. \n \nVideo data \nElsevier accepts video material and animation sequences to support and enhance your scientific \nresearch. Authors who have video or animation files that they wish to submit with their article are \nstrongly encouraged to include these within the body of the article. This can be done in the same \nway as a figure or table by referring to the video or animation content and noting in the body text \nwhere it should be placed. All submitted files should be properly labeled so that they directly relate \nto the video file's content. In order to ensure that your video or animation material is directly usable, \nplease provide the files in one of our recommended file formats with a preferred maximum size of \n50 MB. Video and animation files supplied will be published online in the electronic version of \nyour article in Elsevier Web products, including ScienceDirect: http://www.sciencedirect.com. \nPlease supply 'stills' with your files: you can choose any frame from the video or animation or make \na separate image. These will be used instead of standard icons and will personalize the link to your \nvideo data. For more detailed instructions please visit our video instruction pages at \nhttp://www.elsevier.com/artworkinstructions. Note: since video and animation cannot be embedded \nin the print version of the journal, please provide text for both the electronic and the print version \nfor the portions of the article that refer to this content. \n \nSupplementary data \nElsevier accepts electronic supplementary material to support and enhance your scientific research. \nSupplementary files offer the author additional possibilities to publish supporting applications, \nhigh-resolution images, background datasets, sound clips and more. Supplementary files supplied \nwill be published online alongside the electronic version of your article in Elsevier Web products, \nincluding ScienceDirect: http://www.sciencedirect.com. In order to ensure that your submitted \nmaterial is directly usable, please provide the data in one of our recommended file formats. Authors \nshould submit the material in electronic format together with the article and supply a concise and \ndescriptive caption for each file. For more detailed instructions please visit our artwork instruction \npages at http://www.elsevier.com/artworkinstructions. \n \nData at PANGAEA \nElectronic archiving of supplementary data enables readers to replicate, verify and build upon the \nconclusions published in your paper. We recommend that data should be deposited in the data \nlibrary PANGAEA (http://www.pangaea.de). Data are quality controlled and archived by an editor \nin standard machine-readable formats and are available via Open Access. After processing, the \nauthor receives an identifier (DOI) linking to the supplements for checking. As your data sets will \n\n\n\n90 \n\n \n\nbe citable you might want to refer to them in your article. In any case, data supplements and the \narticle will be automatically linked as in the following example: doi:10.1016/0016-7037(95)00105-\n9. Please use PANGAEA's web interface to submit your data (http://www.pangaea.de/submit/). \nSubmission checklist \nThe following list will be useful during the final checking of an article prior to sending it to the \njournal for review. Please consult this Guide for Authors for further details of any item.  \n \nEnsure that the following items are present: \nOne author has been designated as the corresponding author with contact details:  \n\u2022 E-mail address  \n\u2022 Full postal address  \n\u2022 Telephone and fax numbers  \nAll necessary files have been uploaded, and contain:  \n\u2022 Keywords  \n\u2022 All figure captions  \n\u2022 All tables (including title, description, footnotes)  \nFurther considerations  \n\u2022 Manuscript has been 'spell-checked' and 'grammar-checked'  \n\u2022 References are in the correct format for this journal  \n\u2022 All references mentioned in the Reference list are cited in the text, and vice versa  \n\u2022 Permission has been obtained for use of copyrighted material from other sources (including the \nWeb)  \n\u2022 Color figures are clearly marked as being intended for color reproduction on the Web (free of \ncharge) and in print, or to be reproduced in color on the Web (free of charge) and in black-and-\nwhite in print  \n\u2022 If only color on the Web is required, black-and-white versions of the figures are also supplied for \nprinting purposes  \nFor any further information please visit our customer support site at http://support.elsevier.com. \n\u2022 Ensure that line numbering and double spacing are added to the manuscript. \n \nAdditional information \nComputer programs Algorithms should be described clearly and concisely by means of a suitable \nalgorithmic notation, although a standard high-level programming language may also be used. \nComplete program listings are not normally admissible. Flow charts should be avoided in favour of \na textual or tabulated description of the program or data flow. Statements on the portability of the \nsoftware described to other computer systems, as well as on its availability to interested readers, \nshould be given. \n \nAfter acceptance \nUse of the Digital Object Identifier \nThe Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI \nconsists of a unique alpha-numeric character string which is assigned to a document by the \npublisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is \nan ideal medium for citing a document, particularly 'Articles in press' because they have not yet \nreceived their full bibliographic information. Example of a correctly given DOI (in URL format; \nhere an article in the journal Physics Letters B): http://dx.doi.org/10.1016/j.physletb.2010.09.059 \nWhen you use a DOI to create links to documents on the web, the DOIs are guaranteed never to \nchange. \n \nProofs \nOne set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do \nnot have an e-mail address then paper proofs will be sent by post) or, a link will be provided in the \n\n\n\n91 \n\n \n\ne-mail so that authors can download the files themselves. Elsevier now provides authors with PDF \nproofs which can be annotated; for this you will need to download Adobe Reader version 7 (or \nhigher) available free from http://get.adobe.com/reader. Instructions on how to annotate PDF files \nwill accompany the proofs (also given online). The exact system requirements are given at the \nAdobe site: http://www.adobe.com/products/reader/tech-specs.html. If you do not wish to use the \nPDF annotations function, you may list the corrections (including replies to the Query Form) and \nreturn them to Elsevier in an e-mail. Please list your corrections quoting line number. If, for any \nreason, this is not possible, then mark the corrections and any other comments (including replies to \nthe Query Form) on a printout of your proof and return by fax, or scan the pages and e-mail, or by \npost. Please use this proof only for checking the typesetting, editing, completeness and correctness \nof the text, tables and figures. Significant changes to the article as accepted for publication will only \nbe considered at this stage with permission from the Editor. We will do everything possible to get \nyour article published quickly and accurately \u2013 please let us have all your corrections within 48 \nhours. It is important to ensure that all corrections are sent back to us in one communication: please \ncheck carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. \nProofreading is solely your responsibility. Note that Elsevier may proceed with the publication of \nyour article if no response is received. \n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n92 \n\n \n\n \n\n_______________________________________________________________________________ \n\nPreparation \nUse of wordprocessing software \nIt is important that the file be saved in the native format of the wordprocessor used. The text should \nbe in single-column format. Keep the layout of the text as simple as possible. Most formatting codes \nwill be removed and replaced on processing the article. In particular, do not use the wordprocessor's \noptions to justify text or to hyphenate words. However, do use bold face, italics, subscripts, \nsuperscripts etc. When preparing tables, if you are using a table grid, use only one grid for each \nindividual table and not a grid for each row. If no grid is used, use tabs, not spaces, to align \ncolumns. The electronic text should be prepared in a way very similar to that of conventional \nmanuscripts (see also the Guide to Publishing with Elsevier: \nhttp://www.elsevier.com/guidepublication). Note that source files of figures, tables and text \ngraphics will be required whether or not you embed your figures in the text. See also the section on \nElectronic artwork.  \nTo avoid unnecessary errors you are strongly advised to use the 'spell-check' and 'grammar-check' \nfunctions of your wordprocessor. \n \nArticle structure \nFollow this order when typing manuscripts: Title, Authors, Affiliations, Abstract, Keywords, Main \ntext, Acknowledgements, Appendix, References, Figure Captions and then Tables.  \nAuthors should consult a recent issue of the journal for style if possible. The Editors reserve the \nright to adjust style to certain standards of uniformity.  \nThe use of property names should be avoided as far as possible, but may be acceptable where, in the \nEditors opinion, the proprietary name is a universally known description of the material in question, \neg Kevlar-49. \nText Layout \nUse double spacing and wide (3 cm) margins. (Avoid full justification, i.e., do not use a constant \nright-hand margin.) Ensure that each new paragraph is clearly indicated. Present tables and figure \nlegends on separate pages at the end of the manuscript. If possible, consult a recent issue of the \njournal to become familiar with layout and conventions. Number all pages consecutively, use 12 pt \nfont size and standard fonts. \nSubdivision - numbered sections \nDivide your article into clearly defined and numbered sections. Subsections should be numbered 1.1 \n(then 1.1.1, 1.1.2, ...), 1.2, etc. (the abstract is not included in section numbering). Use this \nnumbering also for internal cross-referencing: do not just refer to 'the text'. Any subsection may be \ngiven a brief heading. Each heading should appear on its own separate line. \nIntroduction \nState the objectives of the work and provide an adequate background, avoiding a detailed literature \nsurvey or a summary of the results. \nMaterial and methods \nProvide sufficient detail to allow the work to be reproduced. Methods already published should be \nindicated by a reference: only relevant modifications should be described. \nResults \nResults should be clear and concise. \nDiscussion \nThis should explore the significance of the results of the work, not repeat them. A combined Results \nand Discussion section is often appropriate. Avoid extensive citations and discussion of published \n\n\n\n93 \n\n \n\nliterature. \nConclusions \nThe main conclusions of the study may be presented in a short Conclusions section, which may \nstand alone or \nform a subsection of a Discussion or Results and Discussion section. \nAppendices \nIf there is more than one appendix, they should be identified as A, B, etc. Formulae and equations in \nappendices should be given separate numbering: Eq. (A.1), Eq. (A.2), etc.; in a subsequent \nappendix, Eq. (B.1) and so on. Similarly for tables and figures: Table A.1; Fig. A.1, etc. \nEssential title page information \n\u2022 Title. Concise and informative. Titles are often used in information-retrieval systems. Avoid \nabbreviations and formulae where possible. \n\u2022 Author names and affiliations. Where the family name may be ambiguous (e.g., a double name), \nplease indicate this clearly. Present the authors' affiliation addresses (where the actual work was \ndone) below the names. Indicate all affiliations with a lower-case superscript letter immediately \nafter the author's name and in front of the appropriate address. Provide the full postal address of \neach affiliation, including the country name and, if available, the e-mail address of each author. \n\u2022 Corresponding author. Clearly indicate who will handle correspondence at all stages of \nrefereeing and publication, also post-publication. Ensure that telephone and fax numbers (with \ncountry and area code) are provided in addition to the e-mail address and the complete postal \naddress. Contact details must be kept up to date by the corresponding author. \n\u2022 Present/permanent address. If an author has moved since the work described in the article was \ndone, or was visiting at the time, a 'Present address' (or 'Permanent address') may be indicated as a \nfootnote to that author's name. The address at which the author actually did the work must be \nretained as the main, affiliation address. Superscript Arabic numerals are used for such footnotes. \n \nAbstract \nA concise and factual abstract is required. The abstract should state briefly the purpose of the \nresearch, the principal results and major conclusions. An abstract is often presented separately from \nthe article, so it must be able to stand alone. For this reason, References should be avoided, but if \nessential, then cite the author(s) and year(s). Also, non-standard or uncommon abbreviations should \nbe avoided, but if essential they must be defined at their first mention in the abstract itself. \n \nKeywords \nAuthors should select a maximum of five keywords from the list at the end of these instructions. \nEach Keyword should be accompanied by the capital letter denoting the category from which the \nkeyword has been selected. If authors wish they may nominate one keyword which is not included \nin the list below. The list of up to five keywords should appear on the title page of each paper \nsubmitted for consideration, following the abstract. \n \nAbbreviations \nDefine abbreviations that are not standard in this field in a footnote to be placed on the first page of \nthe article. Such abbreviations that are unavoidable in the abstract must be defined at their first \nmention there, as well as in the footnote. Ensure consistency of abbreviations throughout the article. \nAbbreviations for units should follow the suggestions of the British Standards publication BS 1991. \nThe full stop should not be included in abbreviations, eg m (not m.), ppm (not p.p.m.): '%' and '/' \nshould be used in preference to 'per cent' and 'per'. Where abbreviations are likely to cause \nambiguity or not be readily understood by an international readership, units should be given in full. \n \nAcknowledgements \nCollate acknowledgements in a separate section at the end of the article before the references and do \nnot, therefore, include them on the title page, as a footnote to the title or otherwise. List here those \n\n\n\n94 \n\n \n\nindividuals who provided help during the research (e.g., providing language help, writing assistance \nor proof reading the article, etc.). \n \nUnits \nFollow internationally accepted rules and conventions: use the international system of units (SI). If \nother units are mentioned, please give their equivalent in SI. \n \nNomenclature and units \nFollow internationally accepted rules and conventions: use the international system of units (SI). If \nother quantities are mentioned, give their equivalent in SI. You are urged to consult IUPAC: \nNomenclature of Organic Chemistry: http://www.iupac.org/ for further information. \n \nMath formulae \nPresent simple formulae in the line of normal text where possible and use the solidus (/) instead of a \nhorizontal line for small fractional terms, e.g., X/Y. In principle, variables are to be presented in \nitalics. Powers of e are often more conveniently denoted by exp. Number consecutively any \nequations that have to be displayed separately from the text (if referred to explicitly in the text). \n \nFootnotes \nFootnotes should be used sparingly. Number them consecutively throughout the article, using \nsuperscript Arabic numbers. Many wordprocessors build footnotes into the text, and this feature \nmay be used. Should this not be the case, indicate the position of footnotes in the text and present \nthe footnotes themselves separately at the end of the article. Do not include footnotes in the \nReference list.  \nTable footnotes \nIndicate each footnote in a table with a superscript lowercase letter. \n \nArtwork \nElectronic artwork \nGeneral points \n\u2022 Make sure you use uniform lettering and sizing of your original artwork.  \n\u2022 Save text in illustrations as 'graphics' or enclose the font.  \n\u2022 Only use the following fonts in your illustrations: Arial, Courier, Times, Symbol.  \n\u2022 Number the illustrations according to their sequence in the text.  \n\u2022 Use a logical naming convention for your artwork files.  \n\u2022 Provide captions to illustrations separately.  \n\u2022 Produce images near to the desired size of the printed version.  \n\u2022 Submit each figure as a separate file.  \nA detailed guide on electronic artwork is available on our website:  \nhttp://www.elsevier.com/artworkinstructions \n \nYou are urged to visit this site; some excerpts from the detailed information are given here. \nFormats \nRegardless of the application used, when your electronic artwork is finalised, please 'save as' or \nconvert the images to one of the following formats (note the resolution requirements for line \ndrawings, halftones, and line/halftone combinations given below):  \nEPS: Vector drawings. Embed the font or save the text as 'graphics'.  \nTIFF: Color or grayscale photographs (halftones): always use a minimum of 300 dpi.  \nTIFF: Bitmapped line drawings: use a minimum of 1000 dpi.  \nTIFF: Combinations bitmapped line/half-tone (color or grayscale): a minimum of 500 dpi is \nrequired.  \n\n\n\n95 \n\n \n\nIf your electronic artwork is created in a Microsoft Office application (Word, PowerPoint, Excel) \nthen please \nsupply 'as is'.  \nPlease do not: \n\u2022 Supply files that are optimised for screen use (e.g., GIF, BMP, PICT, WPG); the resolution is too \nlow;  \n\u2022 Supply files that are too low in resolution;  \n\u2022 Submit graphics that are disproportionately large for the content. \nColor artwork \nPlease make sure that artwork files are in an acceptable format (TIFF, EPS or MS Office files) and \nwith the correct resolution. If, together with your accepted article, you submit usable color figures \nthen Elsevier will ensure, at no additional charge, that these figures will appear in color on the Web \n(e.g., ScienceDirect and other sites) regardless of whether or not these illustrations are reproduced \nin color in the printed version. For color reproduction in print, you will receive information \nregarding the costs from Elsevier after receipt of your accepted article. Please indicate your \npreference for color: in print or on the Web only. For further information on the preparation of \nelectronic artwork, please see \nhttp://www.elsevier.com/artworkinstructions.  \nPlease note: Because of technical complications which can arise by converting color figures to 'gray \nscale' (for the printed version should you not opt for color in print) please submit in addition usable \nblack and white versions of all the color illustrations. \n \nFigure captions \nEnsure that each illustration has a caption. Supply captions separately, not attached to the figure. A \ncaption should comprise a brief title (not on the figure itself) and a description of the illustration. \nKeep text in the illustrations themselves to a minimum but explain all symbols and abbreviations \nused. \n \nText graphics \nText graphics may be embedded in the text at the appropriate position. If you are working with \nLaTeX and have such features embedded in the text, these can be left. Further, high-resolution \ngraphics files must be provided separately whether or not the graphics are embedded. See further \nunder Electronic artwork. \n \nTables \nNumber tables consecutively in accordance with their appearance in the text. Place footnotes to \ntables below the table body and indicate them with superscript lowercase letters. Avoid vertical \nrules. Be sparing in the use of tables and ensure that the data presented in tables do not duplicate \nresults described elsewhere in the article. \n \nReferences \nCitation in text \nPlease ensure that every reference cited in the text is also present in the reference list (and vice \nversa). Any references cited in the abstract must be given in full. Unpublished results and personal \ncommunications are not recommended in the reference list, but may be mentioned in the text. If \nthese references are included in the reference list they should follow the standard reference style of \nthe journal and should include a substitution of the publication date with either 'Unpublished results' \nor 'Personal communication'. Citation of a reference as 'in press' implies that the item has been \naccepted for publication. \nWeb references \nAs a minimum, the full URL should be given and the date when the reference was last accessed. \nAny further information, if known (DOI, author names, dates, reference to a source publication, \n\n\n\n96 \n\n \n\netc.), should also be given. Web references can be listed separately (e.g., after the reference list) \nunder a different heading if desired, or can be included in the reference list. \n \nReferences in a special issue \nPlease ensure that the words 'this issue' are added to any references in the list (and any citations in \nthe text) to other articles in the same Special Issue. \n \nReference management software \nThis journal has standard templates available in key reference management packages EndNote \n(http://www.endnote.com/support/enstyles.asp) and Reference Manager \n(http://refman.com/support/rmstyles.asp). Using plug-ins to wordprocessing packages, authors only \nneed to select the appropriate journal template when preparing their article and the list of references \nand citations to these will be formatted according to the journal style which is described below. \n \nReference style \nAll publications cited in the text should be presented in a list of references following the text of the \nmanuscript. In the text refer to references by a number in square brackets on the line (e.g. Since Wu \n[1]), and the full reference should be given in a numerical list at the end of the paper. \n \nSubmission checklist \nThe following list will be useful during the final checking of an article prior to sending it to the \njournal for review. Please consult this Guide for Authors for further details of any item.  \nEnsure that the following items are present: \nOne author has been designated as the corresponding author with contact details:  \n\u2022 E-mail address  \n\u2022 Full postal address  \n\u2022 Telephone and fax numbers  \nAll necessary files have been uploaded, and contain:  \n\u2022 Keywords  \n\u2022 All figure captions  \n\u2022 All tables (including title, description, footnotes)  \nFurther considerations  \n\u2022 Manuscript has been 'spell-checked' and 'grammar-checked'  \n\u2022 References are in the correct format for this journal  \n\u2022 All references mentioned in the Reference list are cited in the text, and vice versa  \n\u2022 Permission has been obtained for use of copyrighted material from other sources (including the \nWeb)  \n\u2022 Color figures are clearly marked as being intended for color reproduction on the Web (free of \ncharge) and in print, or to be reproduced in color on the Web (free of charge) and in black-and-\nwhite in print  \n\u2022 If only color on the Web is required, black-and-white versions of the figures are also supplied for \nprinting purposes  \nFor any further information please visit our customer support site at http://support.elsevier.com. \n \nAfter acceptance \nUse of the Digital Object Identifier \nThe Digital Object Identifier (DOI) may be used to cite and link to electronic documents. The DOI \nconsists of a unique alpha-numeric character string which is assigned to a document by the \npublisher upon the initial electronic publication. The assigned DOI never changes. Therefore, it is \nan ideal medium for citing a document, particularly 'Articles in press' because they have not yet \nreceived their full bibliographic information. Example of a correctly given DOI (in URL format; \nhere an article in the journal Physics Letters B): \n\n\n\n97 \n\n \n\nhttp://dx.doi.org/10.1016/j.physletb.2010.09.059 \nWhen you use a DOI to create links to documents on the web, the DOIs are guaranteed never to \nchange. \n \nProofs \nOne set of page proofs (as PDF files) will be sent by e-mail to the corresponding author (if we do \nnot have an e-mail address then paper proofs will be sent by post) or, a link will be provided in the \ne-mail so that authors can download the files themselves. Elsevier now provides authors with PDF \nproofs which can be annotated; for this you will need to download Adobe Reader version 7 (or \nhigher) available free from http://get.adobe.com/reader. Instructions on how to annotate PDF files \nwill accompany the proofs (also given online). The exact system requirements are given at the \nAdobe site:  http://www.adobe.com/products/reader/tech-specs.html.  \nIf you do not wish to use the PDF annotations function, you may list the corrections (including \nreplies to the Query Form) and return them to Elsevier in an e-mail. Please list your corrections \nquoting line number. If, for any reason, this is not possible, then mark the corrections and any other \ncomments (including replies to the Query Form) on a printout of your proof and return by fax, or \nscan the pages and e-mail, or by post. Please use this proof only for checking the typesetting, \nediting, completeness and correctness of the text, tables and figures. Significant changes to the \narticle as accepted for publication will only be considered at this stage with permission from the \nEditor. We will do everything possible to get your article published quickly and accurately \u2013 please \nlet us have all your corrections within 48 hours. It is important to ensure that all corrections are sent \nback to us in one communication: please check carefully before replying, as inclusion of any \nsubsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that \nElsevier may proceed with the publication of your article if no response is received. \n \nOffprints \nThe corresponding author, at no cost, will be provided with a PDF file of the article via e-mail. For \nan extra charge, paper offprints can be ordered via the offprint order form which is sent once the \narticle is accepted for publication. The PDF file is a watermarked version of the published article \nand includes a cover sheet with the journal cover image and a disclaimer outlining the terms and \nconditions of use. \n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n98 \n\n \n\n \n\n_______________________________________________________________________________ \n\nGuide for Authors  \n \nSubmission of papers  \nAuthors are encouraged to submit their papers using the Journal of Magnetism and Magnetic \nMaterials online submission tool. Alternatively authors can submit by sending their manuscripts \n(one original + two copies), to one of the Editors. Papers for the section Information Storage: Basic \nand Applied should be submitted to R.W. Chantrell. Letters to the Editor should not exceed six \npages when printed and will be given priority in both the refereeing and production processes. The \nfaster production schedule may preclude sending proofs of letters to authors. Original material: \nSubmission of a manuscript implies it is not being simultaneously considered for publication \nelsewhere and that the authors have obtained the necessary authority for publication. \n \nManuscript preparation  \nAll manuscripts should be written in good English. The paper copies of the text should be prepared \nwith double line spacing and wide margins, on numbered sheets. See notes opposite on the \nelectronic version of manuscripts. Structure. Please adhere to the following order of presentation: \nArticle title, Author(s), Affiliation(s), Abstract, PACS codes and keywords, Main text, \nAcknowledgements, Appendices, References, Figure captions, Tables.Corresponding author. The \nname, complete postal address, telephone and fax numbers and the e-mail address of the \ncorresponding author should be given on the first page of the manuscript. PACS codes/keywords. \nPlease supply one or more relevant PACS-1996 classification codes and about 5 keywords of your \nown choice for indexing purposes. References. References to other work should be consecutively \nnumbered in the text using square brackets and listed by number in the Reference list. Please refer \nto recent issues for examples. \n \nIllustrations  \nIllustrations should also be submitted in triplicate: one master set and two sets of copies. Theline \ndrawings in the master set should be original laser printer or plotter output or drawn in black india \nink, with careful lettering ,large enough (3-5 mm) to remain legible after reduction for printing.The \nphotographs should be originals, with somewhat more contrast than is required in the printed \nversion. They should be unmounted unless part of a composite figure. Any scale markers should be \ninserted on the photograph itself, not drawn below it. Colour plates. Figures may be published in \ncolour, if this is judged essential by the Editor. The Publisher and the author will each bear part of \nthe extra costs involved. Further information is available from the Publisher. \n \nAfter acceptance  \nNotification. You will be notified by the Editor of the journal of the acceptance of your article and \ninvited to supply an electronic version of the accepted text, if this is not already available. \nCopyright transfer. In the course of the production process you will be asked to transfer the \ncopyright of the article to the Publisher. This transfer will ensure the widest possible dissemination \nof information. \n \nElectronic manuscripts  \nThe Publisher heartily welcomes the receipt of an electronic version of your accepted manuscript. If \nthere is not already a copy of this (on diskette) with the Journal Editor at the time the manuscript is \nbeing refereed, you will be asked to send a file with the text of the accepted manuscript directly to \n\n\n\n99 \n\n \n\nthe Publisher by e-mail or on diskette to the address given below. (When e-mailing a non-ASCII \nword-processor file, you should encode it, e.g. with Uuencode or BinHex, so as to retain all \nformatting codes.) The name and version of the word-processing program and the type of operating \nsystem should always be indicated. Please note that no deviations from the version accepted by the \nEditor of the journal are permissible without the prior and explicit approval by the Editor. Such \nchanges should be clearly indicated on an accompanying printout of the file. \n \nAuthor benefits  \nNo page charges. Publishing in the Journal of Magnetism and Magnetic Materials is free. Free \noffprints. The corresponding author will receive 25 offprints free of charge. An offprint order form \nwill be supplied by the Publisher for ordering any additional paid offprints. Discount. Contributors \nto Elsevier journals are entitled to a 30% discount on all Elsevier books. \n \n \n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n100 \n\n \n\n7.2.  Comprova\u00e7\u00e3o da submiss\u00e3o dos artigos \n \n7.2.1. Artigo submetido ao peri\u00f3dico Analytica Chimica Acta \n \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n101 \n\n \n\n7.2.2. Artigo submetido ao peri\u00f3dico Composites Science and Technology \n \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n102 \n\n \n\n7.3. Artigos publicados em peri\u00f3dicos \n \nANGELI, R.; DA PAZ, N.V.N.; MACIEL, J.C.; ARA\u00daJO, F.F.B.; PAIVA, P.M.G.; CALAZANS, \nG.M.T.; VALENTE, A.P.; ALMEIDA, F.C.L.; COELHO, L.C.B.B.; CARVALHO, L.B.; SILVA, \nM.P.C.; CORREIA, M.T.S. Ferromagnetic Levan Composite: An Affinity Matrix to Purify Lectin. \nJournal of Biomedicine and Biotechnology, 2009, 1-7, 2009. \n \nMACIEL, J.C.; ANDRADE, P.L.; NERI, D.F.M.; CARVALHO Jr, L.B.; CARDOSO, C. A.; \nCALAZANS, G.M.T.; AGUIAR, J. ALBINO; SILVA, M.P.C. Preparation and characterization of \nmagnetic levan particles as matrix for trypsin immobilization. Journal of Magnetism and Magnetic \nMaterials, 324, 1312-1316, 2012. \n \n7.4. Artigos a serem submetidos \n \nInvestigation of the molecular weight influence of levans from Zymomonas mobilis in the \nproduction of magnetic levan particles  \nJackeline C. Maciel, Mariana P. Cabrera, Cl\u00e1udio A. Cardoso, David F.M. Neri, Maria da Paz C. \nSilva, Luiz B. Carvalho Jr. \nPeri\u00f3dico: Carbohydrate Polymers FI: 3.628 \n\n \nProperties of immobilized trypsin on magnetic levan particles \nJackeline C. Maciel, Ian P.G. Amaral, Givanildo B. Oliveira, Gl\u00edcia M.T. Calazans, Lu\u00edz B. \nCarvalho Jr., Maria da Paz C. Silva \nPeri\u00f3dico: Applied Catalysis A: General FI: 3.903 \n \n\n \n7.5. Trabalhos apresentados em congressos \n \nMACIEL, J.C.; ANDRADE, P.L.; CALAZANS, G.M.T.; CARDOSO, C.A.; AGUIAR, J.A.; \nSILVA, M.P.C. Synthesis and characterization of levan-coated magnetite particles. In: \nInternational Conference on Science and Technology of synthetic metals, 2008, Porto de \nGalinhas.  \n \nANDRADE, P.L.; MACIEL, J.C.; SILVA, V.A.J.; CALAZANS, G.M.T.; SILVA, M.P.C.; \nAGUIAR, J.A. Synthesis and structural studies of polysaccharides coated magnetite particles. In: II \nSimp\u00f3sio Nacional em Diagn\u00f3stico e Terap\u00eautica Experimental, V Jornada Cient\u00edfica do LIKA e \nII F\u00f3rum Brasileiro de Gen\u00e9tica em Neuropsiquiatria, 2009, Recife. \n \nANDRADE, P.L.; SILVA, V.A.J.; MACIEL, J.C.; CALAZANS, G.M.T.; SILVA, M.P.C.; \nAGUIAR, J.A. S\u00edntese e caracteriza\u00e7\u00e3o da magnetita revestida por levana e fucana como suporte \npara imobiliza\u00e7\u00e3o de enzimas. In: 32a Reuni\u00e3o Anual da Sociedade Brasileira de Qu\u00edmica, 2009, \nFortaleza.  \n \nSILVA, V.A.J.; ANDRADE, P.L.; MACIEL, J.C.; SOARES, M.T.C.V.; SILVA, M.P.C.; \nAGUIAR, J.A. S\u00edntese e caracteriza\u00e7\u00e3o de part\u00edculas de magnetita recobertas pelo polissacar\u00eddeo \nfucana. In: 32a Reuni\u00e3o Anual da Sociedade Brasileira de Qu\u00edmica, 2009, Fortaleza.  \n \nMACIEL, J. C.; SILVA, V.A.J.; ANDRADE, P.L.; AGUIAR, J.A.; NERI, D.F.M.; SILVA, \nM.P.C.; CARVALHO Jr, L.B. Magnetic iron particles coated with polyaniline (PANI). In: IX \nBrazilian MRS Meeting, 2010, Ouro Preto.  \n\n\n\n103 \n\n \n\nMACIEL, J. C.; ANDRADE, P.L.; CARVALHO JR, L.B.; CALAZANS, G.M.T.; AGUIAR, J.A.; \nSILVA, M.P.C. Preparation and characterization of levan magnetite particles. In: XXXIX Annual \nMeeting of the Brazilian Society of Biochemistry and Molecular Biology (SBBq), 2010, Foz do \nIgua\u00e7u.  \n \nANDRADE, P.L.; SILVA, V.A.J.; MACIEL, J.C.; SILVA, M.P.C.; AGUIAR, J.A. Study of fucan-\ncoated cobalt ferrite nanoparticles for immobilization of enzyme. In: III Simp\u00f3sio Internacional \nem Diagn\u00f3stico e Terap\u00eautica e VI Jornada Cient\u00edfica do LIKA, 2011, Recife.  \n \nMOURA, E.M.; MACIEL, J.C.; ANDRADE, P.L.; SILVA, V.A.J.; CARVALHO JR, L.B.; \nSILVA, M.P.C. Magnetic particles coated with PANI and Fucan for enzyme immobilization. In: III \nSimp\u00f3sio Internacional em Diagn\u00f3stico e Terap\u00eautica e VI Jornada Cient\u00edfica do LIKA, 2011, \nRecife.  \n \nMACIEL, J. C.; MOURA, E.M.; ANDRADE, P.L.; NERI, D.F.M.; AGUIAR, J.A.; SILVA, \nM.P.C.; CARVALHO JR, L.B. Preparation of magnetic microparticles magnetite coated with \npolyaniline. In: III Simp\u00f3sio Internacional em Diagn\u00f3stico e Terap\u00eautica e VI Jornada Cient\u00edfica \ndo LIKA, 2011, Recife. \n \nMACIEL, J.C.; MOURA, E.M.; ANDRADE, P.L.; SILVA, V.A.J.; AGUIAR, J.A.; SILVA, \nM.P.C.; CARVALHO Jr, L.B. Characterization of magnetic particles coated with polyaniline for \nenzyme immobilization. In: X Encontro da Sociedade Brasileira de Pesquisa em Materiais - \nSBPMat, 2011, Gramado.  \n \nMOURA, E.M.; MACIEL, J. C.; ANDRADE, P.L.; SILVA, V.A.J.; CARVALHO Jr, L.B.; SILVA, \nM.P.C. Magnetic particles coated with polymers for enzyme immobilization. In: X Encontro da \nSociedade Brasileira de Pesquisa em Materiais - SBPMat, 2011, Gramado.  \n \nSILVA, V.A.J.; ANDRADE, P.L.; MACIEL, J.C.; SILVA, M.P.C.; AGUIAR, J.A. \nCharacterization and application of magnetite-fucan nanoparticles. In: X Encontro da Sociedade \nBrasileira de Pesquisa em Materiais - SBPMat, 2011, Gramado.  \n \n \n7.6. Participa\u00e7\u00e3o em bancas examinadoras \n \nHelena Paula Oliveira do Nascimento. Imobiliza\u00e7\u00e3o de proteases coaguladoras do leite em \nquitosana magnetizada. 2008. Trabalho de Conclus\u00e3o de Curso (Gradua\u00e7\u00e3o em Biologia) \u2013  \nUniversidade Federal de Pernambuco. (Suplente). \n \nLarissa Parra de Ara\u00fajo. Monitoriza\u00e7\u00e3o terap\u00eautica de f\u00e1rmacos. 2009. Trabalho de Conclus\u00e3o de \nCurso (Gradua\u00e7\u00e3o em Farm\u00e1cia) \u2013 Universidade Federal de Pernambuco. (Titular).  \n \nAnna Carolina Araujo Ferreira da Silva. Protocolo quimioter\u00e1pico baseado em fluorouracil e \nleucovorin para tratamento de c\u00e2ncer colorretal: uma revis\u00e3o de suas varia\u00e7\u00f5es. 2010. Trabalho de \nConclus\u00e3o de Curso (Gradua\u00e7\u00e3o em Farm\u00e1cia) \u2013 Universidade Federal de Pernambuco. (Titular). \n \nS\u00edlvia Guedes Braga. Terra de diatom\u00e1ceas magn\u00e9tica revestida com polianilina para imobiliza\u00e7\u00e3o \nde invertase. 2011. Trabalho de Conclus\u00e3o de Curso (Gradua\u00e7\u00e3o em Biomedicina) \u2013 Universidade \nFederal de Pernambuco. (Titular). \n \n \n \n\n\n\n104 \n\n \n\n7.7. Orienta\u00e7\u00f5es e colabora\u00e7\u00f5es \n \nElaine Martins de Moura. Viabiliza\u00e7\u00e3o de part\u00edculas magn\u00e9ticas revestidas com pol\u00edmeros para a \nimobiliza\u00e7\u00e3o de enzimas. 2012. Disserta\u00e7\u00e3o (Mestrado em Bioqu\u00edmica e Fisiologia) \u2013 \nUniversidade Federal de Pernambuco. (Colaboradora).  \n \nAlbert Rocha de Oliveira. A import\u00e2ncia do diagn\u00f3stico precoce e do tratamento adequado para \ngestantes com s\u00edfilis. 2012. Trabalho de Conclus\u00e3o de Curso (Gradua\u00e7\u00e3o em Farm\u00e1cia) - \nUniversidade Federal de Pernambuco. (Orientadora)."}]}}}